IP/QB.10_NNP m.91.b_NN ._.
(_( NEW_NNP SERIES_NNP )_) No:52A_NNP SCIENTIFIC_NNP MEMOIRS_NNP BY_NNP OFFICERS_NNP OF_IN THE_NNP MEDICAL_NNP AND_NNP SANITARY_NNP DEPARTMENTS_NNP OF_IN THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP THE_NNP PHYSIOLOGICAL_NNP ACTION_NNP OF_NNP CERTAIN_NNP DRUGS_NNP IN_NNP TABLET_NNP FORM_NNP BY_NNP MAJOR_NNP H._NNP M._NNP MACKENZIE_NNP ,_, I.M.S._NNP (_( Edited_VBN by_IN the_DT Director-General_NNP ,_, I.M.S._NNP )_) ISSUED_NNP UNDER_NNP THE_NNP AUTHORITY_NNP OF_IN THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP BY_NNP THE_NNP SANITARY_NNP COMMISSIONER_NNP WITH_NNP THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP ,_, SIMLA_NNP [_NNP NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062149.tif_CD ]_NNS CALCUTTA_NNP SUPERINTENDENT_NNP GOVERNMENT_NNP PRINTING_NNP ,_, INDIA_NNP ._.
1912_CD Price_NNP Rs_NNP ._.
3-8_CD or_CC 5s_CD ._.
3d_CD ,_, M_NNP 91_CD b_NN No_NNP ,_, 52A_CD ._.
(_( NEW_NNP SERIES_NNP )_) SCIENTIFIC_NNP MEMOIRS_NNP BY_NNP OFFICERS_NNP OF_IN THE_NNP MEDICAL_NNP AND_NNP SANITARY_NNP DEPARTMENTS_NNP OF_IN THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP THE_NNP PHYSIOLOGICAL_NNP ACTION_NNP OF_NNP CERTAIN_NNP DRUGS_NNP IN_NNP TABLET_NNP FORM_NNP BY_NNP MAJOR_NNP H._NNP M._NNP MACKENZIE_NNP ,_, I.M.S._NNP (_( Edited_VBN by_IN the_DT Director-General_NNP ,_, I.M.S._NNP )_) ISSUED_NNP UNDER_NNP THE_NNP AUTHORITY_NNP OF_IN THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP BY_NNP THE_NNP SANITARY_NNP COMMISSIONER_NNP WITH_NNP THE_NNP GOVERNMENT_NNP OF_NNP INDIA_NNP ,_, SIMLA_NNP [_NNP NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062161.tif_CD ]_JJ [_NNP NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062161.tif_CD ]_NNS CALCUTTA_NNP SUPERINTENDENT_NNP GOVERNMENT_NNP PRINTING_NNP ,_, INDIA_NNP 1912_CD Agents_NNP for_IN the_DT Sale_NNP of_IN Books_NNP published_VBN by_IN the_DT Superintendent_NNP of_IN Government_NNP Printing_NNP ,_, India_NNP ,_, Calcutta_NNP ._.
IN_NNP ENGLAND_NNP ._.
Messrs._NNP CONSTABLE_NNP &_CC Co._NNP ,_, 10_CD ,_, Orange_NNP Street_NNP ,_, Leicester_NNP Square_NNP ,_, W._NNP C._NNP Messrs._NNP KEGAN_NNP PAUL_NNP ,_, TRENCH_NNP ,_, TRÃœBNER_NNP &_CC Co._NNP ,_, 68-74_NNP ,_, Carter_NNP Lane_NNP ,_, E._NNP C._NNP Mr._NNP BERNARD_NNP QUARITCH_NNP ,_, 11_CD ,_, Grafton_NNP Street_NNP ,_, New_NNP Bond_NNP Street_NNP ,_, W._NNP Messrs._NNP P._NNP S._NNP KING_NNP &_CC SON_NNP ,_, 2_CD and_CC 4_CD ,_, Great_NNP Smith_NNP Street_NNP ,_, Westminster_NNP ._.
Messrs._NNP H._NNP S._NNP KING_NNP &_CC Co._NNP ,_, 65_CD ,_, Cornhill_NNP ,_, and_CC 9_CD ,_, Pall_NNP Mall_NNP ,_, London_NNP ._.
Messrs._NNP GRINDLAY_NNP &_CC Co._NNP ,_, 54_CD ,_, Parliament_NNP Street_NNP ,_, London_NNP ,_, S.W_NNP ._.
Mr._NNP T._NNP FISHER_NNP UNWIN_NNP ,_, 1_CD ,_, ADELPHI_NNP TERRACE_NNP ,_, LONDON_NNP ,_, W._NNP C._NNP Messrs._NNP W._NNP THACKER_NNP &_CC Co._NNP ,_, 2_CD ,_, Creed_NNP Lane_NNP ,_, London_NNP ,_, E._NNP C._NNP Mr._NNP B._NNP H._NNP BLACKWELL_NNP ,_, 50_CD and_CC 51_CD ,_, Broad_NNP Street_NNP ,_, Oxford_NNP ._.
Messrs._NNP DEIGHTON_NNP BELL_NNP &_CC Co._NNP ,_, Cambridge_NNP ._.
Messrs._NNP LUZAC_NNP &_CC Co._NNP ,_, 46_CD ,_, Great_NNP Russell_NNP Street_NNP ,_, London_NNP ,_, W._NNP C._NNP ON_NNP THE_NNP CONTINENT_NNP ._.
Mr._NNP OTTO_NNP HARRASOWITZ_NNP Mr._NNP KARL_NNP HIERSEMANN_NNP Leipzig_NNP ._.
Messrs._NNS R._NNP FRIEDLANDER_NNP &_CC SOHN_NNP ,_, Berlin_NNP ,_, W._NNP N._NNP ,_, Carlstrasse_NNP ,_, 11_CD ._.
Mr._NNP ERNEST_NNP LEROUX_NNP ,_, 28_CD ,_, Rue_NNP Bonaparte_NNP ,_, Paris_NNP ._.
Mr._NNP MARTINUS_NNP NIJHOFF_NNP ,_, The_DT Hague_NNP ,_, Holland_NNP ._.
IN_NNP INDIA_NNP ._.
Messrs._NN THACKER_NNP ,_, SPINK_NNP &_CC Co._NNP ,_, Calcutta_NNP and_CC Simla_NNP ._.
Messrs._NNP NEWMAN_NNP &_CC Co._NNP ,_, Calcutta_NNP ._.
Messrs._NNS R._NNP CAMBRAY_NNP &_CC Co._NNP ,_, Calcutta_NNP ._.
IN_NNP INDIAList_NNP of_IN numbers_NNS of_IN Scientific_NNP Memoirs_NNP by_IN Officers_NNP of_IN the_DT Medical_NNP and_CC Sanitary_NNP Departments_NNP of_IN the_DT Government_NNP of_IN India_NNP (_( New_NNP Series_NNP )_) published_VBD previous_JJ to_TO the_DT present_JJ issue_NN ._.
No_DT ._.
1_CD ._.
Standardisation_NN of_IN Calmette_NNP 's_POS Anti-Venomous_JJ Serum_NNP with_IN Pure_NNP Cobra_NNP Venom_NNP :_: the_DT Deterioration_NN of_IN this_DT Serum_NNP through_IN keeping_VBG in_IN India_NNP ,_, by_IN Captain_NNP G._NNP Lamb_NNP ,_, I.M.S._NNP ,_, and_CC Wm_NNP ._.
Hanna_NNP ,_, Esq._NNP ,_, M.B_NNP ._.
Price_NN As_IN ._.
3_CD or_CC 4d_CD ._.
No_DT ._.
2_CD ._.
Malaria_NNP in_IN India_NNP ,_, by_IN Captain_NNP S._NNP P._NNP James_NNP ,_, I.M.S._NNP Price_NNP Re_NNP ._.
1-8_CD or_CC 2s_CD ._.
3d_CD ._.
No_DT ._.
3_CD ._.
Some_DT Observations_NNS on_IN the_DT Poison_NNP of_IN Russell_NNP 's_POS Viper_NNP (_( Daboia_NNP Russellii_NNP )_) ,_, by_IN Captain_NNP G._NNP Lamb_NNP ,_, I.M.S._NNP ,_, and_CC Wm_NNP ._.
Hanna_NNP ,_, Esq._NNP ,_, M._NNP B_NNP ._.
Price_NN As_IN ._.
5_CD or_CC 6d_CD ._.
No_DT ._.
4_CD ._.
On_IN the_DT Action_NNP of_IN the_DT Venoms_NNP of_IN the_DT Cobra_NNP and_CC of_IN the_DT Daboia_NNP on_IN the_DT Red_NNP Blood_NNP corpuscles_NNS and_CC on_IN the_DT blood_NN plasma_NN ,_, by_IN Captain_NNP G._NNP Lamb_NNP ,_, Price_NNP As_NNP ._.
8_CD or_CC 9d_CD ._.
No_DT ._.
5_CD ._.
Specificity_NN of_IN Anti-Venomous_JJ Sera_NNP ,_, by_IN Captain_NNP G._NNP Lamb_NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
3_CD or_CC 4d_CD ._.
No_DT ._.
6_CD ._.
First_NNP Report_NNP on_IN the_DT Anti-Malarial_JJ Operations_NNS in_IN Mian_NNP Mir_NNP ,_, 19012_CD No_UH ._.
20_CD ._.
Serum-Therapy_NN of_IN Plague_NNP in_IN India_NNP ;_: Reports_NNS by_IN Mr._NNP W._NNP M._NNP Haffkine_NNP ,_, C.I.E._NNP ,_, and_CC various_JJ Officers_NNS of_IN the_DT Plague_NNP Research_NNP Laboratory_NNP ,_, Bombay_NNP ,_, by_IN Lieutenant-_NNP Colonel_NNP W._NNP B._NNP Bannerman_NNP ,_, M.D._NNP ,_, B.Sc._NNP ,_, F_NNP ._.
R.C.S._NNP ,_, I._NNP M._NNP S._NNP Price_NNP As_IN ._.
14_CD or_CC 1s_CD ._.
4d_CD ._.
No_DT ._.
21_CD ._.
On_IN the_DT Standardisation_NNP of_IN Anti-Typhoid_NNP Vaccine_NNP ,_, by_IN Captain_NNP George_NNP Lamb_NNP ,_, M.D._NNP ,_, I._NNP M._NNP S._NNP (_( Director_NNP ,_, Pasteur_NNP Institute_NNP of_IN India_NNP )_) ,_, and_CC Captain_NNP W._NNP B._NNP C._NNP Forster_NNP ,_, M._NNP B._NNP ,_, D._NNP P._NNP H._NNP ,_, I._NNP M._NNP S._NNP Price_NNP As_IN ._.
6_CD or_CC 7d_CD ._.
No_DT ._.
22_CD ._.
Mediterranean_JJ Fever_NNP in_IN India_NNP :_: Isolation_NN of_IN the_DT Micrococcus_NNP Melitensis_NNP ,_, by_IN Captain_NNP George_NNP Lamb_NNP ,_, M.D._NNP ,_, I.M.S._NNP ,_, and_CC Assistant_NNP Surgeon_NNP M._NNP Kesava_NNP Pai_NNP ,_, M._NNP B._NNP ,_, C._NNP M._NNP (_( Madras_NNP )_) ._.
Price_NN As_IN ._.
10_CD or_CC 1s_CD ._.
No_DT ._.
23_CD ._.
The_DT Anatomy_NNP and_CC Histology_NNP of_IN Ticks_NNP ,_, by_IN Captain_NNP S._NNP R._NNP Christophers_NNP ,_, M._NNP B._NNP ,_, I._NNP M._NNP S._NNP Price_NNP Rs_NNP ._.
3_CD or_CC 4s_CD ._.
6d_CD ._.
No_DT ._.
24_CD ._.
On_IN a_DT Parasite_NNP found_NN in_IN the_DT White_NNP Corpuscles_NNPS of_IN the_DT blood_NN of_IN Palm_NNP Squirrels_NNP ,_, by_IN Captain_NNP W._NNP S._NNP Patton_NNP ,_, M.B._NNP ,_, I._NNP M._NNP S._NNP Price_NNP As_IN ._.
12_CD or_CC 1s_CD ._.
2d_CD ._.
No_DT ._.
25_CD ._.
On_IN the_DT importance_NN of_IN Larval_NNP Characters_NNP in_IN the_DT Classification_NNP of_IN Mosquitoes_NNP ,_, by_IN Captain_NNP S._NNP R._NNP Christophers_NNP ,_, M._NNP B._NNP ,_, I._NNP M._NNP S._NNP Price_NNP As_IN ._.
8_CD or_CC 9d_CD ._.
No_DT ._.
26_CD ._.
Leucocytozoon_NNP Canis_NNP ,_, by_IN Captain_NNP S._NNP R._NNP Christophers_NNP ,_, M_NNP ._.
B._NNP ,_, I._NNP M._NNP S._NNP Price_NNP As_IN ._.
12_CD or_CC 1s_CD ._.
2d_CD ._.
No_DT ._.
27_CD ._.
Preliminary_JJ Report_NNP on_IN the_DT Development_NNP of_IN the_DT Leishman-Donovan_NNP Body_NNP in_IN the_DT Bed_NNP Bug_NNP ,_, by_IN Captain_NNP W._NNP S._NNP Patton_NNP ,_, M._NNP B._NNP ,_, I._NNP M._NNP S._NNP Price_NNP As_IN ._.
8_CD or_CC 9d_CD ._.
No_DT ._.
28_CD ._.
The_DT Sexual_JJ Cycle_NNP of_IN Leucocytozoon_NNP Canis_NNP in_IN the_DT Tick_NNP ,_, by_IN Captain_NNP S._NNP R._NNP Christophers_NNP ,_, M._NNP B._NNP ,_, I._NNP M._NNP S._NNP Price_NNP As_IN ._.
12_CD or_CC 1s_CD ._.
2d_CD ._.
No_DT ._.
29_CD ._.
Piroplasma_NNP Canis_NNP and_CC its_PRP$ Cycle_NNP in_IN the_DT Tick_NNP ,_, by_IN Captain_NNP S._NNP B._NNP Christophers_NNP ,_, M.B._NNP ,_, I._NNP M._NNP S._NNP Price_NNP Rs_NNP ._.
2_CD or_CC 3s_CD ._.
No_DT ._.
30_CD ._.
The_DT Theory_NNP and_CC Practice_NNP of_IN Anti-Rabic_NNP Immunisation_NNP ,_, by_IN Captain_NNP W._NNP F._NNP Harvey_NNP ,_, M._NNP B._NNP ,_, I.M.S._NNP ,_, and_CC Captain_NNP Anderson_NNP McKendrick_NNP ,_, M.B._NNP ,_, I._NNP M._NNP S._NNP Price_NNP As_IN ._.
12_CD or_CC 1s_CD ._.
2d_CD ._.
No_DT ._.
31_CD ._.
The_DT Development_NNP of_IN the_DT Leishman-Donovan_NNP Parasite_NNP in_IN Cimex_NNP Rotundatus3_NNP No_NNP ._.
41_CD ._.
Quinine_NNP and_CC its_PRP$ Salts_NNS :_: their_PRP$ Solubility_NN and_CC Absorbability_NNP ,_, by_IN Captain_NNP ,_, A._NNP C._NNP MacGilchrist_NNP ,_, M.A._NNP ,_, M.D._NNP ,_, M._NNP R._NNP C._NNP P._NNP ,_, I._NNP M._NNP S._NNP Price_NNP As_IN ._.
9_CD or_CC 10d_CD ._.
No_DT ._.
42_CD ._.
The_DT Cultivation_NNP of_IN the_DT Bacillus_NNP of_IN Leprosy_NNP and_CC the_DT Treatment_NNP of_IN cases_NNS by_IN means_NNS of_IN a_DT Vaccine_NNP prepared_VBN from_IN the_DT Cultivations_NNP ,_, Part_NNP I_PRP ,_, by_IN Major_NNP E._NNP R._NNP Rost_NNP ,_, I.M.S_NNP ._.
The_DT Cultivation_NNP of_IN the_DT Leprosy_NNP Bacillus_NNP ,_, by_IN Captain_NNP T._NNP S._NNP B._NNP Williams_NNP ,_, M.B._NNP ,_, I._NNP M.S_NNP ._.
Price_NN As_IN ._.
8_CD or_CC 9d_CD ._.
No_DT ._.
43_CD ._.
The_DT Relation_NNP of_IN Tetanus_NNP to_TO the_DT Hypodermic_NNP or_CC Intramuscular_NNP Injection_NNP of_IN Quinine_NNP ,_, by_IN Lieutenant-Colonel_NNP Sir_NNP D._NNP Semple_NNP ,_, Kt._NNP ,_, M.D_NNP ._.
Price_NN As_IN ._.
12_CD or_CC 1s_CD ._.
2d_CD ._.
No_DT ._.
44_CD ._.
The_DT Preparation_NNP of_IN a_DT Safe_NNP and_CC Efficient_NNP Anti-rabic_NNP Vaccine_NNP ,_, by_IN Lieutenant-Colonel_NNP Sir_NNP D._NNP Semple_NNP ,_, Kt._NNP ,_, M.D._NNP ,_, D._NNP P._NNP H._NNP ,_, R._NNP A._NNP M._NNP C._NNP (_( Retired_NNP )_) ._.
Price_NN As_IN ._.
8_CD or_CC 9d_CD ._.
No_DT ._.
45_CD ._.
Epidemic_NNP Dropsy_NNP in_IN Calcutta_NNP ,_, ._.
by_IN Major_NNP E._NNP D._NNP W_NNP Greig_NNP ,_, M.D._NNP ,_, D.Sc._NNP ,_, I._NNP M._NNP S._NNP Price_NNP Re_NNP ._.
1_CD and_CC As_NNP ._.
4_CD or_CC 2s_CD ._.
No_DT ._.
46_CD ._.
Malaria_NNP in_IN the_DT Punjab_NNP ,_, by_IN Major_NNP S._NNP R._NNP Christophers_NNP ,_, M._NNP B._NNP ,_, I._NNP M._NNP S.Price_NNP Rs_NNP ._.
2_CD or_CC 3s_CD ._.
No_DT ._.
47_CD ._.
Dysentery_NNP and_CC Liver_NNP Abscess_NNP in_IN Bombay_NNP ,_, by_IN Major_NNP E._NNP D._NNP W._NNP Greig_NNP ,_, M.D._NNP ,_, .D.Sc._NNP ,_, I.M.S._NNP ,_, and_CC Captain_NNP R._NNP P._NNP Wells_NNP ,_, M.A._NNP ,_, M.B._NNP ,_, I.M.S._NNP Price_NNP Rs_NNP ._.
2_CD or_CC 3s_CD ._.
No_DT ._.
48_CD ._.
Investigations_NNS into_IN the_DT Jail_NNP Dietaries_NNP of_IN the_DT United_NNP Provinces_NNPS with_IN some_DT observations_NNS on_IN the_DT influence_NN of_IN dietary_NN on_IN the_DT physical_JJ development_NN and_CC well-being_NN of_IN the_DT people_NNS of_IN United_NNP Provinces_NNPS ,_, by_IN Major_NNP D._NNP McCay_NNP ,_, I._NNP M._NNP S._NNP Price_NNP Re_NNP ._.
1-12_CD or_CC 3s_CD ._.
No_DT ._.
49_CD ._.
Epidemic_NNP Dropsy_NNP in_IN Calcutta_NNP ,_, being_VBG the_DT final_JJ report_NN of_IN an_DT enquiry_NN carried_VBD out_RP by_IN Major_NNP E._NNP D._NNP W._NNP Greig_NNP ,_, M.D._NNP ,_, I.M.S._NNP No_NNP ._.
50_CD ._.
Preliminary_JJ Report_NNP on_IN an_DT Investigation_NNP into_IN the_DT Etiology_NNP of_IN Oriental_NNP Sore_NNP in_IN Cambay_NNP ,_, by_IN Captain_NNP W._NNP S._NNP Patton_NNP ,_, M._NNP B._NNP ,_, I.M.S._NNP Price_NNP As_IN ._.
6_CD ._.
No_DT ._.
51_CD ._.
A_DT Streptothrix_NNP isolated_VBN from_IN the_DT Spleen_NNP of_IN a_DT Leper_NNP ,_, by_IN Major_NNP W._NNP G._NNP Liston_NNP ,_, .M_NNP ._.
D._NNP ,_, D._NNP P._NNP H._NNP ,_, I._NNP M._NNP S._NNP ,_, and_CC Captain_NNP T._NNP S._NNP B._NNP Williams_NNP ,_, I._NNP M._NNP S._NNP Price_NNP As_IN ._.
14_CD or_CC 4d_CD ._.
No_DT ._.
52_CD ._.
Dysentery_NN in_IN Hazaribagh_NNP Central_NNP Jail_NNP ,_, January_NNP 1910CONTENTS_CD ._.
PAGE_NNP Introductory_NNP 1_CD Source_NNP and_CC date_NN of_IN original_JJ Tablets_NNS and_CC Controls_NNP 3_CD Chemical_NNP Examiner_NNP 's_POS Report_NNP 4_CD Aloin_NNP Compound_NNP 5_CD Ammonium_NNP Carbonas_NNP 7_CD Colchicini_NNP Salicylas_NNP 9_CD Extractum_NNP Euonymi_NNP Siccum_NNP 12_CD Hydrargyri_NNP Subchloridum_NNP 13_CD Phenacetinum_NNP 14_CD Phenacetinum_NNP cum_NN CaffeinÃ¢_NNP 15_CD Pil_NNP ._.
Plumbi_NNP cum_NN Opio_NNP 18_CD Pil_NNP ._.
Hydrargyri_NNP Subchloridum_NNP Co._NNP 21_CD Soda_NNP Mint_NNP 22_CD Sodium_NNP Chloridum_NNP 22_CD Tinct_NNP ._.
CamphorÃ¦_NNP Co._NNP 23_CD Tinct_NNP ._.
Digitalis_NNP 25_CD Tinct_NNP ._.
Opii_$ 31_CD Zinci_NNP Sulphas_NNP 33_CD Hypodermic_NNP TabletsThe_NNP Physiological_NNP Action_NNP of_IN Certain_NNP Drugs_NNP in_IN Tablet_NNP Form_NNP THE_NNP investigation_NN whose_WP$ results_NNS are_VBP embodied_VBN in_IN this_DT report_NN was_VBD conducted_VBN during_IN the_DT Winter_NNP of_IN 1910-11_CD ._.
The_DT experiments_NNS which_WDT were_VBD carried_VBN out_RP were_VBD directed_VBN towards_NNS ascertaining_VBG whether_IN the_DT drugs_NNS which_WDT are_VBP made_VBN up_RP in_IN tablet_NN form_NN for_IN Field_NNP Hospitals_NNP deteriorate_NN with_IN age_NN ,_, and_CC ,_, if_IN deterioration_NN occurs_VBZ ,_, to_TO what_WP extent_VB the_DT physiological_JJ action_NN of_IN the_DT drug_NN is_VBZ affected_VBN ._.
In_IN making_VBG out_RP an_DT experimental_JJ scheme_NN for_IN each_DT drug_NN the_DT normal_JJ physio-_JJ logical_JJ effects_NNS of_IN the_DT drug_NN were_VBD first_RB tabulated_VBN ._.
The_DT actions_NNS were_VBD then_RB chosen_VBN which_WDT seemed_VBD to_TO be_VB best_RB adapted_VBN for_IN experiments_NNS on_IN animals_NNS and_CC most_RBS likely_JJ to_TO give_VB accurate_NN recordable_JJ and_CC comparable_JJ results_NNS ._.
Experiments_NNS were_VBD then_RB devised_VBN which_WDT would_MD show_VB the_DT actions_NNS selected_VBN ,_, if_IN any_DT were_VBD present_JJ ,_, and_CC the_DT results_NNS were_VBD recorded_VBN ._.
In_IN every_DT case_NN the_DT drug_NN under_IN investigation_NN was_VBD tested_VBN against_IN an_DT identical_JJ solution_NN or_CC suspension_NN of_IN either_DT fresh_JJ drug_NN or_CC fresh_JJ tablet_NN ,_, and_CC the_DT action_NN of_IN the_DT two_CD compared_VBN ._.
In_IN several_JJ instances_NNS of_IN compound_NN tablets_NNS ,_, for_IN example_NN ,_, Pil_NNP ._.
Hydrarg_NNP ,_, Sub-_NNP chlorid_NN ._.
Co._NNP ,_, in_IN which_WDT the_DT various_JJ ingredients_NNS could_MD not_RB be_VB separated_VBN from_IN one_CD another_DT ,_, it_PRP was_VBD impossible_JJ to_TO obtain_VB precise_JJ physiological_JJ dat2_NN and_CC loss_NN of_IN blood_NN as_IN possible_JJ ._.
A_DT hook_NN was_VBD inserted_VBN superficially_RB in_IN the_DT apex_NN of_IN the_DT heart_NN in_IN such_JJ a_DT manner_NN as_IN to_TO avoid_VB perforating_VBG the_DT whole_JJ thickness_NN of_IN the_DT ventricular_NN wall_NN ,_, and_CC was_VBD connected_VBN by_IN a_DT thread_NN to_TO the_DT end_NN of_IN a_DT light_JJ heart_NN lever_NN ._.
The_DT beats_NNS were_VBD recorded_VBN on_IN a_DT slowly_RB moving_VBG kymograph_NN ,_, the_DT time_NN tracing_VBG being_VBG made_VBN simultaneously_RB by_IN a_DT chronograph_NN marking_VBG seconds_NNS ._.
All_DT tracings_NNS were_VBD made_VBN with_IN the_DT heart_NN in_IN situ_NN and_CC with_IN the_DT nerves_NNS intact_JJ ,_, and_CC no_DT curara_NN or_CC other_JJ drug_NN except_IN that_DT under_IN experiment_NN was_VBD used_VBN ._.
Atropine_NNP was_VBD not_RB used_VBN ,_, as_IN what_WP was_VBD required_VBN was_VBD the_DT combined_JJ effect_NN of_IN the_DT drug_NN under_IN in-_JJ vestigation_NN on_IN the_DT heart_NN muscle_NN and_CC the_DT vagus_JJ terminations_NNS ,_, and_CC not_RB the_DT action_NN on_IN the_DT heart_NN muscle_NN alone_RB ._.
No_DT curves_NNS were_VBD taken_VBN for_IN at_IN least_JJS ten_JJ minutes_NNS after_IN pithing_VBG ,_, in_IN order_NN to_TO avoid_VB irregularities_NNS attributable_JJ to_TO shock_VB ._.
In_IN some_DT cases_NNS the_DT solution_NN of_IN the_DT drug_NN was_VBD allowed_VBN to_TO flow_VB slowly_RB over_IN the_DT external_JJ surface_NN of_IN the_DT heart_NN ._.
In_IN others_NNS it_PRP was_VBD introduced_VBN with_IN a_DT hypodermic_JJ syringe_NN and_CC a_DT very_RB fine_JJ needle_NN into_IN the_DT right_JJ auricle_NN ._.
In_IN the_DT perfusion_NN experiments_NNS ,_, which_WDT were_VBD carried_VBN out_RP in_IN order_NN to_TO show_VB the_DT effect_NN of_IN the_DT drug_NN on_IN the_DT peripheral_JJ vessels_NNS ,_, as_IN regards_NNS vaso-constriction_NN or_CC vaso-_JJ dilatation_NN ,_, the_DT following_JJ procedure_NN was_VBD adopted_VBN :_: A_DT frog_NN was_VBD pithed_VBN and_CC fixed_VBN back_RP downwards_NNS on_IN a_DT frog_JJ board_NN ._.
The_DT heart_NN was_VBD exposed_VBN ,_, one_CD aorta_NN opened_VBD ,_, and_CC the_DT blood_NN permitted_VBD to_TO flow_VB out_RP ._.
A_DT fine_JJ cannula_NN was_VBD then_RB tied_VBN in_IN the_DT aorta_NN ,_, the_DT other_JJ aorta_NN being_VBG closed_VBN by_IN including_VBG it_PRP in_IN the_DT ligature_NN ._.
The_DT cannula_NN was_VBD connected_VBN with_IN a_DT rubber_NN tube_NN containing_VBG normal_JJ saline_JJ solution_NN and_CC having_VBG a_DT Y-shaped_JJ glass_NN tube_NN interposed_VBD so_RB that_IN it_PRP could_MD be_VB put_VBN in_IN communication_NN with_IN either_DT of_IN two_CD bottles_NNS ,_, one_CD of_IN which_WDT con-_JJ tained_VBD normal_JJ saline_JJ solution_NN only_RB ,_, the_DT other_JJ containing_VBG normal_JJ saline_JJ solution_NN mixed_VBN with_IN a_DT solution_NN of_IN the_DT drug_NN under_IN examination_NN ._.
A_DT constant_JJ pressure_NN of_IN 38_CD centimetres_NNS was_VBD maintained_VBN ._.
The_DT sinus_NN venosus_NN was_VBD then_RB opened_VBN and_CC ,_, with_IN due_JJ precaution_NN against_IN the_DT entrance_NN of_IN any_DT air_NN bubbles_NNS ,_, the_DT normal_JJ saline_JJ solu-_JJ tion_NN was_VBD allowed_VBN to_TO flow_VB through_IN the_DT peripheral_JJ circulation_NN of_IN the_DT frog_NN ,_, until_IN all_PDT the_DT blood_NN had_VBD been_VBN washed_VBN out_RP and_CC the_DT fluid_NN was_VBD coming_VBG through_IN clear_JJ and_CC at_IN a_DT constant_JJ or_CC nearly_RB constant_JJ rate_NN ,_, the_DT amount_NN passing_VBG through_IN in_IN succes-_JJ sive_JJ periods_NNS of_IN five_CD minutes_NNS being_VBG recorded_VBN ._.
The_DT fluid_NN containing_VBG the_DT drug_NN was_VBD then_RB perfused_VBN by_IN putting_VBG the_DT cannula_NN in_IN communication_NN with_IN the_DT other_JJ bottle_NN ,_, and_CC the_DT amount_NN passing_VBG through_IN the_DT circulation_NN in_IN successive_JJ five_CD minute_NN periods_NNS measured_VBN and_CC recorded_VBN ._.
If_IN the_DT amount_NN was_VBD less_JJR ,_, vaso-constriction_NN was_VBD present_JJ ,_, if_IN more_JJR ,_, then_RB vaso-dilatation_NN ,_, and_CC the_DT amount_NN by_IN which_WDT the_DT flow_NN was_VBD lessened_VBN or_CC increased_VBN was_VBD in_IN direct_JJ ratio_NN to_TO the_DT amount_NN of_IN vaso-constriction_NN or_CC vaso-dilatation_NN which_WDT was_VBD produced_VBN ._.
Many_JJ of_IN the_DT experiments_NNS recorded_VBN were_VBD repeated_VBN several_JJ times_NNS ,_, and_CC the_DT average_JJ result_NN ,_, or_CC a_DT typical_JJ tracing_NN ,_, given_VBN ._.
Had_NNP time_NN permitted_VBD it_PRP would_MD have_VB been_VBN more_JJR satisfactory_JJ to_TO have_VB done_VBN all_PDT the_DT experiments_NNS several_JJ times_NNS ,_, but_CC with_IN 3_CD the_DT large_JJ number_NN of_IN drugs_NNS to_TO be_VB worked_VBN through_IN in_IN a_DT limited_JJ period_NN this_DT was_VBD impossible_JJ ._.
All_PDT the_DT tracings_NNS shown_VBN are_VBP portions_NNS of_IN continuous_JJ records_NNS and_CC the_DT time_NN tracing_NN ,_, where_WRB shown_VBN ,_, indicates_VBZ seconds_NNS ._.
Table_JJ showing_VBG source_NN and_CC date_NN of_IN original_JJ tablets_NNS and_CC of_IN tablets_NNS or_CC drugs_NNS used_VBN as_IN controls_NNS ._.
Drug_NN ._.
ORIGINAL_NNP ._.
CONTROL_NNP ._.
Source_NN ._.
Date_NNP ._.
Source_NN ._.
Date_NNP ._.
Aloin_NNP Compound_NNP B._NNP W._NNP &_CC Co._NNP 1906_CD B._NNP W._NNP &_CC Co._NNP 1910_CD Ammon_NNP ._.
Carbonas_NNP P._NNP D._NNP &_CC Co._NNP 1907_CD Ditto_NNP 1910_CD Colchicini_NNP Salicylas_NNP Ditto_NNP 1907_CD Ditto_NNP 1910_CD Extr_NNP Euonymin_NNP Siccum_NNP Ditto_NNP 1907_CD Ditto_NNP 1910_CD Hydrarg_NNP ._.
Subchlor_NN ._.
Ditto_NNP 1907_CD B_NNP ._.
&_CC T._NNP 1910_CD Phenacetinum_NNP Ditto_NNP 1907_CD B._NNP W._NNP &_CC Co._NNP 1910_CD Phenacetinum_NNP cum_NN CaffeinÃ¢_NNP Ditto_NNP 1907_CD Ditto_NNP 1910_CD Pil_NNP ._.
Plumbi_NNP cum_NN Opio_NNP Ditto_NNP 1907_CD B._NNP M._NNP S._NNP 1910_CD Pil_NNP ._.
Hydrarg_NNP ._.
Subchlor_NN ._.
Co._NNP Ditto_NNP Unknown_NNP Ditto_NNP 1910_CD Soda_NNP Mint_NNP Ditto_NNP 1907_CD B._NNP W._NNP &_CC Co._NNP 1910_CD Sod_NNP ._.
Chlorid_NNP ._.
Ditto_NNP 1907_CD B_NNP ._.
&_CC T._NNP 1910_CD Tinct_NNP ._.
Camph_NNP ._.
Co._NNP Ditto_NNP Unknown_NNP S._NNP S._NNP &_CC Co._NNP 1910_CD Tinct_NNP ._.
Digitalis_NNP Ditto_NNP 1907_CD B_NNP ._.
&_CC Co._NNP 1910_CD Tinct_NNP ._.
Opii_NNP Ditto_NNP 1907_CD Ditto_NNP 1910_CD Zinc_NNP ._.
Sulphas_NNP B._NNP W._NNP &_CC Co._NNP 1906_CD B_NNP ._.
&_CC T._NNP 1910_CD Hypodermic_NNP Tablets_NNPS ._.
Apomorphin_NNP ._.
Hydrochlorid_NNP ._.
B._NNP W._NNP &_CC Co._NNP 1903_CD P._NNP D._NNP &_CC Co._NNP 1910_CD Atropin_NNP and_CC Morphin_NNP ._.
Sulph_NNP ._.
Ditto_NNP 1903_CD Ditto_NNP 1910_CD Digitalin_NNP Ditto_NNP 1903_CD B._NNP W._NNP &_CC Co._NNP 1910_CD Morphin_NNP ._.
Tartras_CD Ditto_NNP 1903_CD P._NNP D._NNP &_CC Co._NNP 1910_CD PhysostigminÃ¦_NNP Salicylas_NNP Ditto_NNP 1903_CD Ditto_NNP 1910_CD Strophanthin_NNP Ditto_NNP 1903_CD Ditto_NNP 1910_CD Abbreviations_NNP used_VBD in_IN the_DT foregoing_NN table_NN ._.
B._NNP W._NNP &_CC Co.4_NNP All_NNP the_DT control_NN drugs_NNS which_WDT were_VBD used_VBN were_VBD in_IN tablet_NN form_NN ,_, with_IN the_DT exception_NN of_IN those_DT obtained_VBN from_IN Messrs._NNP Baird_NNP and_CC Tatlock_NNP which_WDT were_VBD fresh_JJ salts_NNS guaranteed_VBN chemically_RB pure_JJ ,_, and_CC those_DT obtained_VBN from_IN Messrs._NNP Bathgate_NNP and_CC Co._NNP ,_, and_CC Messrs._NNP Smith_NNP Stanistreet_NNP and_CC Co._NNP ,_, which_WDT were_VBD fresh_JJ tinctures_NNS prepared_VBD according_VBG to_TO ,_, and_CC complying_VBG with_IN the_DT tests_NNS laid_VBD down_RB by_IN ,_, the_DT British_JJ Pharmacop5_NNP Phenacetin_NNP and_CC Caffein6_NNP To_TO another_DT dog_NN of_IN 19.2_CD kilos_NNS ,_, 1.264_CD grams_NNS of_IN old_JJ tablet_NN was_VBD given_VBN in_IN the_DT same_JJ way_NN ._.
In_IN neither_DT case_NN was_VBD there_EX any_DT apparent_JJ effect_NN ,_, the_DT dogs_NNS being_VBG kept_VBN under_IN observation_NN for_IN 48_CD hours_NNS and_CC eating_NN ,_, sleeping_NN ,_, and_CC defÃ¦cating_VBG normally_RB ._.
There_EX was_VBD no_DT sign_NN of_IN cholagogue_NN or_CC cathartic_JJ action_NN ._.
(_( 2_CD )_) PURGATIVE_NNP AND_NNP CHOLAGOGUE_NNP ACTION_NNP ON_NNP MAN_NNP ._.
Two_CD laboratory_JJ attendants_NNS of_IN nearly_RB equal_JJ weight_NN volunteered_VBD for_IN the_DT experiment_NN ,_, and_CC two_CD fresh_JJ tablets_NNS were_VBD given_VBN to_TO one_CD ,_, the_DT other_JJ receiving_VBG two_CD old_JJ tablets_NNS ._.
The_DT man_NN who_WP had_VBD received_VBN the_DT fresh_JJ tablets_NNS had_VBD three_CD motions_NNS within_IN ten_JJ hours_NNS ,_, the_DT first_JJ motion_NN being_VBG passed_VBN three_CD hours_NNS after_IN administration_NN of_IN the_DT drug_NN and_CC being_VBG semi-solid_JJ ,_, the_DT second_JJ and_CC third_JJ being_VBG fluid_NN in_IN consistence_NN ._.
There_EX was_VBD a_DT considerable_JJ amount_NN of_IN griping_VBG which_WDT began_VBD five_CD hours_NNS after_IN the_DT dose_NN had_VBD been_VBN taken_VBN and_CC lasted_VBN five_CD hours_NNS ._.
The_DT man_NN who_WP had_VBD received_VBN the_DT old_JJ tablets_NNS had_VBD no_DT griping_NN and_CC passed_VBD one_CD soft_JJ solid_JJ motion_NN ten_NN hours_NNS after_IN taking_VBG the_DT drug_NN ._.
(_( 3_CD )_) EFFECT_NN WHEN_NNP INJECTED_NNP IN_NNP SOLUTION_NNP INTO_NNP PERITONEAL_NNP CAVITY_NNP OF_NNP FROG_NNP ._.
Two_CD solutions_NNS of_IN equal_JJ strength_NN were_VBD made_VBN ,_, solution_VB A_NNP containing_VBG five_CD old_JJ tablets_NNS in_IN five_CD c.c_NNS ._.
of_IN water_NN ,_, and_CC solution_NN B_NNP five_CD fresh_JJ tablets_NNS in_IN the_DT same_JJ amount_NN of_IN water_NN ._.
The_DT old_JJ tablets_NNS dissolved_VBD more_RBR easily_RB than_IN the_DT fresh_JJ ones_NNS ,_, the_DT solution_NN in_IN both_DT cases_NNS being_VBG turbid_NN and_CC that_IN of_IN the_DT old_JJ tablets_NNS being_VBG darker_NN in_IN colour_NN than_IN that_DT of_IN the_DT new_JJ ._.
The_DT solutions_NNS were_VBD filtered_VBN and_CC one_CD c.c_NN ._.
of_IN A_NNP injected_JJ into_IN frog_JJ X_NNP ,_, frog_JJ Y_NNP receiving_VBG one_CD c.c_NN ._.
of_IN B._NNP Frog_NNP X_NNP ,_, five_CD minutes_NNS after_IN receiving_VBG the_DT injection_NN ,_, showed_VBD strong_JJ muscular_JJ contracture_NN ,_, all_PDT the_DT muscles_NNS being_VBG firmly_RB contracted_VBN ._.
On_IN the_DT application_NN of_IN any_DT external_JJ stimulus_NN to_TO the_DT skin_NN ,_, the_DT contractions_NNS in-_VBP creased_VBN in_IN severity_NN ,_, spasms_JJ typical_NN of_IN strychnine_NN poisoning_VBG being_VBG produced_VBN ._.
This_DT condition_NN lasted_VBD for_IN 25_CD minutes_NNS when_WRB respiration_NN stopped_VBD ,_, death_NN occurred_VBD and_CC the_DT frog_NN ceased_VBD to_TO react_VB to_TO any_DT stimulus_NN ._.
Frog_NNP Y_NNP ,_, which_WDT had_VBD received_VBN the_DT fresh_JJ solution_NN ,_, remained_VBD for_IN five_CD minutes_NNS without_IN showing_VBG any_DT sign_NN of_IN being_VBG affected_VBN by_IN the_DT drug_NN ._.
At_IN the_DT end_NN of_IN that_DT period_NN a_DT condition_NN of_IN rigid_JJ muscular_JJ contracture_NN set_VBN in_IN ,_, the_DT contractions_NNS becoming_VBG spasmodic_NN on_IN the_DT application_NN of_IN external_JJ stimuli_NNS ,_, but_CC the_DT spasms_JJ being_VBG more_JJR severe_JJ and_CC lasting_JJ longer_JJR than_IN in_IN 7_CD the_DT case_NN of_IN frog_NN X_NNP ._.
This_DT condition_NN only_RB lasted_VBD for_IN five_CD minutes_NNS ,_, when_WRB death_NN took_VBD place_NN and_CC the_DT muscles_NNS relaxed_VBP ._.
In_IN both_DT cases_NNS death_NN was_VBD verified_VBN by_IN opening_VBG the_DT animal_NN and_CC exposing_VBG the_DT heart_NN ._.
The_DT results_NNS of_IN these_DT experiments_NNS would_MD appear_VB to_TO indicate_VB that_IN the_DT old_JJ tablets_NNS ,_, while_IN still_RB retaining_VBG a_DT very_RB considerable_JJ degree_NN of_IN activity_NN ,_, have_VBP deterio-_NN rated_VBN to_TO an_DT appreciable_JJ extent_NN when_WRB compared_VBN with_IN the_DT fresh_JJ tablets_NNS ._.
Ammonium_NN Carbonate_NNP Tablets_NNP ._.
These_DT showed_VBD much_JJ efflorescence_NN ,_, and_CC some_DT had_VBD crumbled_VBN to_TO powder_VB ._.
On_IN opening_VBG the_DT bottle_NN a_DT strong_JJ ammoniacal_JJ odour_NN was_VBD given_VBN off_RP ._.
Some_DT of_IN the_DT Pharmacop8_NNP (_( 2_CD )_) Two_CD SOLUTIONS_NNPS WERE_NNP THEN_NNP MADE_NNP ._.
A_DT containing_VBG 5_CD per_IN cent_NN ._.
of_IN the_DT fresh_JJ tablets_NNS and_CC B_NNP containing_VBG 5_CD per_IN cent_NN ._.
of_IN the_DT old_JJ tablets_NNS ,_, i.e._FW ,_, five_CD grams_NNS of_IN each_DT made_VBN up_IN to_TO 100_CD c.c_NN ._.
with_IN distilled_JJ water_NN ._.
Solution_NN A_DT was_VBD clear_JJ and_CC solution_NN B_NNP was_VBD turbid_NN ._.
When_WRB treated_VBN (_( a_DT )_) with_IN Silver_NNP Nitrate_NNP solution_NN and_CC subsequent_JJ supersaturation_NN with_IN Nitric_NNP Acid_NNP ,_, (_( b_NN )_) with_IN Barium_NNP Nitrate_NNP solution_NN ,_, and_CC (_( c_NNS )_) with_IN Barium_NNP Chloride_NNP solution_NN ,_, no_DT difference_NN was_VBD found_VBN between_IN the_DT reactions_NNS given_VBN by_IN A_NNP and_CC B_NNP ._.
(_( 3_CD )_) VOLUMETRIC_NNP ESTIMATION_NNP ._.
Two_CD grams_NNS of_IN the_DT old_JJ tablet_NN were_VBD dissolved_VBN in_IN a_DT mixture_NN of_IN 50_CD c.c_NN ._.
each_DT of_IN water_NN and_CC Normal_NNP Volumetric_NNP Solution_NNP Sulphuric_NNP Acid_NNP ,_, boiled_VBD for_IN ten_JJ minutes_NNS to_TO expel_VB the_DT liberated_JJ CO2_NNP and_CC cooled_VBN ._.
The_DT solution_NN was_VBD then_RB titrated_VBN against_IN Normal_NNP Volumetric_NNP Solution_NNP Potassium_NNP Hydroxide_NNP ,_, Litmus_NNP test_JJS solution_NN being_VBG used_VBN as_IN an_DT indicator_NN ._.
The_DT amount_NN of_IN Normal_NNP KOH_NNP required_VBD for_IN exact_JJ neutrali-_JJ sation_NN was_VBD 22.5_CD c.c_NN ._.
as_IN compared_VBN with_IN 12.7_CD c.c_NNS ._.
which_WDT ought_MD to_TO be_VB sufficient_JJ when_WRB perfectly_RB fresh_JJ translucent_NN salt_NN is_VBZ used_VBN ._.
The_DT test_NN was_VBD repeated_VBN using_VBG two_CD grams_NNS of_IN the_DT fresh_JJ tablets_NNS ,_, and_CC the_DT amount_NN of_IN Normal_NNP KOH_NNP required_VBD for_IN neutralisation_NN was_VBD 23.9_CD c.c_NN ._.
Comparing_VBG the_DT two_CD tablet_NN drugs_NNS with_IN fresh_JJ salt_NN in_IN perfect_JJ condition_NN con-_NN taining_VBG 100_CD per_IN cent_NN ._.
of_IN Ammonia_NNP ,_, the_DT old_JJ tablets_NNS contained_VBD 56_CD per_IN cent_NN ._.
and_CC the_DT fresh_JJ tablets_NNS 53_CD per_IN cent_NN ._.
of_IN Ammonia_NNP ._.
(_( 4_CD )_) PHYSIOLOGICAL_NNP ACTION_NNP OF_IN THE_NNP TABLETS_NNP ._.
(_( See_VB Plate_NNP I_PRP ._. )_)
Ammonium_NN Carbonate_NNP in_IN therapeutic_JJ doses_NNS shows_VBZ activity_NN mainly_RB as_IN a_DT cardiac_NN ,_, gastric_JJ and_CC respiratory_JJ stimulant_NN and_CC an_DT expectorant_NN ._.
The_DT action_NN on_IN the_DT isolated_JJ heart_NN of_IN the_DT frog_NN was_VBD chosen_VBN as_IN an_DT index_NN of_IN comparison_NN between_IN the_DT old_JJ and_CC the_DT new_JJ tablets_NNS ._.
A_DT 1_CD per_IN cent_NN ._.
solution_NN of_IN each_DT was_VBD made_VBN up_RP ,_, A_NNP containing_VBG 1_CD per_IN cent_NN ._.
of_IN old_JJ tablets_NNS and_CC B_NNP containing_VBG 1_CD per_IN cent_NN ._.
of_IN fresh_JJ tablets_NNS ._.
A_DT frog_NN was_VBD pithed_VBN and_CC the_DT heart_NN isolated_VBD and_CC arranged_VBD for_IN recording_VBG contractions_NNS ._.
Normal_JJ contractions_NNS were_VBD recorded_VBN for_IN five_CD minutes_NNS (_( Plate_NNP 1_CD ,_, Chart_NNP 1_CD ,_, No_DT ._.
1_CD )_) ,_, 0.5_CD c.c_NN ._.
of_IN solution_NN B_NNP was_VBD then_RB allowed_VBN to_TO flow_VB slowly_RB over_IN the_DT heart_NN ,_, and_CC an_DT immediate_JJ slight_JJ diminution_NN in_IN the_DT amplitude_NN of_IN the_DT contractions_NNS was_VBD observed_VBN lasting_JJ 13_CD seconds_NNS (_( No_DT ._.
2_CD )_) ._.
Thereafter_RB the_DT contractions_NNS continued_VBD normal_JJ in_IN character_NN and_CC regularity_NN but_CC slightly_RB less_RBR in_IN amplitude_NN for_IN 70_CD seconds_NNS ,_, when_WRB irregu-_JJ larity_NN became_VBD apparent_JJ (_( Nos_NNP ._.
3_CD and_CC 4_CD )_) ,_, which_WDT continued_VBD to_TO the_DT end_NN of_IN the_DT experiment_NN half_PDT an_DT hour_NN after_IN the_DT application_NN of_IN the_DT drug_NN ._.
9_CD The_DT experiment_NN was_VBD repeated_VBN with_IN a_DT fresh_JJ frog_NN ,_, 0.5_CD c.c_NN ._.
of_IN solution_NN A_NNP being_VBG applied_VBN in_IN the_DT same_JJ way_NN ._.
A_DT normal_JJ tracing_NN was_VBD first_RB recorded_VBN (_( Plate_NNP 2_CD ,_, Chart_NNP 2_CD ,_, No_DT ._.
1_CD )_) ._.
The_DT drug_NN was_VBD then_RB applied_VBN and_CC the_DT contractions_NNS became_VBD gradually_RB smaller_JJR for_IN four_CD minutes_NNS ,_, when_WRB they_PRP reached_VBD their_PRP$ minimum_NN (_( Nos_NNP ._.
2_CD ,_, 3_CD ,_, and_CC 5_CD )_) ._.
The_DT contractions_NNS then_RB began_VBD to_TO increase_VB in_IN strength_NN (_( No_UH ._.
6_CD )_) and_CC ,_, at_IN 8_CD minutes_NNS after_IN the_DT application_NN of_IN drug_NN ,_, the_DT tracing_NN was_VBD again_RB very_RB nearly_RB normal_JJ (_( No_UH ._.
7_CD )_) and_CC remained_VBD so_RB to_TO the_DT end_NN of_IN the_DT experiment_NN ._.
The_DT inference_NN to_TO be_VB drawn_VBN from_IN the_DT foregoing_NN experiments_NNS is_VBZ that_IN both_DT sets_NNS of_IN tablets_NNS have_VBP deteriorated_VBN very_RB markedly_RB when_WRB compared_VBN with_IN the_DT fresh_JJ salt_NN ,_, but_CC that_IN between_IN the_DT old_JJ (_( 1907_CD )_) tablet_NN and_CC the_DT new_JJ (_( 1910_CD )_) tablet_NN there_EX is_VBZ very_RB little_JJ difference_NN in_IN degree_NN of_IN deterioration_NN ,_, the_DT old_JJ tablet_NN in_IN fact_NN showing_VBG greater_JJR activity_NN than_IN the_DT new_JJ ._.
Colchicine_NNP Salicylate_NNP Tablets_NNP ._.
These_DT tablets_NNS showed_VBD no_DT visible_JJ signs_NNS of_IN deterioration_NN and_CC were_VBD indistin-_JJ guishable_JJ in_IN appearance_NN from_IN fresh_JJ tablets_NNS against_IN which_WDT they_PRP were_VBD tested_VBN ._.
Frogs_NNS were_VBD used_VBN for_IN the_DT experiments_NNS as_IN being_VBG the_DT most_RBS convenient_JJ and_CC easily_RB obtainable_JJ animals_NNS and_CC as_IN giving_VBG reliable_JJ and_CC comparable_JJ results_NNS ._.
Colchicine_NNP Salicylate_NNP being_VBG a_DT compound_NN salt_NN ,_, one_CD had_VBD to_TO take_VB into_IN account_NN the_DT action_NN both_DT of_IN Colchicine_NNP and_CC of_IN Salicylic_NNP Acid_NNP ._.
Pure_NNP Colchicine_NNP is_VBZ said_VBD to_TO have_VB very_RB little_JJ action_NN on_IN the_DT frog_NN ,_, but_CC the_DT impure_NN preparation_NN produces_VBZ toxic_JJ effects_NNS ._.
Salicylic_JJ Acid_NNP and_CC Salicylates_NNP when_WRB injected_VBN into_IN the_DT frog_NN in_IN large_JJ doses_NNS may_MD produce_VB paralysis_NN ,_, whereas_WP applied_VBN locally_RB they_PRP are_VBP toxic_JJ to_TO frog_VB 's_POS muscle_NN ._.
On_IN the_DT heart_NN ,_, small_JJ doses_NNS have_VBP no_DT effect_NN ,_, but_CC large_JJ doses_NNS cause_VBP cardiac_JJ paralysis_NN ,_, dilatation_NN of_IN peripheral_JJ vessels_NNS ,_, and_CC fall_NN of_IN blood_NN pressure_NN ._.
Two_CD solutions_NNS were_VBD made_VBN ,_, A_NNP being_VBG a_DT 0.1_CD per_IN cent_NN ._.
solution_NN of_IN the_DT old_JJ tablets_NNS and_CC B_NNP being_VBG a_DT 0.1_CD per_IN cent_NN ._.
solution_NN of_IN the_DT fresh_JJ tablets_NNS to_TO be_VB used_VBN as_IN a_DT control_NN ._.
A_DT was_VBD slightly_RB turbid_JJ before_IN filtering_NN ,_, B_NNP was_VBD perfectly_RB clear_JJ ._.
(_( 1_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP OF_NNP PITIED_NNP FROG_NNP ._.
(_( See_VB Plate_NNP II_NNP )_) ._.
Heart_NNP isolated_VBD and_CC arranged_VBD for_IN recording_VBG contractions_NNS on_IN a_DT drum_NN moving_VBG slowly_RB at_IN a_DT constant_JJ rate_NN ._.
Contractions_NNS were_VBD recorded_VBN for_IN five_CD minutes_NNS before_IN the_DT application_NN of_IN the_DT drug_NN (_( Plate_NNP II_NNP ,_, Chart_NNP 1_CD ,_, No_DT ._.
1_CD )_) ._.
0.5_CD c.c_NN ._.
of_IN solution_NN A_NNP was_VBD then_RB allowed_VBN to_TO flow_VB over_IN the_DT heart_NN and_CC the_DT contractions_NNS were_VBD recorded_VBN for_IN five_CD minutes_NNS ._.
Me_NNP result_NN was_VBD a_DT gradual_JJ diminution_NN in_IN the_DT amplitude_NN of_IN the_DT contraction_NN C_NNP 10_CD (_( Nos_NNP ._.
2_CD and_CC 3_CD )_) ._.
At_IN the_DT end_NN of_IN five_CD minutes_NNS a_DT second_JJ dose_NN was_VBD applied_VBN ._.
without_IN any_DT further_JJ diminution_NN in_IN the_DT contractions_NNS being_VBG produced_VBN (_( No_UH ._.
4_CD )_) ._.
The_DT same_JJ experiment_NN was_VBD repeated_VBN in_IN another_DT frog_NN ,_, using_VBG solution_NN B_NNP (_( fresh_JJ drug_NN )_) ._.
The_DT contractions_NNS were_VBD recorded_VBN for_IN five_CD minutes_NNS before_IN the_DT application_NN of_IN the_DT drug_NN (_( No_UH ._.
1_CD )_) ._.
0.5_CD c.c_NN ._.
of_IN solution_NN B_NNP was_VBD then_RB applied_VBN ,_, and_CC an_DT immediate_JJ diminution_NN ._.
in_IN the_DT amplitude_NN and_CC slight_JJ slowing_NN of_IN the_DT rate_NN of_IN contraction_NN were_VBD seen_VBN (_( Plate_NNP II_NNP ,_, Chart_NNP 2_CD ,_, No_DT ._.
2_CD )_) ._.
The_DT contractions_NNS remained_VBD small_JJ and_CC fairly_RB regular_JJ during_IN the_DT next_JJ five_CD minutes_NNS (_( No_DT ._.
3_CD )_) ,_, when_WRB (_( 5_CD minutes_NNS after_IN the_DT first_JJ applica-_JJ tion_NN )_) a_DT second_JJ dose_NN of_IN 0.5_CD c.c_NN ._.
was_VBD applied_VBN ._.
This_DT caused_VBD a_DT still_RB further_JJ reduc-_JJ tion_NN in_IN the_DT amplitude_NN of_IN the_DT contractions_NNS (_( No_DT ._.
4_CD )_) ._.
On_IN the_DT drug_NN being_VBG washed_VBN off_RP with_IN normal_JJ saline_JJ solution_NN ,_, the_DT heart_NN rapidly_RB resumed_VBD its_PRP$ normal_JJ action_NN both_DT as_IN regards_NNS amplitude_VBP and_CC rate_NN of_IN contraction_NN (_( No_UH ._.
5_CD )_) ._.
(_( 2_CD )_) EFFECT_NN ON_NNP PERIPHERAL_NNP VESSELS_NNP ,_, AS_IN SHOWN_NNP BY_NNP PERFUSING_NNP VESSELS_NNP OF_NNP PITHED_NNP FROG_NNP WITH_NNP DRUG_NNP ._.
Pithed_VBN frog_NN and_CC apparatus_RB arranged_VBD as_IN stated_VBN on_IN page_NN 2_CD ._.
The_DT frog_NN was_VBD perfused_VBN with_IN normal_JJ saline_JJ solution_NN until_IN bloodless_NN ,_, and_CC then_RB the_DT saline_JJ solution_NN traversing_VBG the_DT peripheral_JJ circulation_NN was_VBD measured_VBN during_IN successive_JJ five_CD minute_NN periods_NNS ._.
When_WRB the_DT flow_NN had_VBD become_VBN constant_JJ and_CC uniform_JJ ,_, normal_JJ saline_JJ solution_NN containing_VBG 2_CD per_IN cent_NN ._.
of_IN solution_NN A_NNP was_VBD perfused_VBN ,_, and_CC the_DT amount_NN traversing_VBG the_DT peripheral_JJ circulation_NN in_IN successive_JJ five_CD minute_NN periods_NNS was_VBD similarly_RB measured_VBN ._.
The_DT results_NNS obtained_VBN are_VBP noted_VBN below_IN :11_PDT The_DT experiment_NN was_VBD then_RB repeated_VBN with_IN a_DT fresh_JJ frog_NN ,_, using_VBG first_JJ normal_JJ saline_JJ solution_NN and_CC then_RB saline_VB solution_NN containing_VBG 2_CD per_IN cent_NN ._.
of_IN solution_NN B_NNP ,_, the_DT figures_NNS obtained_VBD being_VBG as_IN follows_VBZ :12_VBP The_DT experiment_NN was_VBD then_RB repeated_VBN with_IN a_DT fresh_JJ nerve_NN muscle_NN prepara-_JJ tion_NN ,_, using_VBG solution_NN B_NNP ,_, the_DT same_JJ curves_NNS being_VBG recorded_VBN after_IN the_DT same_JJ intervals_NNS ,_, (_( Chart_NNP 2_CD ,_, Plate_NNP III_NNP )_) ._.
In_IN the_DT case_NN of_IN solution_NN A_NNP (_( old_JJ tablets_NNS )_) ,_, the_DT first_JJ drug_NN curve_NN ,_, two_CD minutes_NNS ._.
after_IN the_DT application_NN of_IN the_DT drug_NN ,_, shows_VBZ only_RB a_DT slight_JJ deviation_NN from_IN the_DT normal_JJ ,_, the_DT contraction_NN being_VBG a_DT shade_NN less_RBR and_CC the_DT relaxation_NN period_NN shorter_NN ._.
In_IN the_DT second_JJ drug_NN curve_NN ,_, five_CD minutes_NNS after_IN the_DT application_NN of_IN the_DT drug_NN ,_, the_DT contraction_NN is_VBZ only_RB half_PDT the_DT normal_JJ ,_, the_DT latent_JJ period_NN is_VBZ considerably_RB prolonged_VBN ,_, and_CC the_DT relaxation_NN period_NN shortened_VBD ._.
In_IN the_DT case_NN of_IN solution_NN B_NNP (_( fresh_JJ tablets_NNS )_) ,_, the_DT first_JJ curve_NN ,_, at_IN two_CD minutes_NNS ,_, shows_VBZ less_JJR amplitude_JJ and_CC considerable_JJ lengthening_VBG both_DT of_IN the_DT latent_NN and_CC of_IN the_DT relaxation_NN periods_NNS ._.
The_DT second_JJ curve_NN ,_, at_IN five_CD minutes_NNS ,_, shows_VBZ a_DT pro-_JJ longed_JJ latent_NN and_CC a_DT shortened_JJ relaxation_NN period_NN ,_, with_IN greatly_RB diminished_VBN amplitude_NN ._.
The_DT results_NNS of_IN these_DT experiments_NNS would_MD indicate_VB that_DT very_RB little_JJ ,_, if_IN any_DT ,_, deterioration_NN has_VBZ occurred_VBN in_IN the_DT 1907_CD tablets_NNS ,_, which_WDT yield_VBP results_NNS varying_VBG very_RB slightly_RB from_IN those_DT obtained_VBN with_IN the_DT 1910_CD tablets_NNS ._.
Euonymin_NNP Siccum_NNP Tablets_NNP ._.
This_DT drug_NN acts_VBZ almost_RB entirely_RB as_IN a_DT drastic_JJ purgative_NN and_CC a_DT cholagogue_NN ._.
Its_PRP$ effect_NN on_IN man_NN and_CC on_IN dogs_NNS was_VBD studied_VBN when_WRB given_VBN by_IN the_DT mouth_NN ,_, crushed_VBN and_CC suspended_VBN in_IN water_NN ._.
Equal_JJ quantities_NNS of_IN freshly_RB prepared_VBN crushed_JJ tablet_NN were_VBD similarly_RB administered_VBN as_IN controls_NNS ._.
(_( 1_CD )_) EFFECT_NN ON_NNP MAN_NNP ._.
Two_CD laboratory_JJ attendants_NNS of_IN nearly_RB equal_JJ weight_NN were_VBD selected_VBN and_CC to_TO one_CD (_( A_DT )_) two_CD grains_NNS of_IN old_JJ tablet_NN ,_, and_CC to_TO the_DT other_JJ (_( B_NNP )_) two_CD grains_NNS of_IN fresh_JJ tablet_NN were_VBD administered_VBN at_IN 3_CD P.M._NNP ``_`` A_NNP ``_`` had_VBD one_CD motion_NN on_IN getting_VBG up_RP at_IN 6_CD A.M._NNP next_JJ morning_NN ,_, solid_JJ but_CC soft_JJ in_IN consistence_NN and_CC greenish_JJ yellow_NN in_IN colour._NN ``_``
B_NNP ``_`` had_VBD two_CD motions_NNS on_IN getting_VBG up_RP at_IN the_DT same_JJ time_NN next_JJ morning_NN ,_, the_DT first_JJ being_VBG soft_JJ but_CC solid_JJ ,_, and_CC the_DT second_JJ being_VBG fluid_NN ._.
The_DT colour_NN of_IN both_DT was_VBD greenish_JJ yellow_NN ._.
(_( 2_CD )_) EFFECT_NN ON_NNP DOGS_NNP ._.
Two_CD dogs_NNS of_IN approximately_RB equal_JJ weight_NN were_VBD taken_VBN and_CC to_TO A_VB a_DT dose_NN of_IN two_CD grains_NNS of_IN fresh_JJ tablet_NN was_VBD given_VBN at_IN 11_CD A.M._NNP ,_, B_NNP at_IN the_DT same_JJ time_NN recei-_JJ ving_VBG two_CD grains_NNS of_IN old_JJ tablet_NN ._.
No_DT effect_NN was_VBD produced_VBN in_IN either_DT dog_NN ,_, 13_CD A_NNP week_NN later_RB the_DT same_JJ dogs_NNS were_VBD taken_VBN and_CC ``_`` A_NNP ``_`` received_VBD six_CD grains_NNS of_IN fresh_JJ and_CC ``_`` B_NNP ``_`` received_VBD six_CD grains_NNS of_IN old_JJ tablet_NN ,_, the_DT drugs_NNS being_VBG administered_VBN at_IN 12-30_CD P.M._NNP ``_`` A_NNP ``_`` at_IN 6_CD P.M._NNP passed_VBD a_DT motion_NN and_CC in_IN the_DT early_JJ morning_NN passed_VBD another_DT ,_, both_DT motions_NNS being_VBG copious_JJ ,_, greenish_JJ yellow_NN in_IN colour_NN and_CC solid_JJ in_IN consistence._NN ``_``
B_IN ``_`` at_IN 5_CD P.M._NNP passed_VBD one_CD motion_NN and_CC passed_VBD another_DT in_IN the_DT night_NN ,_, the_DT total_JJ quantity_NN being_VBG somewhat_RB less_JJR than_IN that_DT passed_VBN by_IN ``_`` A_NNP ``_`` ._.
Both_DT motions_NNS were_VBD solid_JJ and_CC greenish_JJ yellow_NN in_IN colour_NN ._.
From_IN these_DT results_NNS it_PRP would_MD appear_VB that_IN the_DT old_JJ tablets_NNS retain_VBP a_DT very_RB con-_JJ siderable_JJ degree_NN of_IN activity_NN ,_, but_CC show_VBP some_DT slight_JJ deterioration_NN and_CC loss_NN of_IN power_NN when_WRB compared_VBN with_IN the_DT fresh_JJ tablets_NNS ._.
Hydrargyri_NNP Subchloridum_NNP Tablets_NNP ._.
The_DT chief_JJ non-specific_JJ action_NN of_IN Calomel_NNP is_VBZ that_IN of_IN a_DT mild_JJ purgative_NN ._.
These_DT tablets_NNS were_VBD tested_VBN for_IN this_DT on_IN man_NN and_CC on_IN dogs_NNS ,_, control_NN experiments_NNS being_VBG car-_JJ ried_VBN out_RP with_IN equal_JJ quantities_NNS of_IN fresh_JJ Calomel_NNP ,_, not_RB made_VBN up_RP in_IN tablet_NN form_NN ._.
(_( 1_CD )_) ACTION_NN ON_NNP MAN_NNP ._.
Two_CD laboratory_JJ attendants_NNS of_IN nearly_RB equal_JJ weight_NN ,_, A_NNP and_CC B_NNP ,_, were_VBD taken_VBN for_IN this_DT experiment_NN ,_, and_CC at_IN 2_CD P.M._NNP ``_`` A_NNP ``_`` was_VBD given_VBN by_IN the_DT mouth_NN three_CD one-_JJ grain_NN tablets_NNS ,_, ``_`` B_IN ``_`` getting_VBG three_CD grains_NNS of_IN the_DT fresh_JJ salt_NN at_IN 2-30_CD P.M._NNP ``_`` A_NNP ``_`` defÃ¦cated_VBD three_CD times_NNS within_IN the_DT next_JJ eighteen_NN hours_NNS ,_, one_CD ordinary_JJ stool_NN at_IN 6_CD P.M._NNP ,_, one_CD watery_NN stool_NN at_IN 11_CD with_IN much_JJ griping_NN ,_, and_CC one_CD loose_JJ motion_NN at_IN 6_CD A.M._NNP next_JJ morning._NN ``_``
B_NNP ``_`` defÃ¦cated_VBD twice_RB within_IN the_DT same_JJ period_NN ,_, one_CD ordinary_JJ stool_NN at_IN 8_CD P.M._NNP ,_, and_CC one_CD watery_NN motion_NN the_DT following_JJ morning_NN at_IN 5_CD A.M_NNP ._.
He_PRP had_VBD no_DT griping_NN or_CC pain_NN ._.
(_( 2_CD )_) ACTION_NN ON_NNP DOGS_NNP ._.
Two_CD grains_NNS of_IN fresh_JJ salt_NN was_VBD given_VBN to_TO a_DT dog_NN of_IN eighteen_JJ kilos_NNS and_CC two_CD one-_JJ grain_NN tablets_NNS to_TO another_DT dog_NN of_IN nineteen_JJ kilos_NNS without_IN any_DT apparent_JJ effect_NN ._.
This_DT experiment_NN was_VBD repeated_VBN using_VBG a_DT larger_JJR dose_NN ._.
The_DT same_JJ dogs_NNS were_VBD used_VBN ,_, a_DT week_NN having_VBG been_VBN allowed_VBN to_TO elapse_VB in_IN order_NN to_TO ensure_VB their_PRP$ being_VBG quite_RB normal_JJ after_IN the_DT previous_JJ experiment_NN ._.
Five_CD grains_NNS of_IN the_DT fresh_JJ salt_NN was_VBD given_VBN to_TO one_CD dog_NN and_CC five_CD one-grain_JJ tablets_NNS to_TO the_DT other_JJ ._.
The_DT dog_NN which_WDT received_VBD the_DT fresh_JJ salt_NN hiccoughed_VBD for_IN five_CD minutes_NNS after_IN getting_VBG it_PRP ._.
Thereafter_RB it_PRP showed_VBD no_DT abnormal_JJ signs_NNS for_IN eight_CD hours_NNS when_WRB it_PRP vomited_VBD a_DT large_JJ quantity_NN of_IN undigested_JJ food_NN ._.
It_PRP did_VBD not_RB defÃ¦cate_VB during_IN the_DT eighteen_JJ hours_NNS following_VBG the_DT administration_NN of_IN the_DT drug_NN ._.
14_CD The_DT dog_NN which_WDT received_VBD the_DT tablets_NNS passed_VBD urine_JJ ten_NN minutes_NNS later_RB and_CC at_IN fifteen_JJ minutes_NNS passed_VBD a_DT large_JJ black_JJ hard_JJ mass_NN of_IN fÃ¦ces_NNS ._.
At_IN 54_CD minutes_NNS it_PRP vomited_VBD about_IN two_CD ounces_NNS of_IN yellowish_JJ matter_NN mixed_JJ with_IN froth_DT and_CC mucus_NN ._.
At_IN 8Â½_CD hours_NNS it_PRP vomited_VBD a_DT large_JJ quantity_NN of_IN undigested_JJ food_NN ,_, but_CC it_PRP did_VBD not_RB again_RB defecate_VB during_IN the_DT 24_CD hours_NNS it_PRP was_VBD kept_VBN under_IN observation_NN ._.
This_DT experiment_NN was_VBD repeated_VBN later_RB with_IN the_DT same_JJ doses_NNS ,_, a_DT negative_JJ result_NN again_RB being_VBG obtained_VBN ._.
No_DT information_NN was_VBD afforded_VBN by_IN the_DT experiments_NNS on_IN dogs_NNS as_IN to_TO the_DT relative_JJ activity_NN of_IN the_DT tablets_NNS and_CC the_DT fresh_JJ drug_NN ,_, but_CC the_DT human_JJ experiments_NNS show_VBP that_IN the_DT tablets_NNS have_VBP retained_VBN their_PRP$ full_JJ activity_NN and_CC give_VB results_NNS equal_JJ to_TO those_DT of_IN the_DT fresh_JJ drug_NN ._.
Phenacetinum_NNP Tablets_NNP ._.
Phenacetin_NNP being_VBG practically_RB insoluble_JJ in_IN water_NN (_( 1_CD in_IN 1,700_CD )_) ,_, the_DT tablets_NNS had_VBD to_TO be_VB crushed_VBN and_CC administered_VBN suspended_VBN in_IN water_NN ,_, by_IN the_DT mouth_NN ._.
Tablets_NNS manufactured_VBD in_IN 1905_CD were_VBD tested_VBN against_IN an_DT equal_JJ weight_NN of_IN 1910_CD tablets_NNS ._.
(_( 1_CD )_) ANTIPYRETIC_NNP ACTION_NNP ON_NNP RABBITS_NNP ._.
Two_CD rabbits_NNS of_IN equal_JJ weight_NN were_VBD given_VBN an_DT abnormally_RB high_JJ temperature_NN by_IN injecting_VBG hypodermically_RB into_IN each_DT of_IN them_PRP 0.5_CD c.c_NN ._.
of_IN purulent_JJ matter_NN from_IN a_DT septic_JJ wound_NN ._.
Rabbit_VB A_DT ._.
Temperature_NN before_IN injection_NN of_IN septic_JJ material_NN 101.4_CD Temperature_NN 48_CD hours_NNS late_JJ 103_CD With_IN the_DT temperature_NN at_IN 103_CD ,_, 0.5_CD gram_NN of_IN crushed_JJ 1910_CD tablets_NNS were_VBD administer-_JJ ed_NN in_IN water_NN by_IN the_DT mouth_NN at_IN 1-45_CD P.M._NNP ,_, and_CC the_DT temperature_NN recorded_VBD every_DT half_NN hour_NN till_IN 4-30_JJ ._.
Temperature_NN at_IN 1-45_JJ 103_CD ,_, ,_, ,_, ,_, 2-15_JJ 102.5_CD ,_, ,_, ,_, ,_, 2-45_JJ 102_CD ,_, ,_, ,_, ,_, 3_CD 101.6_CD ,_, ,_, ,_, ,_, 3-30_JJ 102.6_CD ,_, ,_, ,_, ,_, 4_CD 103_CD ,_, ,_, ,_, ,_, 4-30_JJ 103_CD Rabbit_NNP B_NNP ._.
Temperature_NN before_IN injection_NN of_IN septic_JJ material_NN 101_CD Temperature_NN 48_CD hours_NNS later_RB 103.3_CD 15_CD With_IN the_DT temperature_NN at_IN 103.3_CD ,_, 0.5_CD gram_NN of_IN crushed_JJ 1905_CD tablets_NNS was_VBD ad-_JJ ministered_VBN in_IN water_NN by_IN the_DT mouth_NN at_IN 1-30_JJ P.M._NNP and_CC the_DT temperature_NN recorded_VBD every_DT half_NN hour_NN till_IN 4-30_JJ ._.
Temperature_NN at_IN 1-30_JJ 103.3_CD ``_`` ``_`` 2-5_JJ 102.1_CD ``_`` ``_`` 2-30_JJ 102_CD ``_`` ``_`` 3_CD 102.5_CD ``_`` ``_`` 3-30_JJ 102.8_CD ``_`` ``_`` 4_CD 103.2_CD ``_`` ``_`` 4-30_JJ 103.2_CD From_IN the_DT above_NN noted_VBD figures_NNS it_PRP will_MD be_VB seen_VBN that_IN the_DT temporary_JJ reduction_NN of_IN temperature_NN was_VBD practically_RB equal_JJ in_IN each_DT case_NN ,_, and_CC the_DT 1905_CD tablets_NNS may_MD be_VB said_VBD to_TO have_VB retained_VBN their_PRP$ activity_NN in_IN full_JJ when_WRB tested_VBN against_IN freshly_RB made_VBN tablets_NNS ._.
Phenacetinum-cum-Caffeina_NNP ,_, Tablets_NNP ._.
Each_DT tablet_NN contains_VBZ four_CD grains_NNS of_IN phenacetin_NN and_CC one_CD grain_NN of_IN caffeine_NN ._.
CAFFEINE_NNP ._.
A_DT separation_NN was_VBD effected_VBN between_IN the_DT phenacetin_NN and_CC the_DT caffeine_NN by_IN utilising_VBG their_PRP$ different_JJ solubilities_NNS ._.
Caffeine_NNP is_VBZ soluble_JJ in_IN water_NN in_IN the_DT propor-_JJ tion_NN of_IN 1_CD in_IN 68_CD ,_, whereas_JJR phenacetin_NN is_VBZ practically_RB insoluble_JJ in_IN water_NN (_( 1_CD in_IN 1,700_CD )_) ._.
By_IN crushing_VBG and_CC dissolving_VBG the_DT tablets_NNS as_RB far_RB as_IN possible_JJ in_IN water_NN ,_, and_CC then_RB filtering_NN ,_, a_DT solution_NN of_IN caffeine_NN was_VBD obtained_VBN containing_VBG phenacetin_NN only_RB to_TO the_DT extent_NN of_IN 1_CD in_IN 1,700_CD ,_, the_DT undissolved_JJ phenacetin_NN being_VBG left_VBN on_IN the_DT filter_NN ._.
Two_CD solutions_NNS were_VBD made_VBN ,_, A_NNP of_IN 2.5_CD grams_NNS of_IN old_JJ (_( 1905_CD )_) tablets_NNS ,_, (_( contain-_JJ ing_VBG 0.5_CD gram_NN of_IN caffeine_NN )_) in_IN 50_CD c._JJ c._NN of_IN water_NN ,_, well_RB filtered_VBN ,_, equalling_VBG a_DT one_CD per_NN cent_NN ,_, solution_NN of_IN caffeine_NN ,_, and_CC B_NNP of_IN the_DT same_JJ strength_NN made_VBN in_IN the_DT same_JJ way_NN with_IN fresh_JJ (_( 1910_CD )_) tablets_NNS ._.
(_( 1_CD )_) EFFECT_NN ON_NNP STRIPED_NNP MUSCLE_NNP OF_NNP FROG_NNP WHEN_NNP APPLIED_NNP LOCALLY_NNP ._.
(_( See_VB Plate_NNP IV_NNP ._. )_)
A_DT nerve_NN muscle_NN preparation_NN was_VBD arranged_VBN for_IN recording_VBG contractions_NNS and_CC a_DT normal_JJ curve_NN first_RB recorded_VBD ._.
Then_RB 0.25_CD c.c_NN ._.
of_IN a_DT ten-fold_JJ dilution_NN of_IN solution_NN A_NNP with_IN normal_JJ saline_JJ solution_NN was_VBD applied_VBN to_TO the_DT muscle_NN ,_, and_CC a_DT curve_NN taken_VBN immediately_RB after_IN the_DT application_NN ._.
This_DT curve_NN was_VBD almost_RB the_DT same_JJ height_NN as_IN the_DT normal_JJ curve_NN but_CC about_IN double_JJ its_PRP$ length_NN ._.
The_DT muscle_NN was_VBD then_RB washed_VBN with_IN normal_JJ saline_NN and_CC a_DT five-fold_JJ dilution_NN of_IN solution_NN A_NNP applied_VBN in_IN the_DT same_JJ way_NN 16_CD and_CC a_DT contraction_NN recorded_VBN ._.
This_DT was_VBD lower_JJR and_CC slower_JJR than_IN the_DT previous_JJ two_CD and_CC relaxation_NN was_VBD not_RB complete_JJ ._.
After_IN Washing_VBG the_DT muscle_NN a_DT two-fold_JJ dilution_NN (_( containing_VBG 0.5_CD per_IN cent_NN ._.
caffeine_NN )_) was_VBD applied_VBN ._.
This_DT caused_VBD a_DT considerable_JJ shortening_NN of_IN the_DT muscle_NN ._.
A_DT contraction_NN was_VBD recorded_VBN which_WDT was_VBD very_RB flat_JJ with_IN incomplete_JJ relaxation_NN ._.
The_DT muscle_NN was_VBD again_RB washed_JJ and_CC undiluted_JJ solution_NN A_DT was_VBD applied_VBN ,_, causing_VBG great_JJ contraction_NN ,_, the_DT base_NN line_NN being_VBG now_RB above_IN the_DT level_NN of_IN the_DT highest_JJS part_NN of_IN the_DT normal_JJ contraction_NN ._.
A_DT contraction_NN was_VBD recorded_VBN ,_, which_WDT was_VBD also_RB very_RB flat_JJ and_CC showed_VBD incomplete_JJ relaxation_NN ._.
These_DT results_NNS are_VBP shown_VBN in_IN Chart_NNP No_NNP ._.
1_CD ,_, Plate_NNP IV_NNP ._.
The_DT experiment_NN was_VBD repeated_VBN with_IN a_DT fresh_JJ muscle_NN nerve_NN preparation_NN and_CC solution_NN B_NNP ,_, the_DT results_NNS being_VBG identical_JJ ,_, and_CC being_VBG shown_VBN in_IN Chart_NNP No_NNP ._.
2_CD ,_, Plate_NNP IV_NNP ._.
(_( 2_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP OF_NNP PITHED_NNP FROG_NNP ._.
(_( See_VB Plates_NNPS V_NNP and_CC VI_NNP ._. )_)
The_DT heart_NN was_VBD isolated_VBN and_CC arranged_VBN for_IN recording_VBG contractions_NNS on_IN a_DT slow-_JJ ly_NN moving_VBG drum_NN ._.
A_DT normal_JJ tracing_NN was_VBD first_RB made_VBN (_( No_UH ._.
1_CD ,_, Plate_NNP V_NNP )_) ._.
0.5_CD c.c_NN ._.
of_IN solution_NN A_NNP was_VBD then_RB allowed_VBN to_TO flow_VB over_IN the_DT heart_NN (_( No_UH ._.
2_CD )_) ._.
The_DT effect_NN became_VBD apparent_JJ in_IN six_CD seconds_NNS ,_, the_DT contractions_NNS gradually_RB diminishing_VBG in_IN amplitude_NN and_CC the_DT diastole_NN becoming_VBG greatly_RB prolonged_VBN ,_, up_RB to_TO as_RB much_JJ as_IN 5.8_CD seconds_NNS (_( Nos_NNP ._.
3_CD and_CC 4_CD )_) ._.
At_IN the_DT end_NN of_IN two_CD minutes_NNS the_DT contractions_NNS were_VBD regular_JJ but_CC only_RB from_IN 0.6_CD to_TO 0.75_CD of_IN the_DT normal_JJ amplitude_NN ,_, and_CC the_DT diastole_NN was_VBD regular_JJ lasting_NN just_RB under_IN two_CD seconds_NNS (_( No_DT ._.
5_CD )_) ._.
At_IN 2_CD minutes_NNS 40_CD seconds_NNS a_DT second_JJ dose_NN of_IN 0.5_CD c.c_NN ._.
was_VBD applied_VBN ,_, but_CC no_DT further_JJ effect_NN was_VBD perceptible_JJ (_( Nos_NNP ._.
6_CD and_CC 7_CD )_) ._.
The_DT experiment_NN was_VBD repeated_VBN with_IN a_DT fresh_JJ frog_NN 's_POS heart_NN ,_, using_VBG solution_NN B_NNP ._.
The_DT normal_JJ tracing_NN was_VBD first_RB taken_VBN (_( No_UH ._.
1_CD ,_, Plate_NNP VI_NNP )_) ,_, and_CC then_RB the_DT drug_NN applied_VBN (_( No_UH ._.
2_CD )_) ._.
The_DT effect_NN was_VBD similar_JJ but_CC not_RB so_RB marked_JJ as_IN with_IN solution_NN A_NNP ,_, and_CC was_VBD recovered_VBN from_IN to_TO a_DT greater_JJR extent_NN (_( Nos_NNP ._.
3_CD and_CC 4_CD )_) ._.
At_IN two_CD minutes_NNS a_DT second_JJ dose_NN was_VBD applied_VBN (_( No_UH ._.
5_CD )_) ,_, which_WDT apparently_RB almost_RB paralysed_VBD the_DT heart_NN (_( Nos_NNP ._.
6_CD ,_, 7_CD ,_, and_CC 8_CD )_) ._.
(_( 3_CD )_) VASO-DILATOR_CD ACTION_NNP ON_NNP PERIPHERAL_NNP VESSELS_NNP OF_NNP PITHED_NNP FROG_NNP ._.
Pithed_VBN frog_NN and_CC apparatus_RB arranged_VBD as_IN stated_VBN on_IN page_NN 2_CD ._.
The_DT frog_NN was_VBD perfused_VBN with_IN normal_JJ saline_JJ solution_NN until_IN bloodless_NN and_CC then_RB the_DT saline_JJ solution_NN traversing_VBG the_DT peripheral_JJ circulation_NN was_VBD measured_VBN during_IN successive_JJ five_CD minute_NN periods_NNS ._.
When_WRB the_DT flow_NN had_VBD become_VBN approximately_RB constant_JJ and_CC uniform_JJ ,_, normal_JJ saline_JJ solution_NN containing_VBG 2_CD per_IN cent_NN ._.
of_IN solution_NN A_NNP ,_, was_VBD 17_CD perfused_JJ and_CC the_DT amount_NN coming_VBG away_RB in_IN successive_JJ five_CD minute_NN periods_NNS was_VBD similarly_RB measured_VBN ._.
The_DT results_NNS obtained_VBN are_VBP noted_VBN below_IN :18_NNP Phenacetin.19_NNP On_IN doing_VBG a_DT quantitative_JJ test_NN with_IN Esbach_NNP 's_POS tubes_NNS ,_, using_VBG an_DT albuminous_JJ solution_NN of_IN known_JJ strength_NN and_CC taking_VBG the_DT same_JJ amount_NN of_IN solution_NN A_NNP and_CC solution_NN B_NNP ,_, both_DT produced_VBD the_DT same_JJ amount_NN of_IN coagulum_NN ._.
(_( 2_CD )_) ACTION_NN ON_NNP EXPOSED_NNP MESENTERY_NNP OF_NNP FROG_NNP ._.
Both_DT solutions_NNS produced_VBD a_DT similar_JJ effect_NN ,_, namely_RB ,_, first_RB a_DT slight_JJ dilatation_NN of_IN the_DT vessels_NNS followed_VBD after_IN between_IN six_CD and_CC seven_CD minutes_NNS by_IN gradual_JJ slowing_NN and_CC finally_RB stasis_NN of_IN ,_, the_DT circulation_NN ,_, with_IN a_DT slight_JJ white_JJ deposit_NN on_IN the_DT surface_NN of_IN the_DT mesentery_NN ,_, probably_RB due_JJ to_TO coagulation_NN of_IN albumin_NN ._.
(_( 3_CD )_) INTRA-PERITONEAL_CD INJECTION_NNP IN_NNP FROG_NNP ._.
One_CD c.c_NN ._.
of_IN solution_NN A_NNP was_VBD injected_VBN into_IN one_CD frog_NN and_CC the_DT same_JJ amount_NN of_IN solution_NN B_NNP into_IN another_DT ._.
No_DT effects_NNS were_VBD observed_VBN during_IN the_DT following_JJ three_CD hours_NNS ,_, the_DT muscular_JJ power_NN remaining_VBG unimpaired_JJ and_CC the_DT reflexes_NNS normal_JJ ._.
The_DT dose_NN was_VBD increased_VBN up_RB to_TO 4_CD c.c_NN ._.
of_IN one_CD per_IN cent_NN ._.
solution_NN without_IN producing_VBG any_DT effect_NN either_CC in_IN the_DT case_NN of_IN solution_NN A_NNP or_CC solution_NN B_NNP ._.
Solutions_NNS were_VBD next_JJ made_VBN from_IN both_CC the_DT old_JJ and_CC the_DT fresh_JJ pills_NNS as_IN follows_VBZ ._.
Five_CD pills_NNS were_VBD crushed_VBN and_CC dissolved_VBN in_IN 20_CD c.c_NN ._.
of_IN water_NN ._.
Then_RB sulphuretted_VBD hydrogen_NN was_VBD passed_VBN through_IN the_DT solution_NN to_TO precipitate_VB the_DT lead_NN in_IN solution_NN as_IN lead_JJ sulphide_NN ._.
The_DT solution_NN was_VBD then_RB thoroughly_RB filtered_VBN to_TO get_VB rid_JJ of_IN the_DT lead_NN ,_, the_DT filtrate_NN containing_VBG no_DT lead_NN and_CC being_VBG clear_JJ and_CC yellowish_JJ in_IN colour_NN ._.
Solution_NNP C_NNP was_VBD made_VBN from_IN the_DT old_JJ pills_NNS and_CC solution_NN D_NNP from_IN the_DT fresh_JJ pills_NNS ._.
(_( 4_CD )_) INTRA-PERITONEAL_NNP INJECTION_NNP OF_IN LEAD-FREE_NNP SOLUTION_NNP ._.
Four_CD c._NN c._NN (_( equal_JJ to_TO 0.04_CD gram_NN of_IN opium_NN )_) of_IN solutions_NNS C_NNP and_CC D_NNP respectively_RB were_VBD injected_VBN into_IN two_CD frogs_NNS ._.
In_IN the_DT case_NN of_IN solution_NN C_NNP the_DT following_JJ events_NNS were_VBD noted_VBN ._.
Diminution_NN of_IN reflexes_NNS was_VBD first_RB perceptible_JJ 15_CD minutes_NNS after_IN the_DT exhibition_NN of_IN the_DT drug_NN ._.
This_DT gradually_RB became_VBD more_RBR marked_JJ and_CC at_IN one_CD hour_NN and_CC forty_NN minutes_NNS the_DT reflexes_NNS were_VBD greatly_RB diminished_VBN and_CC very_RB slow_JJ ._.
The_DT frog_NN was_VBD unable_JJ to_TO walk_VB and_CC response_NN to_TO stimulation_NN was_VBD very_RB late_RB ._.
At_IN 1_CD hour_NN 45_CD minutes_NNS no_DT response_NN could_MD be_VB elicited_VBN to_TO any_DT stimulus_NN applied_VBN to_TO the_DT legs_NN ._.
At_IN 1_CD hour_NN 50_CD minutes_NNS head_VBP spasm_NN occurred_VBD ,_, five_CD spasms_NNS being_VBG counted_VBN in_IN one_CD minute_NN ,_, each_DT followed_VBN by_IN a_DT relaxation_NN of_IN the_DT muscles_NNS ._.
At_IN two_CD hours_NNS from_IN the_DT injection_NN of_IN the_DT drug_NN and_CC thereafter_RB ,_, any_DT stimulus_NN caused_VBD spasmodic_JJ contractions_NNS ,_, but_CC the_DT frog_NN was_VBD unable_JJ to_TO move_VB except_IN when_WRB stimulated_VBN ,_, This_DT condition_NN persisted_VBD for_IN two_CD hours_NNS more_RBR ._.
Next_JJ day_NN the_DT frog_NN had_VBD recovered_VBN and_CC was_VBD apparently_RB normal_JJ ._.
Solution_NNP D_NNP produced_VBD similar_JJ effects_NNS but_CC more_JJR quickly_RB ._.
Diminution_NN of_IN reflexes_NNS was_VBD perceptible_JJ in_IN five_CD minutes_NNS from_IN the_DT injection_NN ._.
The_DT frog_NN could_MD D_VB 2_CD 20_CD still_RB walk_VB but_CC had_VBD stopped_VBN jumping_NN ._.
At_IN 13_CD minutes_NNS the_DT frog_NN could_MD only_RB move_VB about_RB slowly_RB ._.
The_DT corneal_NN reflex_NN was_VBD normal_JJ and_CC the_DT pupil_NN not_RB contracted_VBN ._.
When_WRB placed_VBN on_IN its_PRP$ back_NN it_PRP could_MD still_RB regain_VB its_PRP$ normal_JJ position_NN ._.
At_IN 16_CD minutes_NNS it_PRP was_VBD unable_JJ to_TO right_VB itself_PRP but_CC made_VBD slow_JJ movements_NNS when_WRB in_IN its_PRP$ normal_JJ posi-_JJ tion_NN ._.
The_DT first_JJ spasms_NN appeared_VBD at_IN 25_CD minutes_NNS and_CC at_IN 35_CD minutes_NNS there_RB was_VBD a_DT continuous_JJ spasm_NN lasting_VBG for_IN nearly_RB five_CD minutes_NNS ._.
Any_DT stimulus_NN applied_VBN to_TO the_DT frog_NN or_CC even_RB any_DT movement_NN of_IN its_PRP$ containing_NN cage_NN produced_VBD a_DT spasm_NN ._.
Apart_RB from_IN these_DT spasms_NNS the_DT frog_NN was_VBD unable_JJ to_TO move_VB ,_, and_CC the_DT pupil_NN was_VBD in_IN a_DT state_NN of_IN contraction_NN ._.
This_DT condition_NN lasted_VBD from_IN minute_NN 35_CD to_TO minute_VB 56_CD ,_, after_IN which_WDT no_DT response_NN or_CC spasm_NN was_VBD evoked_VBN by_IN any_DT stimulus_NN ._.
The_DT frog_NN was_VBD dead_JJ in_IN one_CD hour_NN after_IN the_DT injection_NN of_IN the_DT drug_NN ._.
(_( 5_CD )_) EFFECT_NN WHEN_NNP GIVEN_NNP BY_NNP THE_NNP MOUTH_NNP TO_NNP RABBITS_NNP ._.
Twenty_NNP c._NN c._NN of_IN solution_NN C_NNP was_VBD given_VBN to_TO one_CD rabbit_NN and_CC 20_CD c.c_NN ._.
of_IN solution_NN D_NNP to_TO another_DT ,_, being_VBG introduced_VBN into_IN the_DT stomach_NN by_IN a_DT tube_NN ._.
Condition_NN on_IN receiving_VBG the_DT drug_NN ._.
SOLUTION_NNP C_NNP RABBIT_NNP ._.
Temperature_NN 101_CD Respiration_NNP 58_CD Pupil_NNP normal_JJ SOLUTION_NNP D_NNP RABBIT_NNP ._.
Temperature_NN 100.8_CD Respiration_NNP 60_CD Pupil_NNP normal_JJ AFTER_NNP ONE_NNP HOUR_NNP ._.
Temperature_NN 101_CD Respiration_NNP 56_CD Pupil_NNP normal_JJ Temperature_NNP 101_CD Respiration_NNP 56_CD Pupil_NNP normal_JJ Both_NNP animals_NNS were_VBD kept_VBN under_IN close_JJ observation_NN for_IN four_CD hours_NNS ,_, but_CC no_DT effects_NNS attributable_JJ to_TO the_DT drug_NN were_VBD observed_VBN ._.
(_( 6_CD )_) ACTION_NN ON_NNP FROG_NNP 'S_POS MESENTERY_NNP ._.
0.25_CD c.c_NN ._.
of_IN solution_NN C_NNP was_VBD applied_VBN to_TO the_DT mesentery_NN and_CC the_DT application_NN was_VBD followed_VBN at_IN once_RB by_IN some_DT engorgement_NN of_IN the_DT vessels_NNS which_WDT appeared_VBD a_DT deeper_NN red_VBN under_IN the_DT microscope_NN and_CC also_RB showed_VBD perceptible_JJ dilatation_NN ._.
Solution_NNP D_NNP gave_VBD rise_NN to_TO the_DT same_JJ effects_NNS but_CC the_DT engorgement_NN and_CC dilatation_NN were_VBD more_JJR marked_JJ ,_, the_DT smaller_JJR vessels_NNS appearing_VBG bright_JJ red_JJ and_CC considerably_RB increased_VBD in_IN calibre_NN ._.
From_IN the_DT foregoing_VBG results_NNS I_PRP conclude_VBP that_IN the_DT lead_NN in_IN the_DT old_JJ pills_NNS has_VBZ not_RB undergone_JJ deterioration_NN and_CC is_VBZ practically_RB as_RB active_JJ as_IN the_DT lead_NN in_IN the_DT fresh_JJ pill_NN ._.
21_CD The_DT opium_NN in_IN the_DT old_JJ pills_NNS ,_, however_RB ,_, has_VBZ decomposed_VBN considerably_RB and_CC is_VBZ much_RB less_RBR active_JJ than_IN that_DT in_IN the_DT fresh_JJ pills_NNS ._.
In_IN rapidity_NN of_IN solution_NN and_CC ease_NN of_IN disintegration_NN there_EX is_VBZ practically_RB no_DT difference_NN between_IN the_DT old_JJ and_CC the_DT fresh_JJ pills_NNS ._.
Pil_NNP ._.
Hydrargyri_NNP Subchloridi_NNP Co_NNP ._.
Some_DT experiments_NNS were_VBD first_RB made_VBN to_TO compare_VB the_DT ease_NN and_CC quickness_NN of_IN solution_NN of_IN the_DT old_JJ pill_NN with_IN that_DT of_IN the_DT fresh_NN ._.
(_( 1_CD )_) TWO_NNP DISHES_NNP EACH_NNP CONTAINING_NNP 100_CD C.C_NNP ._.
OF_IN A_NNP 5_CD PER_NNP CENT_NNP ._.
SOLUTION_NN OF_NNP HYDROCHLORIC_NNP ACID_NNP IN_NNP WATER_NNP WERE_NNP KEPT_NNP AT_NNP 37Â°_CD CENTIGRADE_NNP ._.
In_IN one_CD was_VBD placed_VBN a_DT fresh_JJ pill_NN and_CC in_IN the_DT other_JJ an_DT old_JJ pill_NN and_CC both_DT were_VBD observed_VBN for_IN an_DT hour_NN ._.
The_DT old_JJ pill_NN showed_VBD no_DT sign_NN of_IN dissolving_NN ,_, only_RB two_CD cracks_NNS having_VBG formed_VBN in_IN the_DT coating_NN ._.
The_DT fresh_NN pill_NN showed_VBD some_DT melting_NN of_IN the_DT coating_NN in_IN five_CD minutes_NNS and_CC the_DT whole_NN of_IN the_DT coating_NN had_VBD dissolved_VBN off_RP in_IN ten_NN minutes_NNS ,_, but_CC the_DT pill_NN itself_PRP re-_JJ mained_VBD undissolved_JJ ,_, the_DT fluid_NN remaining_VBG quite_RB clear_JJ ._.
(_( 2_CD )_) THE_DT EXPERIMENT_NNP WAS_NNP REPEATED_NNP WITH_NNP A_NNP 5_CD PER_NNP CENT_NNP ._.
SODIUM_NNP CARBONATE_NNP SOLUTION_NNP ._.
The_DT old_JJ pill_NN showed_VBD some_DT cracks_NNS in_IN the_DT coating_NN at_IN 15_CD minutes_NNS and_CC in_IN half_PDT an_DT hour_NN the_DT coating_NN was_VBD entirely_RB dissolved_VBN ._.
At_IN the_DT end_NN of_IN an_DT hour_NN the_DT liquid_NN close_RB to_TO the_DT pill_NN showed_VBD some_DT brown_JJ discoloration_NN ,_, indicating_VBG some_DT slight_JJ solu-_JJ tion_NN of_IN the_DT pill_NN itself_PRP ._.
In_IN the_DT case_NN of_IN the_DT fresh_JJ pill_NN the_DT coating_NN took_VBD half_PDT an_DT hour_NN to_TO dissolve_VB completely_RB and_CC the_DT brown_JJ discoloration_NN was_VBD rather_RB more_JJR marked_JJ than_IN in_IN the_DT case_NN of_IN the_DT old_JJ pill_NN ._.
(_( 3_CD )_) THE_DT EXPERIMENT_NNP WAS_NNP REPEATED_NNP WITH_NNP BOILING_NNP WATER_NNP ._.
The_DT old_JJ pill_NN was_VBD entirely_RB broken_VBN down_RP into_IN fine_JJ suspended_VBN matter_NN in_IN be-_JJ tween_JJ eight_CD and_CC nine_CD minutes_NNS ._.
The_DT fresh_NN pill_NN only_RB took_VBD five_CD minutes_NNS to_TO disintegrate_VB ._.
Physiological_JJ action_NN ._.
(_( 4_CD )_) PURGATIVE_NNPS ACTION_NNP ON_NNP MAN_NNP ._.
Two_CD laboratory_NN attendants_NNS who_WP volunteered_VBD for_IN the_DT experiment_NN and_CC were_VBD of_IN approximately_RB the_DT same_JJ weight_NN received_VBD an_DT old_JJ and_CC a_DT fresh_JJ pill_NN respectively_RB at_IN 3-30_JJ P.M._NNP 22_CD The_DT recipient_NN of_IN the_DT old_JJ pill_NN had_VBD one_CD motion_NN at_IN 8_CD Pm._NNP ,_, hard_JJ and_CC yellowish_JJ ._.
At_IN 6-30_JJ A.M._NNP he_PRP passed_VBD a_DT small_JJ quantity_NN of_IN soft_JJ solid_JJ fÃ¦ces_NNS followed_VBN by_IN a_DT large_JJ quantity_NN of_IN yellow_JJ liquid_NN ._.
No_DT griping_NN or_CC loss_NN of_IN appetite_NN was_VBD complained_VBN of_IN ._.
The_DT recipient_NN of_IN the_DT fresh_JJ pill_NN passed_VBD one_CD motion_NN at_IN 7_CD P.M._NNP ,_, soft_JJ but_CC fairly_RB normal_JJ in_IN appearance_NN ._.
He_PRP passed_VBD a_DT second_JJ motion_NN at_IN 9_CD P.M._NNP consisting_VBG almost_RB entirely_RB of_IN yellow_JJ liquid_NN ,_, and_CC a_DT third_JJ motion_NN at_IN 10-30_JJ P.M._NNP consisting_NN of_IN a_DT large_JJ quantity_NN of_IN yellow_JJ liquid_NN containing_VBG a_DT small_JJ amount_NN of_IN solid_JJ fÃ¦cal_JJ matter_NN ._.
He_PRP complained_VBD of_IN loss_NN of_IN appetite_NN and_CC also_RB of_IN griping_VBG which_WDT lasted_VBD four_CD hours_NNS ._.
(_( 5_CD )_) PURGATIVE_NNPS ACTION_NNP ON_NNP DOGS_NNP ._.
Two_CD old_JJ pills_NNS were_VBD crushed_VBN and_CC given_VBN in_IN suspension_NN to_TO a_DT dog_NN weighing_VBG 18_CD kilos_NN ,_, at_IN 11-30_JJ A.M._NNP At_IN 12-33_CD the_DT dog_NN vomited_VBD about_IN two_CD ounces_NNS of_IN greenish_JJ matter_NN mixed_JJ with_IN froth_DT and_CC mucus_NN ._.
At_IN 3-30_JJ it_PRP defecated_VBD once_RB ,_, a_DT small_JJ hard_JJ greenish-black_JJ mass_NN ._.
At_IN 6_CD P.M._NNP it_PRP again_RB vomited_VBD a_DT small_JJ quantity_NN of_IN greenish_JJ frothy_JJ matter_NN ._.
It_PRP passed_VBD no_DT more_RBR fÃ¦ces_NNS during_IN the_DT 24_CD hours_NNS following_VBG the_DT administration_NN of_IN the_DT drug_NN ._.
Two_CD fresh_JJ pills_NNS were_VBD crushed_VBN and_CC given_VBN to_TO a_DT dog_NN weighing_VBG 19_CD kilos_NN at_IN 11-40_JJ A.M_NNP ._.
This_DT dog_NN did_VBD not_RB vomit_NN and_CC passed_VBD one_CD small_JJ liquid_NN yellowish_JJ motion_NN at_IN 8_CD P.M._NNP No_NNP further_JJ action_NN took_VBD place_NN during_IN the_DT 24_CD hours_NNS following_VBG the_DT administration_NN of_IN the_DT drug_NN ._.
Conclusions.23_NNP (_( 2_CD )_) ONE_CD SOLOID_NNP WAS_NNP DISSOLVED_NNP IN_NNP 100_CD C.C_NNP ._.
OF_NNP DISTILLED_NNP WATER_NNP ,_, GIVING_NNP A_NNP SOLUTION_NNP WHICH_NNP SHOULD_NNP BE_NNP 1.944_CD PER_NNP CENT_NNP ._.
This_DT was_VBD titrated_VBN against_IN Standard_NNP Solution_NNP of_IN Silver_NNP Nitrate_NNP and_CC was_VBD found_VBN to_TO correspond_VB to_TO a_DT 1.845_CD per_IN cent_NN ._.
solution_NN ,_, showing_VBG a_DT loss_NN of_IN 99_CD milli-_JJ grams_NNS of_IN Sodium_NNP Chloride_NNP per_IN soloid_NN ._.
The_DT difference_NN between_IN the_DT results_NNS obtained_VBD in_IN experiments_NNS (_( 1_CD )_) and_CC (_( 2_CD )_) is_VBZ probably_RB due_JJ to_TO some_DT of_IN the_DT loss_NN of_IN Sodium_NNP Chloride_NNP being_VBG made_VBN up_RP for_IN by_IN absorbed_JJ moisture_NN ._.
(_( 3_CD )_) A_DT 0.75_CD PER_NNP CENT_NNP ._.
SOLUTION_NN BY_NNP WEIGHT_NNP WAS_NNP MADE_NNP WITH_NNP FRESH_NNP PURE_NNP SODIUM_NNP CHLORIDE_NNP AND_NNP ALSO_NNP WITH_NNP THE_NNP SOLOIDS_NNP AND_NNP EACH_NNP WAS_NNP DILUTED_NNP WITH_NNP DISTILLED_NNP WATER_NNP UNTIL_NNP IT_NNP PRODUCED_NNP PERFECT_NNP AND_NNP COMPLETE_NNP HÃ†MOLYSIS_NNP OF_NNP HUMAN_NNP RED_NNP BLOOD_NNP CORPUSCLES_NNP ._.
Complete_JJ hÃ¦molysis_NN was_VBD only_RB produced_VBN in_IN the_DT case_NN of_IN the_DT fresh_JJ salt_NN when_WRB it_PRP had_VBD been_VBN diluted_VBN up_RP to_TO four_CD volumes_NNS ._.
In_IN the_DT case_NN of_IN the_DT soloid_JJ solution_NN ,_, a_DT dilution_NN to_TO 3.8_CD volumes_NNS produced_VBD complete_JJ hÃ¦molysis_NN ._.
These_DT results_NNS ,_, with_IN those_DT obtained_VBN by_IN the_DT Chemical_NNP Examiner_NNP ,_, show_VBP that_IN the_DT Sodium_NNP Chloride_NNP soloids_NNS ,_, except_IN for_IN a_DT very_RB minute_JJ loss_NN of_IN substance_NN ,_, have_VBP not_RB undergone_JJ deterioration_NN ._.
Tinct_NNP ._.
Camph_NNP ._.
Co._NNP Tablets_NNP ._.
One_CD ounce_NN of_IN Tinct_NNP ._.
Camph_NNP ._.
Co._NNP contains_VBZ two_CD grains_NNS of_IN opium_NN ,_, two_CD grains_NNS of_IN Benzoic_NNP Acid_NNP and_CC one_CD and_CC a_DT half_JJ grains_NNS of_IN Camphor_NNP ._.
One_CD tablet_NN is_VBZ equal_JJ to_TO fifteen_VB minims_NNS and_CC therefore_RB contains_VBZ one-sixteenth_NN of_IN a_DT grain_NN (_( equal_JJ to_TO 0.004_CD gram_NN )_) of_IN opium_NN ._.
Ten_CD tablets_NNS contain_VBP ,_, therefore_RB ,_, 0.04_CD gram_NN of_IN opium_NN ._.
Two_CD solutions_NNS were_VBD made_VBN ._.
Solution_NN A_DT consisted_VBN of_IN 20_CD tablets_NNS dissolved_VBN ._.
in_IN 50_CD c.c_NN ._.
of_IN water_NN and_CC contained_VBD 0.0016_CD gram_NN of_IN opium_NN per_IN c.c_NN ._.
Solution_NN B_NNP (_( control_NN )_) ,_, of_IN the_DT same_JJ strength_NN ,_, consisted_VBN of_IN 300_CD minims_NNS of_IN fresh_JJ Tinct_NNP ._.
Camph_NNP ._.
Co._NNP made_VBD up_RP to_TO 50_CD c.c_NN ._.
with_IN distilled_JJ water_NN ._.
Having_VBG no_DT means_NN of_IN separating_VBG out_RP the_DT constituents_NNS of_IN Tinct_NNP ._.
Camph_NNP ._.
Co._NNP one_CD was_VBD compelled_VBN to_TO take_VB the_DT combined_JJ action_NN of_IN the_DT composite_JJ preparation_NN ._.
(_( 1_CD )_) INTRA-PERITONEAL_CD INJECTION_NNP IN_NNP FROG_NNP ._.
Two_CD frogs_NNS were_VBD taken_VBN ,_, one_CD receiving_VBG an_DT injection_NN of_IN one_CD c.c_NN ._.
of_IN solution_NN A_NNP and_CC one_CD an_DT injection_NN of_IN the_DT same_JJ amount_NN of_IN solution_NN B_NNP ._.
Both_DT frogs_NNS were_VBD kept_VBN under_IN observation_NN for_IN four_CD hours_NNS and_CC in_IN neither_DT case_NN was_VBD any_DT deviation_NN from_IN the_DT normal_JJ detected_VBN ._.
24_CD (_( 2_CD )_) THE_DT SAME_NNP EXPERIMENT_NNP WAS_NNP REPEATED_NNP WITH_NNP A_NNP LARGER_NNP DOSE_NNP ._.
Two_CD frogs_NNS were_VBD taken_VBN ._.
Frog_NNP X_NNP received_VBD an_DT injection_NN of_IN five_CD c.c_NNS ._.
of_IN solution_NN A_DT intra-peritoneally_RB ,_, frog_JJ Y_NNP receiving_VBG five_CD c.c_NNS ._.
of_IN solution_NN B_NNP ._.
In_IN the_DT case_NN of_IN frog_NN X_NNP no_DT deviation_NN from_IN the_DT normal_JJ was_VBD observed_VBN ,_, the_DT animal_NN responding_VBG to_TO stimuli_VB and_CC behaving_VBG in_IN a_DT perfectly_RB natural_JJ manner_NN during_IN the_DT four_CD hours_NNS it_PRP was_VBD kept_VBN under_IN observation_NN ._.
Frog_NNP Y_NNP showed_VBD effects_NNS very_RB soon_RB after_IN the_DT exhibition_NN of_IN the_DT drug_NN ._.
Five_CD minutes_NNS after_IN ,_, it_PRP was_VBD unable_JJ to_TO jump_VB normally_RB when_WRB stimulated_VBN ,_, and_CC could_MD only_RB move_VB at_IN a_DT walk_NN ._.
At_IN nine_CD minutes_NNS ,_, on_IN the_DT hind_NN legs_JJ being_VBG pinched_VBN or_CC pricked_VBN ,_, they_PRP were_VBD withdrawn_VBN very_RB slowly_RB after_IN a_DT considerable_JJ interval_NN ._.
At_IN twelve_NN minutes_NNS the_DT hind_NN legs_NN were_VBD stretched_VBN out_RP and_CC then_RB retracted_VBD ,_, after_IN which_WDT the_DT frog_NN remained_VBD in_IN this_DT position_NN ._.
When_WRB placed_VBN on_IN its_PRP$ back_NN it_PRP was_VBD unable_JJ to_TO right_VB itself_PRP ._.
After_IN twenty_NN minutes_NNS it_PRP ceased_VBD to_TO respond_VB to_TO any_DT cutaneous_JJ stimulation_NN ,_, and_CC the_DT cor-_JJ neal_NN reflex_NN was_VBD greatly_RB impaired_JJ and_CC retarded_VBD ,_, the_DT eyes_NNS being_VBG closed_VBD very_RB slowly_RB ._.
From_IN minute_$ 25_CD to_TO minute_VB 33_CD spasmodic_JJ contractions_NNS of_IN all_PDT the_DT muscles_NNS occurred_VBD four_CD times_NNS at_IN intervals_NNS of_IN about_IN two_CD minutes_NNS ._.
After_IN minute_NN 33_CD the_DT frog_JJ remain-_JJ ed_NN quiet_JJ and_CC no_DT more_JJR spasms_NNS occurred_VBD ._.
Respiration_NN which_WDT had_VBD ceased_VBN to_TO be_VB perceptible_JJ ten_JJ minutes_NNS after_IN the_DT injection_NN of_IN the_DT drug_NN again_RB became_VBD visible_JJ at_IN one_CD hour_NN 20_CD minutes_NNS and_CC the_DT frog_NN gradually_RB recovered_VBD although_IN next_JJ day_NN the_DT reflexes_NNS were_VBD still_RB sluggish_JJ ._.
(_( 3_CD )_) EFFECT_NN WHEN_NNP LOCALLY_NNP APPLIED_NNP TO_NNP EXPOSED_NNP MESENTERIC_NNP VESSELS_NNP OF_NNP PITHED_NNP FROG_NNP ,_, Two_CD frogs_NNS were_VBD pithed_VBN and_CC the_DT abdomen_NNS opened_VBD enough_RB to_TO permit_VB of_IN a_DT loop_NN of_IN intestine_NN and_CC its_PRP$ attached_JJ mesentery_NN being_VBG drawn_VBN out_RP on_IN a_DT slide_NN and_CC kept_VBD under_IN observation_NN with_IN the_DT low_JJ power_NN of_IN a_DT microscope_NN ._.
To_TO the_DT mesentery_NN of_IN frog_NN X_NNP ,_, 0.2_CD c.c_NN ._.
of_IN solution_NN A_NNP was_VBD applied_VBN and_CC to_TO that_DT of_IN frog_NN Y_NNP ,_, 0.2_CD c.c_NN ._.
of_IN solution_NN B._NNP Frog_NNP X.25_NNP Frog_NNP Y.26_NNP (_( 1_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP OF_NNP PITHED_NNP FROG_NNP ._.
(_( See_VB Plate_NNP VII_NNP ._. )_)
Heart_NNP isolated_VBD and_CC arranged_VBD for_IN recording_VBG contractions_NNS on_IN a_DT drum_NN moving_VBG slowly_RB and_CC at_IN a_DT constant_JJ rate_NN ._.
Contractions_NNS were_VBD recorded_VBN for_IN five_CD minutes_NNS before_IN the_DT application_NN of_IN the_DT drug_NN (_( No_UH ._.
1_CD )_) ._.
0.5_CD c.c_NN ._.
of_IN the_DT clear_JJ supernatant_JJ fluid_NN of_IN solution_NN A_NNP was_VBD then_RB allowed_VBN to_TO flow_VB slowly_RB over_IN the_DT heart_NN and_CC the_DT contractions_NNS were_VBD recorded_VBN for_IN five_CD minutes_NNS (_( No_DT ._.
2_CD )_) ._.
The_DT tracing_NN showed_VBD a_DT slight_JJ increase_NN in_IN amplitude_NN of_IN the_DT contraction_NN and_CC a_DT very_RB slight_JJ slowing_NN of_IN the_DT heart_NN ._.
Solution_NN A_DT was_VBD then_RB shaken_VBN up_RP and_CC 0.5_CD c.c_NN ._.
of_IN the_DT turbid_NN fluid_NN was_VBD allowed_VBN to_TO flow_VB over_IN the_DT heart_NN and_CC the_DT contractions_NNS recorded_VBD for_IN five_CD minutes_NNS (_( No_DT ._.
3_LS )_) ._.
There_EX was_VBD no_DT perceptible_JJ change_NN in_IN the_DT curve_NN ._.
The_DT heart_NN and_CC its_PRP$ surroundings_NNS were_VBD then_RB washed_VBN with_IN normal_JJ saline_JJ solution_NN and_CC 0.5_CD c.c_NN ._.
of_IN solution_NN B_NNP applied_VBD to_TO the_DT heart_NN with_IN no_DT apparent_JJ difference_NN in_IN the_DT contractions_NNS (_( No_DT ._.
4_CD )_) ._.
(_( 2_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP OF_NNP PITHED_NNP FROG_NNP ._.
(_( See_VB Plates_NNPS VII_NNP and_CC VIII_NNP ._. )_)
The_DT arrangements_NNS were_VBD as_IN in_IN (_( 1_CD )_) ,_, but_CC the_DT stronger_JJR solution_NN C_NNP was_VBD used_VBN and_CC instead_RB of_IN being_VBG allowed_VBN to_TO flow_VB over_IN the_DT surface_NN of_IN the_DT heart_NN it_PRP was_VBD injected_VBN into_IN the_DT right_JJ auricle_NN ._.
Normal_JJ contractions_NNS were_VBD first_RB recorded_VBN for_IN five_CD minutes_NNS ._.
0.5_CD c.c_NN ._.
of_IN solution_NN C_NNP was_VBD then_RB injected_VBN into_IN the_DT right_JJ auricle_NN with_IN a_DT hypodermic_JJ syringe_NN fitted_VBN with_IN a_DT very_RB fine_JJ needle_NN ._.
The_DT effect_NN was_VBD instantaneous_JJ ._.
The_DT ventricle_NN contracted_VBD firmly_RB and_CC stopped_VBD beating_VBG and_CC only_RB a_DT small_JJ auricular_JJ con-_JJ traction_NN was_VBD maintained_VBN (_( No_UH ._.
1_CD ,_, Plate_NNP VII_NNP )_) ._.
At_IN the_DT end_NN of_IN nine_CD seconds_NNS slight_JJ ventricular_JJ contractions_NNS began_VBD again_RB and_CC these_DT increased_VBN in_IN volume_NN during_IN the_DT next_JJ 24_CD seconds_NNS ,_, when_WRB the_DT curve_NN produced_VBD showed_VBD the_DT same_JJ amplitude_NN as_IN before_IN the_DT exhibition_NN of_IN the_DT drug_NN ,_, the_DT relaxation_NN between_IN the_DT auricular_NN and_CC ventricular_JJ contractions_NNS being_VBG however_RB much_RB less_JJR marked_JJ and_CC relaxation_NN not_RB always_RB being_VBG of_IN equal_JJ completeness_NN (_( No_UH ._.
2_CD )_) ._.
Fifty-five_JJ seconds_NNS after_IN exhibition_NN of_IN the_DT drug_NN ,_, the_DT contractions_NNS began_VBD to_TO show_VB irregularity_NN ,_, a_DT second_JJ contraction_NN occurring_VBG before_IN the_DT relaxation_NN of_IN the_DT previous_JJ one_CD was_VBD complete_JJ (_( No_UH ._.
3_LS )_) ._.
At_IN 2_CD minutes_NNS 15_CD seconds_NNS the_DT first_JJ pro-_JJ longed_VBN diastole_NN occurred_VBD ._.
(_( No_DT ._.
4_CD )_) ._.
Thereafter_RB the_DT tracing_NN showed_VBD groups_NNS of_IN from_IN two_CD to_TO twelve_VB contractions_NNS with_IN incomplete_JJ relaxation_NN ,_, each_DT group_NN being_VBG separated_VBN by_IN a_DT prolonged_JJ diastole_NN (_( No_UH ._.
5_CD )_) ._.
With_IN the_DT exception_NN of_IN some_DT groups_NNS of_IN single_JJ contractions_NNS ,_, each_DT contraction_NN being_VBG followed_VBN by_IN a_DT prolonged_JJ diastole_NN ,_, this_DT characterises_VBZ the_DT record_NN up_RB to_TO the_DT end_NN of_IN the_DT experiment_NN ,_, 25_CD minutes_NNS after_IN the_DT exhibition_NN of_IN the_DT drug_NN ._.
During_IN the_DT last_JJ 10_CD minutes_NNS the_DT contractions_NNS gradually_RB became_VBD feebler_NN ._.
27_CD The_DT experiment_NN was_VBD repeated_VBN with_IN solution_NN D_NNP ,_, normal_JJ contractions_NNS were_VBD first_RB recorded_VBN for_IN five_CD minutes_NNS (_( No_DT ._.
1_CD ,_, Plate_NNP VIII_NNP )_) ._.
0.5_CD c.c_NN ._.
of_IN solution_NN ._.
D_NNP was_VBD then_RB injected_VBN into_IN the_DT right_JJ auricle_NN ._.
The_DT heart_NN at_IN once_RB stopped_VBD beating_VBG ,_, with_IN the_DT ventricle_NN in_IN complete_JJ contraction_NN (_( No_UH ._.
2_CD )_) ._.
At_IN the_DT end_NN of_IN 25_CD seconds_NNS feeble_JJ auricular_JJ contractions_NNS began_VBD and_CC at_IN the_DT end_NN of_IN 60_CD seconds_NNS very_RB slight_JJ ventricular_NN contractions_NNS were_VBD seen_VBN ._.
At_IN the_DT end_NN of_IN five_CD minutes_NNS the_DT contractions_NNS were_VBD again_RB well_RB established_VBN and_CC regular_JJ but_CC smaller_JJR than_IN normal_JJ (_( No_UH ._.
3_LS )_) ._.
At_IN eight_CD minutes_NNS the_DT prolongation_NN of_IN the_DT diastole_NN first_RB appeared_VBD (_( No_UH ._.
4_CD )_) ,_, and_CC from_IN this_DT point_NN to_TO the_DT finish_NN of_IN the_DT record_NN at_IN 27_CD minutes_NNS ,_, the_DT contractions_NNS showed_VBD this_DT characteristic_NN ._.
The_DT contractions_NNS were_VBD both_DT single_JJ and_CC arranged_VBN in_IN groups_NNS of_IN two_CD ,_, three_CD and_CC four_CD ,_, the_DT majority_NN being_VBG single_JJ or_CC in_IN pairs_NNS (_( No_DT ._.
5_CD )_) ._.
The_DT amplitude_NN was_VBD normal_JJ from_IN 9_CD minutes_NNS 30_CD seconds_NNS to_TO 25_CD minutes_NNS when_WRB the_DT contractions_NNS began_VBD to_TO diminish_VB and_CC show_VB great_JJ irregularity_NN (_( No_UH ._.
6_CD )_) ._.
(_( 3_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP OF_NNP PITHED_NNP FROG_NNP ._.
(_( See_VB Plate_NNP VIII_NNP ._. )_)
In_IN this_DT experiment_NN a_DT frog_NN was_VBD used_VBN to_TO whose_WP$ heart_NN solutions_VBZ A_DT and_CC B_NNP had_VBD already_RB been_VBN applied_VBN externally_RB with_IN practically_RB no_DT effect_NN ._.
The_DT heart_NN was_VBD beating_VBG normally_RB and_CC a_DT tracing_NN was_VBD first_RB recorded_VBN at_IN this_DT stage_NN ._.
0.5_CD c.c_NN ._.
of_IN solution_NN D_NNP was_VBD then_RB injected_VBN into_IN the_DT right_JJ auricle_NN ._.
The_DT effect_NN was_VBD instantaneous_JJ ._.
The_DT ventricle_NN stopped_VBD beating_VBG and_CC remained_VBD firmly_RB contracted_VBN ,_, very_RB slight_JJ auricular_NN contractions_NNS being_VBG still_RB perceptible_JJ (_( No_UH ._.
1_CD )_) ._.
This_DT condition_NN persisted_VBD as_RB long_RB as_IN the_DT record_NN was_VBD maintained_VBN ,_, namely_RB ,_, 25_CD minutes_NNS ._.
The_DT probable_JJ explanation_NN of_IN the_DT difference_NN in_IN the_DT results_NNS of_IN this_DT experiment_NN and_CC those_DT of_IN the_DT previous_JJ experiment_NN is_VBZ that_IN some_DT of_IN the_DT previously_RB applied_VBN Digitalis_NNP had_VBD already_RB been_VBN absorbed_VBN and_CC the_DT combined_JJ effect_NN of_IN that_DT and_CC of_IN the_DT dose_NN now_RB injected_VBN was_VBD sufficient_JJ to_TO account_VB for_IN the_DT more_RBR severe_JJ effect_NN ._.
(_( 4_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP OF_NNP PITHED_NNP FROG_NNP ._.
(_( See_VB Plate_NNP IX_NNP ._. )_)
Arrangements_NNS as_IN before_RB ._.
A_DT normal_JJ tracing_NN was_VBD first_RB taken_VBN (_( No_UH ._.
1_CD ,_, Plate_NNP IX_NNP )_) ._.
0.5_CD c.c_NN ._.
of_IN solution_NN C_NNP was_VBD then_RB allowed_VBN to_TO flow_VB over_IN the_DT surface_NN of_IN the_DT heart_NN ._.
No_DT effect_NN was_VBD perceptible_JJ until_IN 3_CD '_POS 36_CD ''_'' after_IN the_DT application_NN of_IN the_DT drug_NN ,_, when_WRB considerable_JJ slowing_NN of_IN the_DT beat_NN ,_, increased_JJ amplitude_NN ,_, and_CC a_DT marked_JJ in-_JJ crease_NN in_IN the_DT auricular_JJ contraction_NN became_VBD evident_JJ (_( No_UH ._.
2_CD )_) ._.
This_DT was_VBD main-_JJ tained_VBN for_IN 1_CD '_POS 40_CD ''_'' ,_, the_DT contractions_NNS being_VBG mostly_RB in_IN pairs_NNS with_IN an_DT exaggerated_JJ and_CC prolonged_JJ relaxation_NN between_IN each_DT pair_NN (_( No_UH ._.
3_LS )_) ._.
For_IN the_DT next_JJ three_CD minutes_NNS there_RB was_VBD considerable_JJ irregularity_NN (_( No_UH ._.
4_CD )_) ,_, but_CC this_DT gradually_RB passed_VBN off_RB and_CC at_IN the_DT end_NN of_IN fifteen_JJ minutes_NNS from_IN the_DT first_JJ injection_NN the_DT action_NN was_VBD ,_, again_RB regular_JJ (_( No_UH ._.
5_CD )_) ._.
This_DT regularity_NN was_VBD maintained_VBN till_IN the_DT end_NN of_IN the_DT experiment_NN ._.
E_RB 2_CD 28_CD (_( 5_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP OF_NNP PITHED_NNP FROG_NNP ._.
(_( See_VB Plate_NNP IX_NNP ._. )_)
Arrangements_NNS as_IN before_RB ._.
A_DT normal_JJ tracing_NN was_VBD first_RB taken_VBN (_( No_UH ._.
1_CD ,_, Plate_NNP IX_NNP )_) ._.
0.5_CD c.c_NN ._.
of_IN solution_NN D_NNP was_VBD then_RB allowed_VBN to_TO flow_VB over_IN the_DT surface_NN of_IN the_DT heart_NN ._.
A_DT considerable_JJ slowing_NN of_IN the_DT beat_NN was_VBD at_IN once_RB produced_VBN with_IN an_DT in-_JJ crease_NN in_IN the_DT force_NN of_IN the_DT systole_NN (_( No_UH ._.
2_CD )_) ._.
The_DT prolonged_JJ diastole_NN seen_VBN in_IN experiment_NN (_( 4_CD )_) was_VBD not_RB apparent_JJ here_RB and_CC the_DT heart_NN continued_VBD to_TO beat_VB regularly_JJ ,_, with_IN a_DT slightly_RB prolonged_VBN ``_`` systolic_JJ plateau_NN ``_`` to_TO the_DT end_NN of_IN the_DT experiment_NN 20_CD minutes_NNS after_IN the_DT application_NN of_IN the_DT drug_NN (_( Nos_NNP ._.
3_CD and_CC 4_CD )_) ._.
(_( 6_CD )_) VASO-CONSTRICTION_NNP EFFECT_NNP ,_, AS_NNP OBSERVED_NNP MICROSCOPICALLY_NNP IN_NNP INTER-DIGITAL_NNP MEMBRANE_NNP OF_NNP FROG_NNP ._.
Two_CD frogs_NNS were_VBD pithed_VBN and_CC an_DT inter-digital_JJ membrane_NN of_IN each_DT fixed_VBN under_IN a_DT microscope_NN ._.
Frog_NNP X_NNP received_VBD 0.5_CD c.c_NN ._.
of_IN solution_NN C_NNP injected_VBD into_IN its_PRP$ dorsal_NN lymph_NN sac_NN ,_, frog_JJ Y_NNP receiving_VBG 0.5_CD c.c_NN ._.
of_IN solution_NN D_NNP similarly_RB ._.
In_IN neither_DT case_NN could_MD any_DT change_NN in_IN the_DT calibre_NN of_IN the_DT vessels_NNS of_IN the_DT mem-_JJ brane_NN be_VB made_VBN out_RP during_IN fifteen_JJ minutes_NNS '_POS observation_NN ._.
(_( 7_CD )_) VASO-CONSTRICTOR_JJ EFFECT_NNP AS_NNP OBSERVED_NNP MICROSCOPICALLY_NNP IN_NNP MESEN-_NNP TERY_NNP OF_IN PITHED_NNP FROG-_NNP AFTER_NNP LOCAL_NNP APPLICATION_NNP OF_IN DRUG-_NNP ._.
Two_CD frogs_NNS (_( X_NNP and_CC Y_NNP )_) were_VBD pithed_VBN and_CC the_DT mesentery_NN of_IN each_DT placed_VBN on_IN the_DT stage_NN of_IN a_DT microscope_NN and_CC kept_VBD moist_NN with_IN normal_JJ saline_JJ solution_NN ._.
Two_CD minims_NNS of_IN solution_NN C_NNP was_VBD applied_VBN to_TO mesentery_NN of_IN frog_JJ X_NNP and_CC the_DT same_JJ amount_NN of_IN solution_NN D_NNP to_TO that_DT of_IN frog_NN Y_NNP ._.
In_IN X_NNP on_IN the_DT application_NN of_IN the_DT drug_NN the_DT circula-_NN tion_NN which_WDT had_VBD been_VBN very_RB slow_JJ ,_, occasionally_RB showing_VBG only_RB a_DT pulsatile_JJ movement_NN ,_, instantaneously_RB became_VBD very_RB active_JJ ,_, but_CC no_DT change_NN in_IN the_DT diameter_NN of_IN the_DT vessels_NNS was_VBD apparent_JJ for_IN 9_CD minutes_NNS when_WRB a_DT slight_JJ narrowing_NN became_VBD perceptible_JJ ._.
This_DT diminution_NN in_IN the_DT diameter_NN became_VBD more_RBR marked_VBN up_IN to_TO 14_CD minutes_NNS but_CC never_RB approached_VBN in_IN degree_NN that_IN shown_VBN in_IN frog_NN Y._NNP Fourteen_NNP minutes_NNS after_IN the_DT application_NN of_IN the_DT drug_NN an_DT appearance_NN of_IN inflammation_NN was_VBD seen_VBN ._.
This_DT became_VBD much_RB more_JJR intense_JJ during_IN the_DT following_VBG 5_CD minutes_NNS and_CC the_DT vessels_NNS began_VBD to_TO dilate_VB again_RB ._.
Half_PDT an_DT hour_NN after_IN the_DT application_NN there_EX was_VBD intense_JJ inflamma-_JJ tion_NN over_IN the_DT area_NN to_TO which_WDT the_DT drug_NN had_VBD been_VBN applied_VBN ,_, with_IN considerable_JJ dilatation_NN of_IN the_DT vessels_NNS ,_, but_CC the_DT circulation_NN was_VBD still_RB rapid_JJ ._.
In_IN the_DT case_NN of_IN Y_NNP ,_, to_TO which_WDT fresh_JJ Tinct_NNP ._.
Digitalis_NNP (_( solution_NN D_NNP )_) had_VBD been_VBN applied_VBN ,_, the_DT circulation_NN which_WDT had_VBD been_VBN similar_JJ to_TO that_DT seen_VBN in_IN X_NNP ,_, immediately_RB became_VBD very_RB rapid_JJ and_CC a_DT considerable_JJ degree_NN of_IN constriction_NN of_IN the_DT arterioles_NNS and_CC to_TO a_DT less_RBR extent_NN of_IN the_DT small_JJ veins_NNS was_VBD at_IN once_RB apparent_JJ ._.
This_DT constriction_NN increased_VBD for_IN a_DT period_NN of_IN 6_CD minutes_NNS ,_, after_IN which_WDT the_DT calibre_NN of_IN the_DT vessels_NNS 29_CD remained_VBD unaltered_JJ during_IN the_DT rest_NN of_IN the_DT experiment_NN ._.
The_DT membrane_NN and_CC adjacent_JJ intestine_NN were_VBD kept_VBN under_IN observation_NN for_IN 30_CD minutes_NNS after_IN the_DT applica-_JJ tion_NN of_IN the_DT drug_NN and_CC no_DT sign_NN of_IN inflammation_NN or_CC irritation_NN was_VBD seen_VBN ._.
(_( 8_CD )_) EFFECT_NN ON_NNP PERIPHERAL_NNP VESSELS_NNP ,_, AS_IN SHOWN_NNP BY_NNP PERFUSING_NNP VESSELS_NNP OF_NNP PITHED_NNP FROG_NNP WITH_NNP DRUG_NNP ._.
Pithed_VBN frog_NN and_CC apparatus_RB arranged_VBD as_IN stated_VBN on_IN page_NN 2_CD ._.
Several_JJ prelimi-_JJ nary_JJ experiments_NNS were_VBD done_VBN to_TO determine_VB the_DT best_JJS perfusing_NN fluid_NN ,_, the_DT optimum_JJ pressure_NN ,_, the_DT time_NN taken_VBN to_TO render_VB the_DT frog_NN bloodless_NN ,_, the_DT best_JJS strength_NN of_IN the_DT drug_NN in_IN the_DT perfusing_NN solution_NN ,_, and_CC some_DT other_JJ minor_JJ points_NNS ._.
At_IN first_JJ Ringer_NNP 's_POS solution_NN was_VBD used_VBN ,_, but_CC later_RB it_PRP was_VBD found_VBN that_IN normal_JJ saline_JJ solution_NN ,_, which_WDT took_VBD much_RB less_JJR time_NN to_TO prepare_VB ,_, gave_VBD equally_RB good_JJ results_NNS ._.
The_DT best_JJS marked_JJ effects_NNS were_VBD got_VBN with_IN normal_JJ saline_JJ solution_NN containing_VBG 6_CD per_IN cent_NN ._.
of_IN solution_NN A_NNP and_CC solution_NN B_NNP ._.
The_DT following_JJ figures_NNS were_VBD obtained_VBN :_: (_( The_DT frog_NN was_VBD perfused_VBN with_IN normal_JJ saline_JJ solution_NN until_IN bloodless_NN ,_, and_CC then_RB the_DT saline_JJ solution_NN traversing_VBG the_DT peri-_JJ pheral_JJ circulation_NN was_VBD measured_VBN during_IN successive_JJ 5_CD minute_NN periods_NNS ._.
When_WRB the_DT flow_NN had_VBD become_VBN approximately_RB constant_JJ ,_, normal_JJ saline_JJ solution_NN containing_VBG 6_CD per_IN cent_NN ._.
of_IN solution_NN A_NNP was_VBD perfused_VBN and_CC the_DT amount_NN traversing_VBG the_DT peripheral_JJ circulation_NN in_IN successive_JJ 5_CD minute_NN periods_NNS was_VBD similarly_RB measured_VBN ._. )_)
Amount_NN passed_VBD in_IN successive_JJ 5_CD minute_NN periods_NNS in_IN c.c_NN ._.
Normal_JJ Saline_NNP Solution_NNP ._.
Saline_NNP containing_VBG Solution_NNP A_NNP ._.
30_CD 22_CD 34_CD 19_CD 34_CD 16_CD 29_CD 17_CD 28_CD 14_CD 26_CD 24.5_CD 22.5_CD 26_CD 25_CD 30_CD The_DT experiment_NN was_VBD then_RB repeated_VBN with_IN a_DT fresh_JJ frog_NN ,_, using_VBG first_JJ normal_JJ saline_NN and_CC then_RB saline_VB containing_VBG 6_CD per_IN cent_NN ._.
of_IN solution_NN B_NNP ,_, the_DT figures_NNS obtained_VBD being_VBG as_IN follows_VBZ :31_NNS compared_VBN with_IN the_DT fresh_JJ preparation_NN ,_, but_CC the_DT deterioration_NN does_VBZ not_RB affect_VB all_DT its_PRP$ actions_NNS equally_RB ._.
In_IN its_PRP$ action_NN on_IN the_DT heart_NN ,_, which_WDT is_VBZ its_PRP$ most_RBS important_JJ one_CD therapeutically_RB ,_, it_PRP shows_VBZ a_DT distinctly_RB weaker_JJR effect_NN ,_, and_CC its_PRP$ action_NN on_IN peripheral_JJ vessels_NNS ,_, when_WRB applied_VBN locally_RB to_TO the_DT exposed_VBN mesentery_NN ,_, is_VBZ weaker_JJR and_CC at_IN the_DT same_JJ time_NN more_RBR irritating_NN ._.
On_IN the_DT other_JJ hand_NN ,_, perfusion_NN experiments_NNS show_VBP that_IN its_PRP$ vaso-constricting_JJ power_NN is_VBZ slightly_RB greater_JJR than_IN that_DT of_IN the_DT fresh_JJ preparation_NN ._.
The_DT administration_NN of_IN very_RB large_JJ doses_NNS to_TO guinea-pigs_NNS without_IN any_DT evil_JJ effects_NNS indicates_VBZ the_DT absence_NN of_IN any_DT undesirable_JJ toxic_JJ bodies_NNS from_IN both_DT tablets_NNS and_CC fresh_JJ drug_NN ._.
To_TO summarise.32_VB Two_CD frogs_NNS were_VBD taken_VBN ,_, frog_JJ X_NNP got_VBD 5_CD c.c_NN ._.
of_IN solution_NN C_NNP and_CC frog_$ 5_CD c.c_NN ._.
of_IN solution_NN D._NNP Frog_NNP X_NNP ,_, 20_CD minutes_NNS after_IN the_DT injection_NN ,_, was_VBD moving_VBG about_RB freely_RB and_CC responded_VBD normally_RB to_TO stimuli_VB ._.
At_IN 60_CD minutes_NNS the_DT condition_NN was_VBD practically_RB the_DT same_JJ ._.
At_IN 2_CD hours_NNS and_CC 5_CD minutes_NNS movements_NNS in_IN response_NN to_TO stimuli_VB were_VBD not_RB quite_RB so_RB marked_JJ ,_, but_CC there_EX was_VBD no_DT delay_NN of_IN response_NN ._.
This_DT condition_NN per-_RB sisted_VBD to_TO the_DT end_NN of_IN the_DT experiment_NN ._.
The_DT pupil_NN remained_VBD normal_JJ throughout_IN ._.
Frog_NNP Y_NNP ,_, 22_CD minutes_NNS after_IN the_DT injection_NN ,_, had_VBD ceased_VBN to_TO make_VB any_DT spontaneous_JJ movements_NNS and_CC responded_VBD very_RB slowly_RB and_CC feebly_RB to_TO stimuli_VB ._.
Very_RB slight_JJ con-_JJ traction_NN of_IN the_DT pupil_NN was_VBD present_JJ ._.
At_IN 52_CD minutes_NNS stimuli_RB produced_VBD convulsive_JJ movements_NNS ,_, and_CC spasmodic_JJ contractions_NNS occurred_VBD at_IN intervals_NNS during_IN the_DT next_JJ hour_NN ._.
At_IN two_CD hours_NNS and_CC seven_CD minutes_NNS after_IN the_DT injection_NN respiration_NN had_VBD ceased_VBN and_CC the_DT frog_NN was_VBD apparently_RB dead_JJ ,_, although_IN on_IN opening_VBG the_DT body_NN the_DT heart_NN was_VBD found_VBN still_RB to_TO be_VB beating_VBG ._.
It_PRP is_VBZ well_RB known_VBN ,_, however_RB ,_, that_IN frogs_NNS can_MD recover_VB after_IN very_RB large_JJ doses_NNS of_IN Morphine_NNP and_CC after_IN their_PRP$ respiration_NN has_VBZ been_VBN stopped_VBN for_IN several_JJ hours_NNS ._.
(_( 3_CD )_) VASO-DILATOR_NNP EFFECT_NNP ON_NNP VESSELS_NNP OF_NNP EXPOSED_NNP MESENTERY_NNP OF_NNP PITHED_NNP FROG_NNP ._.
Two_CD frogs_NNS were_VBD pithed_VBN and_CC a_DT loop_NN of_IN intestine_NN with_IN its_PRP$ attached_JJ mesentery_NN brought_VBD out_RP and_CC fixed_VBN under_IN the_DT low_JJ power_NN of_IN a_DT microscope_NN ._.
0.2_CD c.c_NN ._.
of_IN solution_NN C_NNP was_VBD applied_VBN to_TO one_CD and_CC 0.2_CD c.c_NN ._.
of_IN solution_NN D_NNP to_TO the_DT other_JJ ._.
In_IN the_DT case_NN of_IN solution_NN C_NNP ,_, the_DT application_NN of_IN the_DT drug_NN was_VBD followed_VBN immediately_RB by_IN a_DT perceptible_JJ dilatation_NN of_IN both_CC the_DT larger_JJR vessels_NNS and_CC the_DT capillaries_NNS ._.
Thirteen_NNP minutes_NNS later_RB slowing_VBG of_IN the_DT circulation_NN in_IN the_DT capillaries_NNS became_VBD apparent_JJ ,_, dilatation_NN of_IN all_PDT the_DT vessels_NNS remaining_VBG about_IN the_DT same_JJ ._.
At_IN 40_CD minutes_NNS the_DT vessels_NNS had_VBD returned_VBN to_TO their_PRP$ original_JJ calibre_NN and_CC circulation_NN had_VBD stopped_VBN completely_RB in_IN the_DT smaller_JJR capillaries_NNS ._.
At_IN 55_CD minutes_NNS circulation_NN in_IN the_DT larger_JJR vessels_NNS was_VBD still_RB taking_VBG place_NN but_CC much_RB more_RBR slowly_RB ,_, and_CC it_PRP gradually_RB came_VBD to_TO a_DT standstill_NN in_IN the_DT course_NN of_IN the_DT next_JJ half_NN hour_NN ._.
In_IN the_DT case_NN of_IN solution_NN D_NNP ,_, application_NN of_IN the_DT drug_NN was_VBD at_IN once_RB followed_VBN by_IN dilatation_NN of_IN all_PDT the_DT vessels_NNS ,_, but_CC to_TO a_DT greater_JJR extent_NN than_IN in_IN the_DT case_NN of_IN solution_NN C._NNP Three_NNP minutes_NNS after_IN application_NN the_DT larger_JJR vessels_NNS had_VBD dilated_VBN to_TO about_IN twice_RB their_PRP$ original_JJ calibre_NN ._.
Some_DT of_IN the_DT capillaries_NNS showed_VBD an_DT appearance_NN of_IN engorgement_NN ,_, but_CC the_DT circulation_NN remained_VBD quite_RB free_JJ ._.
Some_DT of_IN the_DT smallest_JJS capillaries_NNS showed_VBD a_DT very_RB marked_JJ increase_NN in_IN size_NN ._.
At_IN 28_CD minutes_NNS dilatation_NN was_VBD still_RB maintained_VBN ,_, but_CC the_DT circulation_NN was_VBD much_RB less_JJR rapid_JJ and_CC there_EX was_VBD a_DT tendency_NN to_TO stasis_VB in_IN some_DT of_IN the_DT vessels_NNS ,_, specially_RB the_DT capillaries_NNS ._.
At_IN 33_CD 43_CD minutes_NNS the_DT circulation_NN had_VBD almost_RB stopped_VBN and_CC complete_JJ stasis_NN occurred_VBD within_IN an_DT hour_NN ._.
(_( 4_CD )_) EFFECT_NN WHEN_NNP GIVEN_NNP BY_NNP THE_NNP MOUTH_NNP TO_NNP RABBITS_NNP ._.
Two_CD rabbits_NNS of_IN 478_CD and_CC 464_CD grams_NNS were_VBD taken_VBN and_CC to_TO one_CD (_( X_NN )_) five_CD tablets_NNS crushed_VBN in_IN 30_CD c.c_NN ._.
of_IN water_NN were_VBD administered_VBN by_IN a_DT stomach_NN tube_NN ,_, the_DT other_JJ (_( Y_NNP )_) receiving_VBG 50_CD minims_NNS of_IN fresh_JJ Tinct_NNP ._.
Opii_NNP in_IN 30_CD c.c_NN ._.
of_IN water_NN ._.
Both_DT animals_NNS were_VBD kept_VBN under_IN observation_NN for_IN five_CD hours_NNS ._.
X_NN 's_POS temperature_NN before_IN receiving_VBG the_DT drug_NN was_VBD 101.2_CD ._.
No_DT difference_NN in_IN temperature_NN ,_, contraction_NN of_IN pupil_NN or_CC other_JJ effect_NN of_IN the_DT drug_NN was_VBD apparent_JJ throughout_IN the_DT experiment_NN ._.
Y_NNP 's_POS temperature_NN was_VBD 101.2_CD before_IN receiving_VBG the_DT drug_NN ._.
At_IN 25_CD minutes_NNS after_IN administration_NN slight_VBD contraction_NN of_IN the_DT pupils_NNS was_VBD perceptible_JJ ._.
At_IN 70_CD minutes_NNS the_DT animal_NN was_VBD sitting_VBG quietly_RB with_IN eyes_NNS half_JJ shut_JJ and_CC appeared_VBD rather_RB dizzy_JJ ,_, staggering_VBG slightly_RB when_WRB pushed_VBN ._.
The_DT temperature_NN had_VBD dropped_VBN to_TO 100.2_CD ._.
At_IN 1_CD hour_NN and_CC 40_CD minutes_NNS the_DT pupil_NN contraction_NN had_VBD passed_VBN off_RB and_CC the_DT animal_NN was_VBD moving_VBG about_RB occasionally_RB ._.
Thereafter_RB no_DT further_JJ effects_NNS were_VBD noticed_VBN ._.
These_DT results_NNS would_MD indicate_VB that_IN ,_, although_IN by_IN no_DT means_NNS on_IN a_DT par_NN with_IN the_DT fresh_JJ tincture_NN in_IN physiological_JJ effect_NN ,_, the_DT tablets_NNS have_VBP retained_VBN a_DT portion_NN of_IN their_PRP$ activity_NN ._.
They_PRP can_MD not_RB ,_, however_RB ,_, be_VB regarded_VBN as_IN a_DT satisfactory_JJ substitute_NN for_IN the_DT fresh_JJ tincture_NN ._.
Zinc_NNP Sulphate_NNP ._.
These_DT one_CD grain_NN tablets_NNS were_VBD tested_VBN against_IN fresh_JJ pure_NN zinc_NN sulphate_NN obtained_VBN from_IN Messrs._NNP Baird_NNP and_CC Tatlock_NNP ._.
(_( 1_CD )_) CHEMICAL_NN TESTS_NNP ._.
(_( a_DT )_) Solutions_NNS of_IN equal_JJ strength_NN (_( 5_CD per_IN cent_NN )_) of_IN tablets_NNS and_CC of_IN fresh_JJ salt_NN give_VB a_DT similar_JJ reaction_NN with_IN Ammonia_NNP ,_, both_DT giving_VBG a_DT precipitate_NN which_WDT dis-_NN solved_VBD in_IN excess_NN ._.
(_( b_NN )_) Both_DT solutions_NNS were_VBD precipitated_VBN by_IN Barium_NNP Chloride_NNP ._.
(_( c_NN )_) Both_DT solutions_NNS were_VBD precipitated_VBN by_IN Ammonium_NNP Sulphydrate_NNP ._.
(_( 2_CD )_) COAGULATION_NN OF_IN ALBUMIN_NNP ._.
An_DT aqueous_JJ solution_NN containing_VBG 4_CD per_IN cent_NN ._.
of_IN egg_NN albumin_NN was_VBD prepared_VBN and_CC two_CD Esbach_NNP tubes_NNS were_VBD filled_VBN with_IN it_PRP up_RP to_TO the_DT U_NNP mark_NN ._.
One_CD tube_NN was_VBD filled_VBN up_RP to_TO the_DT R_NNP mark_NN with_IN 2.6_CD per_IN cent_NN ._.
solution_NN of_IN tablets_NNS ,_, the_DT other_JJ being_VBG similarly_RB filled_VBN up_RP with_IN 2.6_CD per_IN cent_NN ._.
solution_NN of_IN fresh_JJ salt_NN ._.
The_DT tubes_NNS were_VBD shaken_VBN and_CC allowed_VBN to_TO stand_VB for_IN 24_CD hours_NNS ,_, the_DT precipitate_NN being_VBG thus_RB given_VBN time_NN to_TO settle_VB ._.
The_DT precipitate_NN was_VBD the_DT same_JJ in_IN both_DT tubes_NNS ,_, viz._NN ,_, 0.025_CD per_IN cent_NN ._.
34_CD The_DT experiment_NN was_VBD repeated_VBN with_IN undiluted_JJ beaten_VBN up_RP and_CC filtered_JJ egg_NN albumin_NN and_CC again_RB the_DT solution_NN of_IN the_DT tablets_NNS and_CC that_DT of_IN the_DT fresh_JJ salt_NN gave_VBD the_DT same_JJ result_NN ,_, viz._NN ,_, 0.24_CD per_IN cent_NN ._.
(_( 3_CD )_) EMETIC_NNP ACTION_NNP ON_NNP DOGS_NNP ._.
Thirty_NN grains_NNS being_VBG taken_VBN as_IN a_DT dose_NN for_IN a_DT man_NN of_IN 75_CD kilos_NN ,_, this_DT works_VBZ out_RP at_IN 0.4_CD grain_NN (_( 0.026_CD gram_NN )_) per_FW kilo_NN as_IN an_DT emetic_JJ ._.
Two_CD solutions_NNS of_IN different_JJ strengths_NNS were_VBD made_VBN ,_, both_DT with_IN the_DT tablets_NNS and_CC with_IN the_DT fresh_JJ salt_NN ._.
Solution_NN A_DT 2.6_CD per_IN cent_NN ._.
Tablets._CD ``_``
B_NNP 2.6_CD ``_`` Fresh_NNP Salt._NNP ``_``
C_$ 26_CD ``_`` Tablets._NNP ``_``
D_NNP 26_CD ``_`` Fresh_JJ Salt_NNP ._.
Two_CD dogs_NNS were_VBD taken_VBN and_CC weighed_VBN ,_, one_CD weighing_VBG 3.02_CD kilos_NN and_CC the_DT other_JJ 16.41_CD kilos_NNS ._.
To_TO the_DT smaller_JJR one_CD 0.078_CD gram_NN of_IN tablet_NN was_VBD given_VBN by_IN the_DT mouth_NN ,_, i.e._NN ,_, 3_CD c.c_NN ._.
of_IN solution_NN A_NNP ._.
It_PRP was_VBD kept_VBN under_IN observation_NN for_IN six_CD hours_NNS ,_, but_CC no_DT effects_NNS attributable_JJ to_TO the_DT drug_NN were_VBD seen_VBN ._.
To_TO the_DT larger_JJR dog_NN 0.853_CD gram_NN of_IN fresh_JJ salt_NN was_VBD given_VBN ,_, i.e._FW ,_, 3.3_CD c.c_NN ._.
of_IN solu-_JJ tion_NN B_NNP ._.
The_DT dog_NN was_VBD kept_VBN under_IN observation_NN for_IN six_CD hours_NNS and_CC showed_VBD no_DT signs_NNS of_IN vomiting_VBG or_CC salivation_NN ._.
Two_CD days_NNS later_RB the_DT experiment_NN was_VBD repeated_VBN ,_, reversing_VBG the_DT drugs_NNS ,_, i.e._NN ,_, the_DT small_JJ dog_NN receiving_VBG the_DT fresh_JJ salt_NN and_CC the_DT larger_JJR one_CD the_DT tablets_NNS ._.
The_DT small_JJ dog_NN ,_, 10_CD minutes_NNS after_IN receiving_VBG the_DT drug_NN ,_, began_VBD to_TO bark_VB and_CC yawn_VB and_CC passed_VBD urine_JJ three_CD times_NNS during_IN the_DT first_JJ hour_NN and_CC a_DT quarter_NN ._.
There-_NN after_IN its_PRP$ behaviour_NN was_VBD quite_RB normal_JJ ._.
The_DT larger_JJR clog_NN ,_, 9_CD minutes_NNS after_IN receiving_VBG the_DT drug_NN ,_, began_VBD to_TO show_VB signs_NNS of_IN uneasiness_NN ,_, swaying_VBG about_IN and_CC trembling_VBG ._.
At_IN 11_CD minutes_NNS it_PRP vomited_VBD once_RB ,_, a_DT small_JJ quantity_NN of_IN frothy_JJ thick_JJ fluid_NN ._.
It_PRP kept_VBD shaking_VBG its_PRP$ head_NN to_TO and_CC fro_VB for_IN 15_CD minutes_NNS after_IN this_DT ,_, and_CC then_RB lay_VBD down_RB quietly_RB ,_, remaining_VBG quiet_JJ and_CC showing_VBG no_DT further_JJ signs_NNS of_IN any_DT action_NN on_IN the_DT part_NN of_IN the_DT drug_NN ._.
The_DT Zinc_NNP Sulphate_NNP tablets_NNS appear_VBP to_TO be_VB in_IN all_DT respects_NNS equal_JJ to_TO the_DT fresh_JJ salt_NN and_CC show_VB no_DT sign_NN of_IN having_VBG deteriorated_VBN ._.
Hypodermic_NNP Tablets_NNP ._.
Apomorphinum_NNP Hydrochloridum_NNP (_( 0.1_CD grain_NN =0.0065_NNP gram_NN )_) ._.
The_DT solubility_NN of_IN this_DT salt_NN is_VBZ one_CD in_IN sixty_NN in_IN water_NN ._.
In_IN its_PRP$ action_NN it_PRP is_VBZ emetic_JJ ,_, acting_VBG on_IN the_DT central_JJ nervous_JJ system_NN ._.
Locally_RB applied_VBN it_PRP diminishes_VBZ 35_CD and_CC finally_RB abolishes_VBZ the_DT irritability_NN of_IN both_DT striped_VBN and_CC cardiac_JJ muscle_NN in_IN the_DT frog_NN ._.
A_DT solution_NN of_IN 0.005_CD gram_NN per_IN c.c_NN ._.
was_VBD made_VBN by_IN dissolving_VBG 5_CD old_JJ tablets_NNS in_IN 6.5_CD c.c_NN ._.
of_IN distilled_VBN water36_VBP The_DT experiment_NN was_VBD repeated_VBN with_IN a_DT fresh_JJ muscle_NN nerve_NN preparation_NN ,_, using_VBG solution_NN B_NNP ,_, when_WRB the_DT maximum_JJ distance_NN separating_VBG the_DT coils_NNS and_CC giving_VBG an_DT effective_JJ stimulus_NN was_VBD found_VBN to_TO be_VB 24_CD c.m_NN ._.
before_IN and_CC 19_CD c.m_NN ._.
after_IN the_DT appli-_JJ cation_NN of_IN the_DT drug_NN ._.
Taking_VBG the_DT normal_JJ irritability_NN of_IN the_DT muscle_NN as_IN 100_CD ,_, the_DT old_JJ tablet_NN solution_NN reduces_NNS it_PRP by_IN 15_CD per_IN cent_NN ._.
and_CC the_DT new_JJ tablet_NN solution_NN by_IN 21_CD per_IN cent_NN ._.
(_( 3_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP OF_NNP PITHED_NNP FROG_NNP ._.
(_( See_VB Plates_NNPS XI_NNP and_CC XII_NNP ._. )_)
A_DT frog_NN was_VBD pithed_VBN and_CC its_PRP$ heart_NN exposed_VBN and_CC arranged_VBN for_IN recording_VBG con-_JJ tractions_NNS ._.
Normal_JJ contractions_NNS were_VBD recorded_VBN for_IN five_CD minutes_NNS (_( No_DT ._.
1_CD ,_, Plate_NNP XI_NNP )_) ._.
0.5_CD c.c_NN ._.
of_IN solution_NN A_NNP was_VBD then_RB allowed_VBN to_TO flow_VB slowly_RB over_IN the_DT heart_NN (_( No_UH ._.
2_CD ,_, Plate_NNP X_NNP )_) ._.
No_DT immediate_JJ effect_NN was_VBD perceptible_JJ ,_, but_CC in_IN the_DT course_NN of_IN one_CD minute_NN the_DT action_NN became_VBD perceptibly_RB slower_JJR ,_, the_DT rate_NN of_IN contraction_NN falling_VBG to_TO 75_CD per_IN cent_NN ._.
of_IN the_DT normal_JJ as_IN taken_VBN before_IN the_DT application_NN of_IN the_DT drug_NN (_( No_UH ._.
3_LS )_) ._.
This_DT diminution_NN in_IN rate_NN increased_VBD up_RB to_TO three_CD minutes_NNS after_IN the_DT application_NN of_IN the_DT drug_NN and_CC then_RB the_DT rate_NN remained_VBD constant_JJ until_IN the_DT end_NN of_IN the_DT experi-_JJ ment_NN (_( Nos_NNP ._.
4_CD ,_, 5_CD ,_, and_CC 6_CD )_) ._.
The_DT experiment_NN was_VBD repeated_VBN with_IN a_DT fresh_JJ frog_NN using_VBG solution_NN B_NNP ._.
A_DT nor-_JJ mal_NN tracing_NN was_VBD first_RB taken_VBN (_( No_UH ._.
1_CD ,_, Plate_NNP XII_NNP )_) ,_, and_CC then_RB the_DT drug_NN was_VBD applied_VBN ,_, (_( No_UH ._.
2_CD ,_, Plate_NNP X_NNP )_) ._.
No_DT immediate_JJ result_NN was_VBD seen_VBN ,_, but_CC in_IN the_DT course_NN of_IN the_DT next_JJ forty_NN seconds_VBZ the_DT rate_NN of_IN contraction_NN had_VBD become_VBN noticeably_RB slower_JJR (_( No_UH ._.
3_CD )_) ,_, and_CC at_IN the_DT end_NN of_IN one_CD minute_NN the_DT rate_NN of_IN contraction_NN had_VBD fallen_VBN to_TO 77_CD per_IN cent_NN ._.
of_IN the_DT normal_JJ as_IN taken_VBN before_IN the_DT application_NN of_IN the_DT drug_NN (_( No_UH ._.
4_CD )_) ._.
The_DT rate_NN gradually_RB got_VBD slower_JJR and_CC slower_JJR until_IN at_IN the_DT end_NN of_IN 7_CD minutes_NNS 30_CD seconds_NNS it_PRP had_VBD fallen_VBN to_TO 29_CD per_IN cent_NN ._.
of_IN the_DT normal_JJ ._.
The_DT slowing_NN was_VBD chiefly_JJ due_JJ to_TO prolongation_NN of_IN the_DT diastole_NN ,_, the_DT systole_NN being_VBG only_RB very_RB slightly_RB lengthened_VBN (_( Nos_NNP ._.
5_CD ,_, 6_CD ,_, and_CC 7_CD )_) ._.
This_DT condition_NN of_IN prolonged_JJ and_CC irregular_JJ diastole_JJ per-_NN sisted_VBD up_RB to_TO the_DT end_NN of_IN the_DT experiment_NN ._.
(_( 4_CD )_) EFFECT_NN ON_NNP CONTRACTION_NNP OF_NNP STRIPED_NNP MUSCLE_NNP OF_NNP FROG_NNP ._.
(_( See_VB Plate_NNP X_NNP ._. )_)
A_DT nerve_NN muscle_NN preparation_NN was_VBD dissected_VBN out_RP and_CC arranged_VBD to_TO record_VB con-_JJ tractions_NNS on_IN a_DT rapidly_RB moving_VBG drum_NN ,_, a_DT revolving_VBG contact-maker_NN being_VBG attached_VBN to_TO the_DT shaft_NN of_IN the_DT drum_NN in_IN such_JJ a_DT manner_NN that_WDT successive_JJ stimuli_NNS were_VBD applied_VBN at_IN the_DT same_JJ point_NN in_IN each_DT revolution_NN of_IN the_DT drum_NN ._.
A_DT muscle_NN curve_NN was_VBD then_RB recorded_VBN under_IN normal_JJ conditions_NNS (_( Plate_NNP X_NNP ,_, Chart_NNP 1_CD ,_, No_DT ._.
1_CD )_) ._.
0.25_CD c.c_NN ._.
of_IN solution_NN A_NNP was_VBD then_RB allowed_VBN to_TO flow_VB over_IN the_DT muscle_NN and_CC a_DT second_JJ curve_NN was_VBD recorded_VBN ,_, superimposed_VBN on_IN the_DT first_JJ ,_, two_CD minutes_NNS after_IN the_DT application_NN of_IN the_DT drug_NN (_( Chart_NNP 1_CD ,_, No_DT ._.
2_CD )_) ._.
37_CD The_DT experiment_NN was_VBD then_RB repeated_VBN with_IN a_DT fresh_JJ muscle_NN nerve_NN preparation_NN ,_, using_VBG solution_NN B_NNP (_( Plate_NNP X_NNP ,_, Chart_NNP 2_CD ,_, No_DT ._.
1_CD normal_JJ ,_, No_NNP ._.
2_CD drug_NN )_) ._.
In_IN the_DT case_NN of_IN solution_NN A_NNP ,_, the_DT only_JJ noticeable_JJ feature_NN in_IN the_DT drug_NN affected_VBD curve_NN is_VBZ a_DT diminution_NN in_IN speed_NN ,_, both_CC the_DT contraction_NN and_CC the_DT relaxation_NN being_VBG slower_JJR than_IN normal_JJ ._.
In_IN the_DT case_NN of_IN solution_NN B_NNP there_EX is_VBZ a_DT marked_JJ lengthening_NN of_IN the_DT latent_JJ period_NN ,_, a_DT slowing_NN of_IN the_DT whole_JJ contraction_NN ,_, and_CC a_DT diminution_NN in_IN its_PRP$ amplitude_NN ._.
The_DT results_NNS of_IN these_DT experiments_NNS show_VBP that_IN the_DT rapidity_NN of_IN solution_NN of_IN the_DT old_JJ tablets_NNS is_VBZ greatly_RB diminished_VBN ,_, and_CC ,_, although_IN they_PRP retain_VBP considerable_JJ emetic_JJ action_NN ,_, they_PRP have_VBP suffered_VBN a_DT marked_JJ loss_NN of_IN activity_NN when_WRB compared_VBN with_IN fresh_JJ tablets_NNS ._.
Physostigmine_NNP Salicylate_NNP ._.
(_( 0.01_CD grain_NN =_VBD 0.00065_CD gram_NN ._. )_)
Solubility.38_NNP No_NNP muscular_JJ twitchings_NNS ,_, loss_NN of_IN reflexes_NNS ,_, or_CC muscular_JJ weakness_NN were_VBD detected_VBN ._.
Both_DT frogs_NNS remained_VBD apparently_RB perfectly_RB normal_JJ ._.
(_( 4_CD )_) ACTION_NN WHEN_NNP APPLIED_NNP LOCALLY_NNP TO_NNP FROG_NNP 'S_POS MUSCLE_NNP ._.
(_( See_VB Plate_NNP XIII_NNP ._. )_)
A_DT nerve_NN muscle_NN preparation_NN was_VBD arranged_VBN for_IN recording_VBG contractions_NNS on_IN a_DT rapidly_RB moving_VBG drum_NN ._.
The_DT minimal_JJ stimulus_NN was_VBD obtained_VBN with_IN a_DT distance_NN of_IN 20_CD cm_NN ._.
between_IN the_DT coils_NNS ._.
A_DT normal_JJ contraction_NN was_VBD recorded_VBN with_IN the_DT secondary_JJ coil_NN at_IN a_DT distance_NN of_IN 20_CD cm_NN ._.
from_IN the_DT primary_JJ ,_, i.e._FW ,_, with_IN the_DT minimal_JJ stimulus_NN ._.
0.25_CD c.c_NN ._.
of_IN solution_NN A_NNP was_VBD then_RB applied_VBN to_TO the_DT muscle_NN and_CC five_CD minutes_NNS later_RBR curves_NNS were_VBD taken_VBN with_IN a_DT distance_NN between_IN the_DT coils_NNS of_IN 20_CD ,_, 22_CD ,_, and_CC 24_CD cm_NN ._.
(_( Chart_NNP 1_CD ,_, Plate_NNP XIII_NNP )_) ._.
The_DT minimal_JJ stimulus_NN was_VBD obtained_VBN at_IN 24_CD cm._NN ,_, beyond_IN which_WDT no_DT contrac-_NN tion_NN was_VBD elicited_VBN ._.
The_DT experiment_NN was_VBD repeated_VBN with_IN a_DT fresh_JJ muscle_NN nerve_NN preparation_NN and_CC solution_NN B_NNP and_CC very_RB similar_JJ results_NNS were_VBD obtained_VBN ,_, the_DT increased_JJ irritability_NN of_IN the_DT muscle_NN after_IN the_DT application_NN of_IN the_DT drug_NN not_RB ,_, however_RB ,_, being_VBG so_RB great_JJ ._.
The_DT minimal_JJ stimulus_NN was_VBD at_IN 24_CD cm_NN ._.
here_RB also_RB (_( Plate_NNP XIII_NNP ,_, Chart_NNP 2_CD )_) ._.
(_( 5_CD )_) VASO-CONSTRICTOR_CD ACTION_NNP ON_NNP PERIPHERAL_NNP VESSELS_NNP OF_NNP PITHED_NNP FROG_NNP ._.
The_DT arrangements_NNS for_IN perfusion_NN of_IN the_DT drug_NN were_VBD the_DT same_JJ as_IN in_IN the_DT case_NN of_IN digitalis_NN ._.
Each_DT frog_NN was_VBD first_RB perfused_VBN with_IN normal_JJ saline_JJ solution_NN till_NN bloodless_NN ,_, then_RB the_DT saline_JJ solution_NN traversing_VBG the_DT circulation_NN in_IN periods_NNS of_IN five_CD minutes_NNS was_VBD measured_VBN and_CC when_WRB the_DT flow_NN was_VBD fairly_RB constant_JJ ,_, saline_JJ solution_NN containing_VBG 0.2_CD per_IN cent_NN ._.
of_IN solution_NN A_NNP or_CC solution_NN B_NNP was_VBD perfused_VBN and_CC the_DT amount_NN flowing_VBG through_IN was_VBD measured_VBN ._.
Amount_NN passed_VBD in_IN successive_JJ 5-minute_JJ periods_NNS in_IN c.c_NN ._.
Normal_JJ Saline_NNP Solution_NNP ._.
Saline_NNP containing_VBG Solution_NNP A_NNP ._.
60_CD 56_CD 59_CD 51_CD 62_CD 48_CD 60_CD 47_CD 39_CD SECOND_JJ FROG_NNP ._.
Amount_NN passed_VBD in_IN successive_JJ 5-minute_JJ periods_NNS in_IN c.c_NN ._.
Normal_JJ Saline_NNP Solution_NNP ._.
Saline_NNP containing_VBG Solution_NNP B_NNP ._.
64_CD 62_CD 63_CD 59_CD 63_CD 58_CD 63_CD 52_CD 62_CD 50_CD In_IN both_DT cases_NNS the_DT vaso-constrictor_JJ action_NN was_VBD well_RB marked_VBN and_CC approxi-_JJ mately_RB equal_JJ ._.
(_( 6_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP OF_NNP PITHED_NNP FROG_NNP ._.
(_( See_VB Plates_NNPS XIV_NNP and_CC XV_NNP ._. )_)
Tracings_NNS were_VBD first_RB taken_VBN using_VBG 0.5_CD c.c_NN ._.
of_IN solution_NN A_NNP and_CC solution_NN B_NNP which_WDT were_VBD applied_VBN locally_RB to_TO the_DT heart_NN ._.
In_IN neither_DT case_NN was_VBD any_DT deviation_NN from_IN the_DT normal_JJ perceptible_JJ ._.
The_DT experiment_NN was_VBD then_RB repeated_VBN with_IN fresh_JJ frogs_NNS ,_, using_VBG stronger_JJR solu-_JJ tions_NNS ._.
A_DT normal_JJ tracing_NN was_VBD first_RB taken_VBN (_( Plate_NNP XIV_NNP ,_, No_NNP ._.
1_CD )_) ,_, and_CC then_RB 0.5_CD of_IN an_DT old_JJ tablet_NN dissolved_VBN in_IN 0.5_CD c.c_NN ._.
of_IN water_NN was_VBD allowed_VBN to_TO flow_VB over_IN the_DT heart_NN (_( No_UH ._.
2_CD )_) ._.
No_DT immediateeffect_NN was_VBD seen_VBN ,_, and_CC during_IN the_DT following_JJ 90_CD seconds_VBZ the_DT tracing_NN was_VBD identical_JJ with_IN that_DT taken_VBN before_IN the_DT application_NN of_IN the_DT drug_NN (_( Nos_NNP ._.
3_CD and_CC 4_CD )_) ;_: 2_CD minutes_NNS 3_CD seconds_NNS after_IN the_DT application_NN the_DT only_JJ alteration_NN in_IN the_DT action_NN was_VBD a_DT slight_JJ increase_NN in_IN the_DT auricular_JJ contraction_NN (_( No_UH ._.
5_CD )_) ,_, which_WDT gradually_RB passed_VBD off_RP (_( No_UH ._.
6_CD )_) ._.
The_DT experiment_NN was_VBD repeated_VBN using_VBG a_DT solution_NN of_IN fresh_JJ (_( 1910_CD )_) tablet_NN of_IN equal_JJ strength_NN on_IN a_DT fresh_JJ frog_NN ._.
Curves_NNS are_VBP shown_VBN (_( Plate_NNP XV_NNP ,_, Nos_NNP ._.
1_CD to_TO 6_CD )_) ,_, corres-_JJ ponding_NN to_TO those_DT shown_VBN in_IN the_DT case_NN of_IN the_DT old_JJ tablet_NN ._.
The_DT drug_NN has_VBZ very_RB little_JJ effect_NN ._.
The_DT foregoing_NN experiments_NNS indicate_VBP that_IN there_EX is_VBZ no_DT recordable_JJ deterioration_NN of_IN the_DT old_JJ tablets_NNS on_IN comparison_NN with_IN fresh_JJ ones_NNS ,_, the_DT action_NN of_IN both_DT being_VBG ,_, identical_JJ ._.
40_CD Strophanthin_NNP ._.
(_( 0.002_CD grain=0.00013_NN gram_NN ._. )_)
Rapidity_NN of_IN Solution.41_NNP (_( 2_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP (_( STRONGER_NNP SOLUTIONS_NNP )_) ._.
(_( See_VB Plates_NNPS XIX_NNP and_CC XX_NNP ._. )_)
Heart_NNP arranged_VBD as_IN before_RB and_CC normal_JJ tracing_NN taken_VBN (_( Plate_NNP XIX_NNP ,_, No_NNP ._.
1_CD )_) ._.
0.5_CD c.c_NN ._.
of_IN solution_NN C_NNP applied_VBD at_IN X_NNP (_( No_NNP ._.
2_CD )_) ._.
No_DT immediate_JJ effect_NN was_VBD produced_VBN ,_, but_CC at_IN the_DT end_NN of_IN 1_CD minute_NN the_DT rate_NN had_VBD slowed_VBN down_RP ._.
to_TO 93_CD per_IN cent_NN ._.
of_IN the_DT normal_JJ (_( No_UH ._.
3_CD )_) ,_, This_DT slowing_NN was_VBD transient_NN ,_, however_RB ,_, and_CC at_IN 2_CD minutes_NNS the_DT rate_NN was_VBD normal_JJ (_( No_UH ._.
4_CD )_) ,_, and_CC at_IN 3_CD minutes_NNS 40_CD seconds_VBZ the_DT rate_NN was_VBD some_DT 5_CD per_IN cent_NN ._.
over_IN normal_JJ (_( No_UH ._.
5_CD )_) ._.
The_DT contractions_NNS got_VBD slightly_RB weaker_JJR and_CC at_IN 7_CD minutes_NNS the_DT first_JJ prolonged_JJ diastole_NN was_VBD recorded_VBN (_( No_UH ._.
6_CD )_) ._.
prolonged_JJ diastole_NN kept_VBD recurring_VBG up_RP to_TO the_DT end_NN of_IN the_DT experiment_NN ,_, usually_RB at_IN intervals_NNS of_IN seven_CD beats_NNS (_( Nos_NNP ._.
7_CD and_CC 8_CD )_) ._.
The_DT experiment_NN was_VBD repeated_VBN with_IN solution_NN D_NNP and_CC a_DT fresh_JJ frog_NN ._.
The_DT result_NN was_VBD identical_JJ ,_, even_RB to_TO the_DT recurrence_NN of_IN the_DT prolonged_JJ diastole_NN at_IN intervals_NNS of_IN seven_CD beats_NNS ._.
(_( Plate_NNP XX_NNP ._. )_)
(_( 3_CD )_) EFFECT_NN ON_NNP CONTRACTION_NNP OF_NNP STRIPED_NNP MUSCLE_NNP OF_NNP FROG_NNP ._.
(_( See_VB Plate_NNP XXI_NNP ._. )_)
A_DT nerve_NN muscle_NN preparation_NN was_VBD arranged_VBN for_IN recording_VBG single_JJ contractions_NNS on_IN a_DT quickly_RB moving_VBG drum_NN with_IN an_DT automatic_JJ key_NN ._.
A_DT normal_JJ curve_NN was_VBD first_RB recorded_VBN ._.
0.5_CD c.c_NN ._.
of_IN solution_NN A_NNP was_VBD then_RB applied_VBN to_TO the_DT muscle_NN and_CC three_CD minutes_NNS later_RBR a_DT second_JJ contraction_NN was_VBD recorded_VBN ._.
The_DT curve_NN showed_VBD a_DT consider-_JJ able_JJ lengthening_NN of_IN the_DT latent_JJ period_NN ,_, and_CC a_DT slight_JJ lengthening_NN of_IN the_DT relaxation_NN period_NN ,_, as_RB well_RB as_IN a_DT smaller_JJR contraction_NN (_( Plate_NNP XXI_NNP ,_, Chart_NNP 1_CD )_) ._.
The_DT experiment_NN was_VBD repeated_VBN with_IN a_DT fresh_JJ muscle_NN nerve_NN preparation_NN using_VBG solution_NN B_NNP ._.
The_DT curves_NNS three_CD and_CC five_CD minutes_NNS after_IN the_DT application_NN of_IN the_DT drug_NN show_VBP the_DT same_JJ features_NNS as_IN in_IN the_DT case_NN of_IN solution_NN A_NNP except_IN that_IN the_DT curve_NN recorded_VBD after_IN three_CD minutes_NNS is_VBZ slightly_RB higher_JJR than_IN the_DT normal_JJ one_CD (_( Chart_NNP 2_CD )_) ._.
The_DT first_JJ experiment_NN would_MD show_VB the_DT old_JJ tablets_NNS to_TO be_VB considerably_RB more_RBR toxic_JJ than_IN the_DT fresh_JJ ,_, but_CC the_DT other_JJ experiments_NNS (_( several_JJ others_NNS were_VBD done_VBN giving_VBG results_NNS similar_JJ to_TO those_DT recorded_VBN )_) 42_CD dissolved_VBN in_IN 1_CD c.c_NN ._.
water_NN in_IN 65_CD seconds_NNS and_CC one_CD new_JJ tablet_NN dissolved_VBN in_IN an_DT equal_JJ quantity_NN in_IN 55_CD seconds_NNS ._.
(_( 1_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP OF_NNP PITHED_NNP FROG_NNP WHEN_NNP INJECTED_NNP INT_NNP )_) AURICLE_NNP ._.
(_( See_VB Plates_NNP XXII_NNP ,_, XXIII_NNP ,_, XXIV_NNP and_CC XXV_NNP ._. )_)
Two_CD solutions_NNS were_VBD made_VBN ,_, A_DT being_VBG one_CD old_JJ tablet_NN in_IN 10_CD c.c_NN ._.
of_IN normal_JJ saline_JJ solution_NN ,_, and_CC B_NNP being_VBG one_CD fresh_JJ tablet_NN in_IN an_DT equal_JJ amount_NN of_IN saline_NN ._.
The_DT heart_NN was_VBD arranged_VBN in_IN the_DT usual_JJ way_NN and_CC a_DT normal_JJ tracing_NN was_VBD first_RB recorded_VBN (_( Plate_NNP XXII_NNP ,_, No_NNP ._.
1_CD )_) ._.
0.5_CD c.c_NN ._.
of_IN solution_NN A_NNP was_VBD then_RB injected_VBN into_IN the_DT right_JJ auricle_NN with_IN a_DT hypodermic_JJ syringe_NN having_VBG a_DT very_RB fine_JJ needle_NN ._.
The_DT immediate_JJ effect_NN was_VBD a_DT well_NN marked_JJ increase_NN in_IN the_DT amplitude_NN of_IN the_DT contrac-_JJ tions_NNS ,_, the_DT rate_NN however_RB remaining_VBG the_DT same_JJ (_( No_UH ._.
2_CD )_) ._.
This_DT effect_NN lasted_VBD for_IN less_JJR than_IN a_DT minute_NN ,_, the_DT contractions_NNS dropping_VBG to_TO smaller_JJR than_IN the_DT normal_JJ and_CC also_RB quickening_VBG up_RP to_TO 7_CD per_IN cent_NN ._.
above_IN normal_JJ (_( Nos_NNP ._.
3_CD and_CC 4_CD )_) ._.
The_DT amplitude_NN of_IN the_DT contraction_NN continued_VBD to_TO diminish_VB up_RP to_TO the_DT end_NN of_IN the_DT experiment_NN (_( 30_CD minutes_NNS )_) ._.
The_DT rate_NN increased_VBD up_RB to_TO 18_CD per_IN cent_NN ._.
over_IN the_DT normal_JJ (_( Nos_NNP ._.
5_CD ,_, 6_CD ,_, 7_CD ,_, and_CC 8_CD )_) ._.
The_DT experiment_NN was_VBD repeated_VBN with_IN a_DT fresh_JJ frog_NN using_VBG 0.5_CD c.c_NN ._.
of_IN solution_NN B_NNP ._.
Plate_NNP XXIII_NNP ,_, No_NNP ._.
1_CD ,_, is_VBZ the_DT normal_JJ tracing_NN ._.
The_DT drug_NN was_VBD injected_VBN at_IN X_NNP (_( No_NNP ._.
2_CD )_) ,_, and_CC the_DT almost_RB immediate_JJ effect_NN was_VBD a_DT slowing_NN of_IN the_DT rate_NN of_IN contraction_NN to_TO 87_CD per_IN cent_NN ._.
of_IN the_DT normal_JJ ._.
There_EX was_VBD no_DT increase_NN in_IN the_DT amplitude_NN ._.
The_DT slowness_NN was_VBD maintained_VBN for_IN the_DT next_JJ 4_CD minutes_NNS and_CC 40_CD seconds_NNS (_( Nos_NNP ._.
3_CD and_CC 4_CD )_) ,_, when_WRB it_PRP gradually_RB dropped_VBD to_TO 82_CD per_IN cent_NN ._.
and_CC finally_RB to_TO 80_CD per_IN cent._NN ,_, the_DT amplitude_NN being_VBG greatly_RB diminished_VBN and_CC falling_VBG to_TO about_IN 65_CD per_IN cent_NN ._.
of_IN what_WP it_PRP was_VBD before_IN the_DT application_NN of_IN the_DT drug_NN (_( Nos_NNP ._.
5_CD ,_, 6_CD ,_, 7_CD ,_, and_CC 8_CD )_) ._.
(_( 2_CD )_) EFFECT_NN WHEN_NNP APPLIED_NNP TO_NNP EXTERNAL_NNP SURFACE_NNP OF_NNP ISOLATED_NNP HEART_NNP OF_NNP PITHED_NNP FROG_NNP ._.
In_IN this_DT experiment_NN stronger_JJR solutions_NNS were_VBD used_VBN ,_, solution_NN C_NNP consisting_VBG of_IN two_CD old_JJ tablets_NNS dissolved_VBN in_IN 2_CD c.c_NN ._.
of_IN water_NN and_CC solution_NN D_NNP being_VBG the_DT same_JJ but_CC made_VBD with_IN fresh_JJ tablets_NNS ._.
The_DT heart_NN was_VBD arranged_VBN as_IN usual_JJ and_CC a_DT normal_JJ tracing_NN taken_VBN ,_, Plate_NNP XXIV_NNP (_( No_NNP ._.
1_CD )_) ._.
0.5_CD c.c_NN ._.
of_IN solution_NN C_NNP was_VBD then_RB allowed_VBN to_TO flow_VB slowly_RB over_IN the_DT sur-_JJ face_NN of_IN the_DT heart_NN (_( No_UH ._.
2_CD )_) ._.
The_DT immediate_JJ effect_NN was_VBD a_DT slowing_VBG down_RP to_TO 90_CD per_IN cent_NN ._.
of_IN the_DT normal_JJ ._.
At_IN the_DT end_NN of_IN 1_CD minute_NN 40_CD seconds_VBZ the_DT rate_NN was_VBD again_RB normal_JJ and_CC the_DT tracing_NN was_VBD identical_JJ with_IN the_DT normal_JJ one_CD (_( No_UH ._.
3_LS )_) ._.
From_IN 43_CD this_DT point_NN onward_RB till_IN the_DT end_NN of_IN the_DT experiment_NN ,_, the_DT contractions_NNS remained_VBD the_DT same_JJ ,_, varying_VBG between_IN a_DT slight_NN slowing_VBG down_RB to_TO 95_CD per_IN cent_NN ._.
and_CC normal_JJ (_( Nos_NNP ._.
4_CD ,_, 5_CD ,_, 6_CD ,_, 7_CD ,_, and_CC 8_CD )_) ._.
The_DT experiment_NN was_VBD repeated_VBN using_VBG 0.5_CD c.c_NN ._.
of_IN solution_NN D._NNP (_( Plate_NNP XXV_NNP ._. )_)
The_DT immediate_JJ effect_NN was_VBD a_DT quickening_NN of_IN the_DT rate_NN to_TO 4_CD per_IN cent_NN ._.
over_IN nor-_JJ mal_NN (_( No_UH ._.
2_CD )_) ,_, but_CC this_DT was_VBD replaced_VBN 40_CD seconds_NNS after_IN the_DT application_NN of_IN the_DT drug_NN by_IN a_DT slowing_NN of_IN the_DT rate_NN to_TO 96_CD per_IN cent_NN ._.
of_IN the_DT normal_JJ (_( No_UH ._.
3_LS )_) ._.
2_CD minutes_NNS 30_CD seconds_NNS later_RB the_DT rate_NN was_VBD again_RB normal_JJ (_( No_UH ._.
4_CD )_) ,_, and_CC it_PRP remained_VBD normal_JJ to_TO the_DT end_NN of_IN the_DT experiment_NN (_( Nos_NNP ._.
5_CD ,_, 6_CD ,_, and_CC 7_CD )_) ._.
The_DT amplitude_NN throughout_IN was_VBD slightly_RB greater_JJR than_IN before_IN the_DT application_NN of_IN the_DT drug_NN and_CC the_DT action_NN of_IN the_DT heart_NN was_VBD regular_JJ ._.
(_( 3_CD )_) VASO-CONSTRICTOR_CD ACTION_NNP ON_NNP THE_NNP PERIPHERAL_NNP VESSELS_NNP OF_NNP PITHED_NNP FROG_NNP ._.
For_IN this_DT experiment_NN a_DT solution_NN of_IN five_CD tablets_NNS in_IN 25_CD c.c_NN ._.
of_IN water_NN was_VBD used_VBN ,_, A_DT being_VBG the_DT solution_NN of_IN the_DT old_JJ tablets_NNS and_CC B_NNP being_VBG that_IN of_IN the_DT fresh_NN ._.
The_DT usual_JJ arrangements_NNS for_IN perfusing_VBG the_DT fluid_NN through_IN the_DT peripheral_JJ circulation_NN of_IN the_DT frog_NN were_VBD made_VBN ,_, and_CC after_IN the_DT frog_NN was_VBD bloodless_NN and_CC the_DT rate_NN of_IN the_DT saline_JJ solution_NN flowing_VBG through_IN was_VBD fairly_RB constant_JJ ,_, norma_JJ saline_JJ solu-_JJ tion_NN containing_VBG 2_CD per_IN cent_NN ,_, of_IN the_DT drug_NN solution_NN was_VBD perfused_VBN and_CC the_DT effect_NN recorded_VBD ._.
The_DT results_NNS obtained_VBN are_VBP noted_VBN below:44_IN The_DT experiment_NN was_VBD repeated_VBN with_IN a_DT fresh_JJ frog_NN using_VBG first_JJ normal_JJ saline_JJ solution_NN and_CC then_RB saline_VB solution_NN containing_VBG 2_CD per_IN cent_NN ._.
of_IN solution_NN B_NNP ._.
The_DT figures_NNS obtained_VBN were_VBD as_IN follows:45_NN (_( 4_CD )_) ACTION_NN WHEN_NNP APPLIED_NNP LOCALLY_NNP TO_NNP EXPOSED_NNP MESENTERIC_NNP VESSELS_NNP OF_NNP PITHED_NNP FROG_NNP ._.
Two_CD frogs_NNS were_VBD pithed_VBN and_CC a_DT loop_NN of_IN intestine_NN of_IN each_DT with_IN its_PRP$ attached_JJ mesentery_NN was_VBD placed_VBN under_IN the_DT low_JJ power_NN of_IN a_DT microscope_NN ._.
To_TO the_DT mesentery_NN of_IN frog_JJ X_NNP 0.25_CD c.c_NN ._.
of_IN solution_NN A_NNP was_VBD applied_VBN and_CC to_TO the_DT mesentery_NN of_IN frog_NN Y_NNP ,_, 0.25_CD of_IN solution_NN B_NNP ._.
In_IN frog_JJ X_NNP circulation_NN was_VBD sluggish_JJ and_CC came_VBD to_TO a_DT stand46_NN In_IN all_DT four_CD cases_NNS the_DT results_NNS observed_VBD were_VBD identical_JJ ,_, namely_RB ,_, slight_VBD slowing_VBG and_CC diminution_NN of_IN reflexes_NNS on_IN cutaneous_JJ stimulation_NN ._.
No_DT loss_NN of_IN muscular_JJ power_NN ,_, no_DT spasms_NN and_CC no_DT effect_NN on_IN respiration_NN were_VBD perceptible_JJ ._.
(_( 2_CD )_) ACTION_NN WHEN_NNP APPLIED_NNP LOCALLY_NNP TO_NNP EXPOSED_NNP MESENTERIC_NNP VESSELS_NNP OF_NNP PITHED_NNP FROG_NNP ._.
Solution_NN A_DT and_CC solution_NN B_NNP produced_VBD the_DT same_JJ result_NN in_IN equal_JJ times_NNS ,_, namely_RB ,_, dilatation_NN of_IN vessels_NNS ,_, most_JJS marked_VBN in_IN the_DT arteries_NNS and_CC arterioles_NNS ._.
The_DT dilatation_NN was_VBD of_IN an_DT approximately_RB equal_JJ degree_NN ,_, and_CC in_IN both_DT cases_NNS stasis_NN occurred_VBD in_IN the_DT sixth_JJ minute_NN after_IN the_DT application_NN of_IN the_DT drug_NN ._.
(_( 3_CD )_) ACTION_NN ON_NNP CATS_NNP ,_, HYPODERMICALLY_NNP INJECTED_NNP ._.
Two_CD cats_NNS of_IN approximately_RB equal_JJ weight_NN were_VBD used_VBN ._.
One_CD cat_NN received_VBD one_CD old_JJ tablet_NN dissolved_VBN in_IN 1_CD c.c_NN ._.
of_IN water_NN and_CC hypodermically_RB injected_VBN ,_, the_DT other_JJ cat_NN receiving_VBG one_CD fresh_JJ tablet_NN in_IN similar_JJ fashion_NN ._.
The_DT animals_NNS remained_VBD under_IN observation_NN for_IN five_CD hours_NNS and_CC failed_VBD to_TO show_VB symptoms_NNS of_IN any_DT kind_NN ,_, apparently_RB remaining_VBG in_IN a_DT perfectly_RB normal_JJ state_NN ._.
No_DT difference_NN was_VBD detected_VBN between_IN the_DT behaviour_NN of_IN the_DT two_CD animals_NNS ._.
(_( 4_CD )_) ACTION_NN OF_NNP LARGER_NNP DOSE_NNP ON_NNP CAT_NNP HYPODERMICALLY_NNP INJECTED_NNP ._.
A_DT cat_NN weighing_VBG 1.6_CD kilos_NNS received_VBD two_CD old_JJ tablets_NNS in_IN solution_NN hypoder-_NN mically_RB ._.
Ten_CD minutes_NNS later_RB there_EX was_VBD salivation_NN ,_, frothy_JJ mucus_NN running_VBG from_IN the_DT mouth_NN ._.
The_DT cat_NN was_VBD drowsy_JJ and_CC lay_VBD down_RB and_CC could_MD not_RB be_VB made_VBN to_TO stand_VB or_CC move_VB by_IN stimuli_NNS such_JJ as_IN pricking_NN or_CC pinching_NN ._.
It_PRP would_MD not_RB touch_VB food_NN and_CC one_CD hour_NN after_IN the_DT injection_NN its_PRP$ pupils_NNS showed_VBD slight_JJ contraction_NN ._.
Two_CD and_CC a_DT half_NN hours_NNS after_IN the_DT injection_NN it_PRP took_VBD food_NN and_CC thereafter_VB its_PRP$ behaviour_NN was_VBD normal_JJ ._.
At_IN no_DT time_NN was_VBD there_RB any_DT appearance_NN of_IN excitement_NN ._.
Four_CD days_NNS later_RB ,_, the_DT same_JJ cat_NN ,_, having_VBG quite_RB recovered_VBN from_IN the_DT effects_NNS of_IN the_DT old_JJ tablets_NNS ,_, was_VBD given_VBN two_CD fresh_JJ tablets_NNS hypodermically_RB ._.
Within_IN five_CD minutes_NNS of_IN the_DT injection_NN mucus_NN and_CC froth_NN began_VBD to_TO run_VB from_IN its_PRP$ mouth_NN and_CC at_IN ten_JJ minutes_NNS the_DT cat_NN seemed_VBD drowsy_JJ and_CC lay_VBD down_RB ,_, moving_VBG its_PRP$ head_NN ._.
to_TO and_CC fro_VB laterally_RB for_IN five_CD minutes_NNS ._.
It_PRP could_MD not_RB be_VB made_VBN to_TO stand_VB ._.
One_CD hour_NN after_IN the_DT injection_NN it_PRP again_RB began_VBD to_TO move_VB its_PRP$ head_NN laterally_RB from_IN side_NN to_TO side_NN and_CC continued_VBD to_TO do_VB so_RB for_IN nearly_RB half_PDT an_DT hour_NN ._.
There_EX was_VBD slight_JJ contraction_NN of_IN the_DT pupil_NN ._.
It_PRP took_VBD food_NN 3Â¾_CD hours_NNS after_IN the_DT injection_NN ._.
At_IN no_DT time_NN were_VBD there_RB any_DT signs_NNS of_IN excitement_NN ._.
These_DT results_NNS fail_VBP to_TO show_VB any_DT difference_NN in_IN activity_NN between_IN the_DT old_JJ and_CC the_DT new_JJ tablets_NNS ._.
47_CD Atropine_NNP and_CC Morphine_NNP Sulphate_NNP ._.
(_( Atropin_NNP ._.
Sulph_NNP ._.
1/155_CD grain=0.00043_JJ gram_NN ._.
Morphin_NNP ._.
Sulph_NNP ._.
Â¼_JJ grain=0.0162_NN gram_NN ._. )_)
Action.48_NNP (_( 3_CD )_) ACTION_NN ON_NNP SKIN_NNP AND_NNP CENTRAL_NNP NERVOUS_NNP SYSTEM_NNP IN_NNP FROG_NNP ._.
Two_CD frogs_NNS were_VBD taken_VBN ;_: one_CD received_VBD 1_CD c.c_NN ._.
of_IN solution_NN A_NNP intraperitoneally_RB ,_, the_DT other_JJ receiving_VBG 1_CD c.c_NN ._.
of_IN solution_NN B_NNP in_IN the_DT same_JJ way_NN ._.
No_DT difference_NN between_IN the_DT two_CD was_VBD perceptible_JJ ._.
In_IN both_DT cases_NNS at_IN the_DT end_NN of_IN one_CD hour_NN there_EX was_VBD slight_JJ exaggeration_NN of_IN reflexes_NNS ._.
In_IN neither_DT case_NN was_VBD there_EX any_DT apparent_JJ inhibition_NN of_IN the_DT skin_JJ glands_NNS ._.
(_( 4_CD )_) PARALYSIS_NN OF_NNP VAGUS_NNP TERMINATIONS_NNP AS_NNP SHOWN_NNP IN_NNP ISOLATED_NNP HEART_NNP OF_NNP PITHED_NNP FROG_NNP ._.
(_( See_VB Plates_NNPS XXVI_NNP and_CC XXVII_NNP ._. )_)
A_DT frog_NN was_VBD pithed_VBN ,_, the_DT heart_NN exposed_VBD and_CC isolated_JJ ,_, and_CC arranged_VBD for_IN recording_VBG contractions_NNS ,_, the_DT vago-sympathetic_JJ having_VBG first_RB been_VBN exposed_VBN on_IN one_CD side_NN and_CC placed_VBD upon_IN a_DT pair_NN of_IN electrodes_NNS connected_VBN with_IN a_DT secondary_JJ coil_NN ._.
A_DT normal_JJ tracing_NN was_VBD first_RB taken_VBN (_( Plate_NNP XXVI_NNP ,_, No_NNP ._.
1_CD )_) ._.
The_DT vago-_JJ sympathetic_NN was_VBD then_RB stimulated_VBN for_IN ten_JJ seconds_NNS (_( No_DT ._.
2_CD )_) ._.
On_IN the_DT application_NN of_IN the_DT stimulus_NN all_PDT the_DT muscular_JJ structures_NNS were_VBD thrown_VBN into_IN contraction_NN so_IN that_IN the_DT heart_NN was_VBD retracted_VBN considerably_RB ,_, the_DT tracing_VBG moving_VBG proportionately_RB higher_JJR up_RP on_IN the_DT paper_NN ._.
Two_CD abortive_JJ beats_NNS occurred_VBD after_IN the_DT stimulus_NN was_VBD applied_VBN and_CC then_RB the_DT heart_NN 's_POS action_NN was_VBD entirely_RB inhibited_VBN until_IN the_DT current_JJ was_VBD stopped_VBN ,_, when_WRB the_DT heart_NN resumed_VBD its_PRP$ former_JJ position_NN and_CC began_VBD to_TO beat_VB again_RB ._.
The_DT beats_NNS were_VBD slower_JJR and_CC of_IN less_JJR amplitude_NN for_IN the_DT first_JJ 14_CD seconds_NNS ._.
Thereafter_RB they_PRP were_VBD first_JJ normal_JJ and_CC eventually_RB of_IN greater_JJR amplitude_NN than_IN normal_JJ (_( No_UH ._.
3_LS )_) ;_: 0.5_CD c.c_NN ._.
of_IN solution_NN A_NNP was_VBD then_RB allowed_VBN to_TO flow_VB slowly_RB over_IN the_DT heart_NN and_CC five_CD minutes_NNS later_RB the_DT vago-sympathetic_JJ was_VBD again_RB stimulated_VBN for_IN 13_CD seconds_NNS ._.
This_DT time_NN there_EX was_VBD no_DT stoppage_NN ,_, the_DT contractions_NNS only_RB showing_VBG slight_JJ irregularity_NN and_CC diminished_VBN amplitude_NN (_( No_UH ._.
4_CD )_) ._.
The_DT experiment_NN was_VBD repeated_VBN with_IN a_DT fresh_JJ frog_NN and_CC using_VBG solution_NN B_NNP ._.
Plate_NNP XXVII_NNP ,_, Curves_NNP Nos_NNP ._.
1_CD ,_, 2_CD ,_, 3_CD ,_, and_CC 4_CD ,_, show_VBP the_DT same_JJ phases_NNS as_IN are_VBP described_VBN above_IN ._.
Before_IN the_DT application_NN of_IN the_DT drug_NN ,_, stimulation_NN of_IN the_DT vago-sympathe-_JJ tic_JJ caused_VBD complete_JJ temporary_JJ stoppage_NN of_IN the_DT heart_NN 's_POS contraction_NN ,_, whereas_JJ vagal_JJ stimulation_NN five_CD minutes_NNS after_IN the_DT application_NN of_IN the_DT drug_NN failed_VBD to_TO stop_VB the_DT heart_NN and_CC led_VBD to_TO the_DT same_JJ results_NNS as_IN occurred_JJ in_IN the_DT case_NN of_IN solution_NN A_NNP ._.
Both_DT the_DT fresh_JJ and_CC the_DT old_JJ tablets_NNS ,_, therefore_RB ,_, show_VBP equal_JJ activity_NN in_IN para-_JJ lysing_VBG the_DT terminations_NNS of_IN the_DT vagi_NN ._.
These_DT results_NNS indicate_VBP that_IN the_DT old_JJ tablets_NNS have_VBP not_RB deteriorated_VBN and_CC that_IN they_PRP possess_VBP activity_NN equal_JJ to_TO that_DT of_IN the_DT fresh_NN (_( 1910_CD )_) tablets_NNS ._.
Summary_NNP of_IN results_NNS ._.
Aloin_NNP Compound.49_NNP Ammonium_NNP Carbonate.50_NNP dissolve_NN ._.
Their_PRP$ activity_NN ,_, physiologically_RB ,_, is_VBZ considerably_RB less_JJR than_IN that_DT of_IN the_DT new_JJ tablets_NNS ._.
Physostigmine_NNP Salicylate.51_NNP The_DT Effects_NNPS of_IN Chloride_NNP ,_, Sulphate_NNP ,_, Nitrate_NNP and_CC Nitrite_NNP Radicles_NNP of_IN some_DT common_JJ Bases_NNS on_IN the_DT frog_NN 's_POS heart_NN ,_, Cook_NNP ;_: (_( American_JJ Journal_NNP of_IN Physiology_NNP ,_, Vol_NNP ._.
XXIV_NN ,_, p._NN 263_CD ,_, May_NNP 1st_CD ,_, 1909_CD ._. )_)
The_DT Action_NNP of_IN Caffeine_NNP on_IN the_DT capacity_NN for_IN muscular_JJ work_NN ,_, Rivers_NNPS and_CC Webber_NNP ;_: (_( Journal_NNP of_IN Physiology_NNP ,_, Vol_NNP ._.
XXXVI_NN ,_, p._NN 33_CD ,_, August_NNP 27th_CD ,_, 1907_CD ._. )_)
Strychnine_NNP and_CC Reflex_NNP Inhibition_NNP of_IN Skeletal_NNP Muscle_NNP ,_, Sherrington_NNP ;_: (_( Journal_NNP of_IN Physio-_NNP logy_NN ,_, Vol_NNP ._.
XXXVI_NN ,_, p._NN 185_CD ,_, November_NNP 29th_CD ,_, 1907_CD ._. )_)
On_IN the_DT physiological_JJ action_NN of_IN the_DT seeds_NNS of_IN Garcia_NNP Nutans_NNP ,_, Omphalea_NNP Megacarpa_NNP ,_, and_CC Omphalea_NNP Triandra_NNP from_IN Trinidad_NNP ,_, Cash_NNP ;_: (_( Journal_NNP of_IN Physiology_NNP ,_, Vol_NNP ._.
XXXVI_NN ,_, p._NN 488_CD ,_, February_NNP 28th_CD ,_, 1908_CD ._. )_)
Concerning_VBG the_DT action_NN of_IN Curara_NNP and_CC Physostigmine_NNP upon_IN Nerve_NNP Endings_NNP or_CC Muscles_NNP ,_, Edmunds_NNP and_CC Roth_NNP ;_: (_( American_JJ Journal_NNP of_IN Physiology_NNP ,_, Vol_NNP ._.
XXIII_NN ,_, p._NN 28_CD ,_, October_NNP 1st_CD ,_, 1908_CD ._. )_)
The_DT Action_NNP of_IN the_DT Alkaloids_NNP of_IN the_DT PapaveraceÃ¦_NNP upon_IN the_DT isolated_JJ Frog_NNP s_JJ Heart_NNP ,_, Hale_NNP ;_: (_( American_JJ Journal_NNP of_IN Physiology_NNP ,_, Vol_NNP ._.
XXIII_NN ,_, p._NN 389_CD ,_, March_NNP 1st_CD ,_, 1909_CD ._. )_)
On_IN the_DT Munchi_NNP arrow_NN poison_NN and_CC Strophanthin_NNP ,_, Mines_NNP ;_: (_( Journal_NNP of_IN Physiology_NNP ,_, Vol_NNP ._.
XXXVII_NN ,_, p._NN 37_CD ,_, May_NNP 6th_CD ,_, 1908_CD ._. )_)
CALCUTTA_NN :_: SUPDT_NNP ._.
GOVT_NNP ._.
PRINTING_NN ,_, 8_CD ,_, HASTINGS_NNP STREET_NNP ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062335.tif_CD ]_JJ AMMONIUM_NNP CARBONATE_NNP ._.
FRESH_NNP TABLETS_NNP ._.
PLATE_NN I_PRP ._.
CHART_NNP 1_CD ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062341.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062341.tif_CD ]_JJ No_DT 3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062341.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062341.tif_CD ]_JJ AMMONIUM_NNP CARBONATE_NNP ,_, OLD_NNP TABLETS_NNP ._.
CHART_NNP 2_CD ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062341.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062341.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062341.tif_CD ]_JJ AMMONIUM_NNP CARBONATE_NNP ._.
FRESH_NNP TABLETS_NNP ._.
PLATE_NN I_PRP ._.
CHART_NNP 1_CD ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062344.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062344.tif_CD ]_JJ No_DT 3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062344.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062344.tif_CD ]_JJ AMMONIUM_NNP CARBONATE_NNP ,_, OLD_NNP TABLETS_NNP ._.
CHART_NNP 2_CD ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062344.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062344.tif_CD ]_JJ No_DT 3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062344.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062344.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062344.tif_CD ]_JJ No_NNP ._.
6_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062344.tif_CD ]_JJ No_NNP ._.
7_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062344.tif_CD ]_JJ PLATE_NNP II_NNP ._.
COLCHICINE_NNP SALICYLATE_NNP ,_, OLD_NNP TABLETS_NNP ._.
Chart_NNP 1_CD ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062350.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062350.tif_CD ]_NNS X_VBD 1_CD 57/.._CD
DOSE_NNP ._.
No_DT ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062350.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062350.tif_CD ]_NNS X_VBD 2_CD DOSE_NNP ._.
COLCHICINE_NNP SALICYLATE_NNP ,_, FRESH_NNP TABLETS_NNP ._.
Chart_NNP 2_CD ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062350.tif_CD ]_JJ No_NNP ._.
2_CD [_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062350.tif_CD ]_JJ X_NNP DRUG_NNP APPLIED_NNP ._.
No_DT ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062350.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062350.tif_CD ]_JJ X_NNP ANOTHER_NNP DOSE_NNP ._.
No_DT ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062350.tif_CD ]_JJ PLATE_NNP III_NNP ._.
COLCHICINE_NNP SALICYLATE_NNP ,_, OLD_NNP TABLETS_NNP ,_, Chart_NNP 1_CD ._.
Muscle_NNP Curve_NNP ,_, (_( a_DT )_) Normal_NNP ._.
(_( b_NN )_) Two_CD minutes_NNS after_IN application_NN of_IN drug_NN ._.
(_( c_NN )_) Five_CD PLATE_NNP IV_NNP ._.
CHART_NNP No_NNP ._.
1_CD ._.
CAFFEINE_NNP ,_, OLD_NNP TABLETS_NNP ,_, EFFECT_NNP ON_NNP STRIPED_NNP MUSCLE_NNP ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062362.tif_CD ]_JJ CHART_NNP No_NNP ._.
2_CD ._.
CAFFEINE_NNP ,_, FRESH_NNP TABLETS_NNP ,_, EFFECT_NNP ON_NNP STRIPED_NNP MUSCLE_NNP ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062362.tif_CD ]_JJ Normal_NNP ._.
PLATE_NNP V_NNP CAFFEINE_NNP ,_, OLD_NNP TABLETS_NNP ,_, EFFECT_NNP ON_NNP ISOLATED_NNP HEART_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062368.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062368.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062368.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062368.tif_CD ]_JJ PLATE_NNP V_NNP CAFFEINE_NNP ,_, OLD_NNP TABLETS_NNP ,_, EFFECT_NNP ON_NNP ISOLATED_NNP HEART_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062371.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062371.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062371.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062371.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062371.tif_CD ]_JJ No_NNP ._.
6_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062371.tif_CD ]_JJ No_NNP ._.
7_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062371.tif_CD ]_JJ PLATE_NNP VI_NNP ._.
(_( CAFFEINE_NNP ,_, FRESH_NNP TABLETS_NNP )_) ,_, EFFECT_NNP ON_NNP ISOLATED_NNP HEART_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062377.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062377.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062377.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062377.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062377.tif_CD ]_JJ PLATE_NNP VI_NNP ._.
(_( CAFFEINE_NNP ,_, FRESH_NNP TABLETS_NNP )_) ,_, EFFECT_NNP ON_NNP ISOLATED_NNP HEART_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062380.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062380.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062380.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062380.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062380.tif_CD ]_JJ No_NNP ._.
6_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062380.tif_CD ]_JJ No_NNP ._.
7_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062380.tif_CD ]_JJ No_NNP ._.
8_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062380.tif_CD ]_JJ PLATE_NNP VII_NNP ._.
TINCT_NNP ._.
DIGITALIS_NNP ;_: EXPERIMENT_NNP 1_CD ._.
Solution_NN A_DT ._.
EFFECT_NN ON_NNP ISOLATED_NNP HEART_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062386.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062386.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062386.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062386.tif_CD ]_JJ TINCT_NNP ._.
DIGITALIS_NNP ;_: EXPERIMENT_NNP 2_CD ._.
Solution_NNP C._NNP EFFECT_NNP ON_NNP ISOLATED_NNP HEART_NNP ._.
A_DT ._.
PLATE_NNP VII_NNP ._.
TINCT_NNP ._.
DIGITALIS_NNP ;_: EXPERIMENT_NNP 1_CD ._.
Solution_NN A_DT ._.
EFFECT_NN ON_NNP ISOLATED_NNP HEART_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062389.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062389.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062389.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062389.tif_CD ]_JJ TINCT_NNP ._.
DIGITALIS_NNP ;_: EXPERIMENT_NNP 2_CD ._.
Solution_NNP C._NNP EFFECT_NNP ON_NNP ISOLATED_NNP HEART_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062389.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062389.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062389.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062389.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062389.tif_CD ]_JJ PLATE_NNP VIII_NNP ._.
TINCT_NNP ._.
DIGITALIS_NNP ;_: EXPERIMENT_NNP 2_CD ._.
Solution_NNP D._NNP EFFECT_NNP ON_NNP ISOLATED_NNP HEART_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062395.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062395.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062395.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062395.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062395.tif_CD ]_JJ No_NNP ._.
6_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062395.tif_CD ]_JJ TINCT_NNP ._.
DIGITALIS_NNP ;_: EXPERIMENT_NNP 3_CD ._.
EFFECT_NN ON_NNP ISOLATED_NNP HEART_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062395.tif_CD ]_JJ PLATE_NNP IX_NNP ._.
TINCT_NNP ._.
DIGITALIS_NNP ;_: EXPERIMENT_NNP 4_CD ._.
EFFECT_NN ON_NNP ISOLATED_NNP HEART_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062401.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062401.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062401.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062401.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062401.tif_CD ]_JJ TINCT_NNP ._.
DIGITALIS_NNP ;_: EXPERIMENT_NNP 5_CD ._.
EFFECT_NN ON_NNP ISOLATED_NNP HEART_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062401.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062401.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062401.tif_CD ]_JJ PLATE_NNP X._NNP TABLETS_NNP APOMORPHINUM_NNP HYDROCHLORIDUM_NNP ._.
ACTION_NNP ON_NNP STRIPED_NNP MUSCLE_NNP ._.
Chart_NNP 1_CD ,_, Solution_NNP A_NNP ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062407.tif_CD ]_JJ Chart_NNP 2_CD ,_, Solution_NNP B_NNP ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062407.tif_CD ]_JJ PLATE_NNP XI_NNP ._.
TABLETS_NNP APOMORPHINUM_NNP HYDROCHLORIDUM_NNP ._.
ACTION_NNP ON_NNP ISOLATED_NNP HEART_NNP ._.
Solution_NN A_DT ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062413.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062413.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062413.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062413.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062413.tif_CD ]_JJ No_NNP ._.
6_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062413.tif_CD ]_JJ PLATE_NNP XII_NNP ._.
TABLETS_NNP APOMORPHINUM_NNP HYDROCHLORIDUM_NNP ._.
ACTION_NNP ON_NNP ISOLATED_NNP HEART_NNP ._.
Solution_NN B_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062419.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062419.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062419.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062419.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062419.tif_CD ]_JJ No_NNP ._.
6_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062419.tif_CD ]_JJ No_NNP ._.
7_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062419.tif_CD ]_JJ PLATE_NNP XIII_NNP ._.
TABLETS_NNP PHYSOSTIGMINAE_NNP SALICYLAS_NNP ._.
(_( 4_CD )_) ACTION_NN ON_NNP STRIPED_NNP MUSCLE_NNP ._.
Chart_NNP 1_CD ,_, Solution_NNP A_NNP ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062425.tif_CD ]_JJ Chart_NNP 2_CD ,_, Solution_NNP B_NNP ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062425.tif_CD ]_JJ PLATE_NNP XIV_NNP ._.
PHYSOSTIGMINAE_NNP SALICYLAS_NNP ._.
ACTION_NNP ON_NNP ISOLATED_NNP HEART_NNP ,_, OLD_NNP TABLET_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062431.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062431.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062431.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062431.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062431.tif_CD ]_JJ No_NNP ._.
6_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062431.tif_CD ]_JJ PLATE_NNP XV_NNP ._.
PHYSOSTIGMINAE_NNP SALICYLAS_NNP ._.
ACTION_NNP ON_NNP ISOLATED_NNP HEART_NNP ,_, NEW_NNP TABLET_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062437.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062437.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062437.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062437.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062437.tif_CD ]_JJ No_NNP ._.
6_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062437.tif_CD ]_JJ PLATE_NNP XVI_NNP ._.
STROPHANTHIN_NNP ._.
(_( 1_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP OF_NNP PITHED_NNP FROG_NNP ._.
Solution_NN A_DT ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062443.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062443.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062443.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062443.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062443.tif_CD ]_JJ No_NNP ._.
6_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062443.tif_CD ]_JJ No_NNP ._.
7_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062443.tif_CD ]_JJ No_NNP ._.
8_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062443.tif_CD ]_JJ PLATE_NNP XVII_NNP ._.
STROPHANTHIN_NNP ._.
(_( 1_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP ._.
Solution_NN B_NNP ,_, first_JJ experiment_NN ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062449.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062449.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062449.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062449.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062449.tif_CD ]_JJ No_NNP ._.
6_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062449.tif_CD ]_JJ No_NNP ._.
7_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062449.tif_CD ]_JJ PLATE_NNP XVIII_NNP ._.
STROPHANTHIN_NNP ._.
(_( 1_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP ._.
Solution_NN B_NNP ,_, second_JJ experiment_NN ._.
No_DT ._.
1a_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062455.tif_CD ]_JJ No_NNP ._.
2a_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062455.tif_CD ]_JJ No_NNP ._.
3a_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062455.tif_CD ]_JJ No_NNP ._.
4a_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062455.tif_CD ]_JJ No_NNP ._.
5a_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062455.tif_CD ]_JJ No_NNP ._.
6a_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062455.tif_CD ]_JJ No_NNP ._.
7a_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062455.tif_CD ]_JJ PLATE_NNP XIX_NNP ._.
STROPHANTHIN_NNP ._.
(_( 2_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP ._.
Solution_NNP C._NNP No_NNP ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062461.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062461.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062461.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062461.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062461.tif_CD ]_JJ No_NNP ._.
6_CD [_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062461.tif_CD ]_JJ No_NNP ._.
7_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062461.tif_CD ]_JJ No_NNP ._.
8_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062461.tif_CD ]_JJ PLATE_NNP XX_NNP ._.
STROPHANTHIN_NNP ._.
(_( 2_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP ._.
Solution_NNP D._NNP No_NNP ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062467.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062467.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062467.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062467.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062467.tif_CD ]_JJ No_NNP ._.
6_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062467.tif_CD ]_JJ No_NNP ._.
7_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062467.tif_CD ]_JJ No_NNP ._.
8_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062467.tif_CD ]_JJ PLATE_NNP XXI_NNP ._.
STROPHANTHIN_NNP ._.
(_( 3_CD )_) ACTION_NN ON_NNP STRIPED_NNP MUSCLE_NNP ._.
Chart_NNP 1_CD ,_, Solution_NNP A_NNP ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062473.tif_CD ]_JJ Chart_NNP 2_CD ,_, Solution_NNP B_NNP ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062473.tif_CD ]_JJ PLATE_NNP XXII_NNP ._.
DIGITALIN_NNP ._.
(_( 1_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP ._.
Solution_NN A_DT ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062479.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062479.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062479.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062479.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062479.tif_CD ]_JJ No_NNP ._.
6_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062479.tif_CD ]_JJ No_NNP ._.
7_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062479.tif_CD ]_JJ No_NNP ._.
8_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062479.tif_CD ]_JJ PLATE_NNP XXIII_NNP ._.
DIGITALIN_NNP ._.
(_( 1_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP ._.
Solution_NN B_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062485.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062485.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062485.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062485.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062485.tif_CD ]_JJ No_NNP ._.
6_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062485.tif_CD ]_JJ No_NNP ._.
7_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062485.tif_CD ]_JJ No_NNP ._.
8_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062485.tif_CD ]_JJ PLATE_NNP XXIV_NNP ._.
DIGITALIN_NNP ._.
(_( 2_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP ._.
Solution_NNP C._NNP No_NNP ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062491.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062491.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062491.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062491.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062491.tif_CD ]_JJ No_NNP ._.
6_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062491.tif_CD ]_JJ No_NNP ._.
7_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062491.tif_CD ]_JJ No_NNP ._.
8_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062491.tif_CD ]_JJ PLATE_NNP XXV_NNP ._.
DIGITALIN_NNP ._.
(_( 2_CD )_) ACTION_NN ON_NNP ISOLATED_NNP HEART_NNP ._.
Solution_NNP D._NNP No_NNP ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062497.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062497.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062497.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062497.tif_CD ]_JJ No_NNP ._.
5_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062497.tif_CD ]_JJ No_NNP ._.
6_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062497.tif_CD ]_JJ No_NNP ._.
7_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062497.tif_CD ]_JJ PLATE_NNP XXVI_NNP ._.
ATROPINE_NNP AND_NNP MORPHINE_NNP ._.
(_( 4_CD )_) PARALYSIS_NN OF_NNP VAGUS_NNP TERMINATIONS_NNP ._.
Solution_NN A_DT ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062503.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062503.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062503.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062503.tif_CD ]_JJ PLATE_NNP XXVII_NNP ._.
ATROPINE_NNP AND_NNP MORPHINE_NNP ._.
(_( 4_CD )_) PARALYSIS_NN OF_NNP VAGUS_NNP TERMINATIONS_NNP ._.
Solution_NN B_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062509.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062509.tif_CD ]_JJ No_NNP ._.
3_CD ._.
PLATE_NNP XXVII_NNP ._.
ATROPINE_NNP AND_NNP MORPHINE_NNP ._.
(_( 4_CD )_) PARALYSIS_NN OF_NNP VAGUS_NNP TERMINATIONS_NNP ._.
Solution_NN B_NNP ._.
No_DT ._.
1_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062512.tif_CD ]_JJ No_NNP ._.
2_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062512.tif_CD ]_JJ No_NNP ._.
3_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062512.tif_CD ]_JJ No_NNP ._.
4_CD ._.
[_JJ NLS_NNP note_NN :_: a_DT graphic_JJ appears_VBZ here_RB -_: see_VBP image_NN of_IN 75062512.tif_CD ]_JJ Reg_NNP ._.
No.4269_NNP E.,11_NNP ._.
